Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Soldano Ferrone, Ph.D., M.D.

TitleProfessor in Residence of Surgery
InstitutionMassachusetts General Hospital
DepartmentSurgery
AddressMassachusetts General Hospital
Yaw 7
55 Fruit St
Boston MA 02114
Phone617/724-3868
vCardDownload vCard (login for email)

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Ali TH, Pisanti S, Ciaglia E, Mortarini R, Anichini A, Garofalo C, Tallerico R, Santinami M, Gulletta E, Ietto C, Galgani M, Matarese G, Bifulco M, Ferrone S, Colucci F, Moretta A, Kärre K, Carbone E. Enrichment of CD56(dim)KIR+CD57+ highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients. Nat Commun. 2014; 5:5639.
    View in: PubMed
  2. Sucker A, Zhao F, Real B, Heeke C, Bielefeld N, Maßen S, Horn S, Moll I, Maltaner R, Horn PA, Schilling B, Sabbatino F, Lennerz V, Kloor M, Ferrone S, Schadendorf D, Falk CS, Griewank K, Paschen A. Genetic evolution of T-cell resistance in the course of melanoma progression. Clin Cancer Res. 2014 Dec 15; 20(24):6593-604.
    View in: PubMed
  3. Ferrone S. Therapeutic monoclonal antibodies: introduction. Semin Oncol. 2014 Oct; 41(5):556-8.
    View in: PubMed
  4. Sabbatino F, Fusciello C, Somma D, Pacelli R, Poudel R, Pepin D, Leonardi A, Carlomagno C, Della Vittoria Scarpati G, Ferrone S, Pepe S. Effect of p53 activity on the sensitivity of human glioblastoma cells to PARP-1 inhibitor in combination with topoisomerase i inhibitor or radiation. Cytometry A. 2014 Nov; 85(11):953-61.
    View in: PubMed
  5. Beard RE, Zheng Z, Lagisetty KH, Burns WR, Tran E, Hewitt SM, Abate-Daga D, Rosati SF, Fine HA, Ferrone S, Rosenberg SA, Morgan RA. Multiple chimeric antigen receptors successfully target chondroitin sulfate proteoglycan 4 in several different cancer histologies and cancer stem cells. J Immunother Cancer. 2014; 2:25.
    View in: PubMed
  6. Sabbatino F, Wang Y, Wang X, Schwab JH, Ferrone S, Ferrone CR. Novel tumor antigen-specific monoclonal antibody-based immunotherapy to eradicate both differentiated cancer cells and cancer-initiating cells in solid tumors. Semin Oncol. 2014 Oct; 41(5):685-99.
    View in: PubMed
  7. Wang Y, Li W, Patel SS, Cong J, Zhang N, Sabbatino F, Liu X, Qi Y, Huang P, Lee H, Taghian A, Li JJ, DeLeo AB, Ferrone S, Epperly MW, Ferrone CR, Ly A, Brachtel EF, Wang X. Blocking the formation of radiation-induced breast cancer stem cells. Oncotarget. 2014 Jun 15; 5(11):3743-55.
    View in: PubMed
  8. Riccardo F, Iussich S, Maniscalco L, Lorda Mayayo S, La Rosa G, Arigoni M, De Maria R, Gattino F, Lanzardo S, Lardone E, Martano M, Morello E, Prestigio S, Fiore A, Quaglino E, Zabarino S, Ferrone S, Buracco P, Cavallo F. CSPG4-Specific Immunity and Survival Prolongation in Dogs with Oral Malignant Melanoma Immunized with Human CSPG4 DNA. Clin Cancer Res. 2014 Jul 15; 20(14):3753-62.
    View in: PubMed
  9. Shen JK, Cote GM, Choy E, Yang P, Harmon D, Schwab J, Nielsen GP, Chebib I, Ferrone S, Wang X, Wang Y, Mankin H, Hornicek FJ, Duan Z. Programmed cell death ligand 1 expression in osteosarcoma. Cancer Immunol Res. 2014 Jul; 2(7):690-8.
    View in: PubMed
  10. Sabbatino F, Wang Y, Wang X, Flaherty KT, Yu L, Pepin D, Scognamiglio G, Pepe S, Kirkwood JM, Cooper ZA, Frederick DT, Wargo JA, Ferrone S, Ferrone CR. PDGFRa up-regulation mediated by sonic hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation. Oncotarget. 2014 Apr 15; 5(7):1926-41.
    View in: PubMed
  11. Leone P, Di Tacchio M, Berardi S, Santantonio T, Fasano M, Ferrone S, Vacca A, Dammacco F, Racanelli V. Dendritic cell maturation in HCV infection: Altered regulation of MHC class I antigen processing-presenting machinery. J Hepatol. 2014 Aug; 61(2):242-51.
    View in: PubMed
  12. Della Vittoria Scarpati G, Fusciello C, Perri F, Sabbatino F, Ferrone S, Carlomagno C, Pepe S. Ipilimumab in the treatment of metastatic melanoma: management of adverse events. Onco Targets Ther. 2014; 7:203-9.
    View in: PubMed
  13. Morandi F, Di Carlo E, Ferrone S, Petretto A, Pistoia V, Airoldi I. IL-27 in Human Secondary Lymphoid Organs Attracts Myeloid Dendritic Cells and Impairs HLA Class I-Restricted Antigen Presentation. J Immunol. 2014 Mar 15; 192(6):2634-42.
    View in: PubMed
  14. Sconocchia G, Eppenberger-Castori S, Zlobec I, Karamitopoulou E, Arriga R, Coppola A, Caratelli S, Spagnoli GC, Lauro D, Lugli A, Han J, Iezzi G, Ferrone C, Ferlosio A, Tornillo L, Droeser R, Rossi P, Attanasio A, Ferrone S, Terracciano L. HLA Class II Antigen Expression in Colorectal Carcinoma Tumors as a Favorable Prognostic Marker. Neoplasia. 2014 Jan; 16(1):31-42.
    View in: PubMed
  15. Gameiro SR, Jammeh ML, Wattenberg MM, Tsang KY, Ferrone S, Hodge JW. Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing. Oncotarget. 2014 Jan; 5(2):403-16.
    View in: PubMed
  16. Wang Y, Sabbatino F, Wang X, Ferrone S. Detection of Chondroitin Sulfate Proteoglycan 4 (CSPG4) in Melanoma. Methods Mol Biol. 2014; 1102:523-35.
    View in: PubMed
  17. Geldres C, Savoldo B, Hoyos V, Caruana I, Zhang M, Yvon E, Del Vecchio M, Creighton CJ, Ittmann M, Ferrone S, Dotti G. T Lymphocytes Redirected against the Chondroitin Sulfate Proteoglycan-4 Control the Growth of Multiple Solid Tumors both In Vitro and In Vivo. Clin Cancer Res. 2014 Feb 15; 20(4):962-71.
    View in: PubMed
  18. Volonté A, Di Tomaso T, Spinelli M, Todaro M, Sanvito F, Albarello L, Bissolati M, Ghirardelli L, Orsenigo E, Ferrone S, Doglioni C, Stassi G, Dellabona P, Staudacher C, Parmiani G, Maccalli C. Cancer-Initiating Cells from Colorectal Cancer Patients Escape from T Cell-Mediated Immunosurveillance In Vitro through Membrane-Bound IL-4. J Immunol. 2014 Jan 1; 192(1):523-32.
    View in: PubMed
  19. Fauci JM, Sabbatino F, Wang Y, Londoño-Joshi AI, Straughn JM, Landen CN, Ferrone S, Buchsbaum DJ. Monoclonal antibody-based immunotherapy of ovarian cancer: Targeting ovarian cancer cells with the B7-H3-specific mAb 376.96. Gynecol Oncol. 2014 Jan; 132(1):203-10.
    View in: PubMed
  20. Sabbatino F, Wang Y, Wang X, Ferrone S, Ferrone CR. Emerging BRAF inhibitors for melanoma. Expert Opin Emerg Drugs. 2013 Dec; 18(4):431-43.
    View in: PubMed
  21. Morandi B, Bonaccorsi I, Mesiti M, Conte R, Carrega P, Costa G, Iemmo R, Martini S, Ferrone S, Cantoni C, Mingari MC, Moretta L, Ferlazzo G. Characterization of human afferent lymph dendritic cells from seroma fluids. J Immunol. 2013 Nov 1; 191(9):4858-66.
    View in: PubMed
  22. Scarpati GD, Fusciello C, Sabbatino F, Ferrone S, Caponigro F, Perri F, Carlomagno C, Pepe S. Multidisciplinary approach to patient with malignant melanoma. Anticancer Agents Med Chem. 2013 Jul 1; 13(6):887-900.
    View in: PubMed
  23. Ascierto PA, Grimaldi AM, Acquavella N, Borgognoni L, Calabrò L, Cascinelli N, Cesano A, Del Vecchio M, Eggermont AM, Faries M, Ferrone S, Fox BA, Gajewski TF, Galon J, Gnjatic S, Gogas H, Kashani-Sabet M, Kaufman HL, Larkin J, Lo RS, Mantovani A, Margolin K, Melief C, McArthur G, Palmieri G, Puzanov I, Ribas A, Seliger B, Sosman J, Suenaert P, Tarhini AA, Trinchieri G, Vidal-Vanaclocha F, Wang E, Ciliberto G, Mozzillo N, Marincola FM, Thurin M. Future perspectives in melanoma research. Meeting report from the "Melanoma Bridge. Napoli, December 2nd-4th 2012". J Transl Med. 2013; 11:137.
    View in: PubMed
  24. Hamilton R, Krauze M, Romkes M, Omolo B, Konstantinopoulos P, Reinhart T, Harasymczuk M, Wang Y, Lin Y, Ferrone S, Whiteside T, Bortoluzzi S, Werley J, Nukui T, Fallert-Junecko B, Kondziolka D, Ibrahim J, Becker D, Kirkwood J, Moschos S. Pathologic and gene expression features of metastatic melanomas to the brain. Cancer. 2013 Aug 1; 119(15):2737-46.
    View in: PubMed
  25. Eisenberg G, Uzana R, Pato A, Frankenburg S, Merims S, Yefenof E, Ferrone S, Peretz T, Machlenkin A, Lotem M. Imprinting of lymphocytes with melanoma antigens acquired by trogocytosis facilitates identification of tumor-reactive T cells. J Immunol. 2013 Jun 1; 190(11):5856-65.
    View in: PubMed
  26. Hodge JW, Garnett CT, Farsaci B, Palena C, Tsang KY, Ferrone S, Gameiro SR. Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death. Int J Cancer. 2013 Aug 1; 133(3):624-36.
    View in: PubMed
  27. Srivastava RM, Lee SC, Andrade Filho PA, Lord CA, Jie HB, Davidson HC, López-Albaitero A, Gibson SP, Gooding WE, Ferrone S, Ferris RL. Cetuximab-activated natural killer and dendritic cells collaborate to trigger tumor antigen-specific T-cell immunity in head and neck cancer patients. Clin Cancer Res. 2013 Apr 1; 19(7):1858-72.
    View in: PubMed
  28. Yeung JT, Hamilton RL, Ohnishi K, Ikeura M, Potter DM, Nikiforova MN, Ferrone S, Jakacki RI, Pollack IF, Okada H. LOH in the HLA class I region at 6p21 is associated with shorter survival in newly diagnosed adult glioblastoma. Clin Cancer Res. 2013 Apr 1; 19(7):1816-26.
    View in: PubMed
  29. Schilling B, Harasymczuk M, Schuler P, Egan J, Ferrone S, Whiteside TL. IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cells. PLoS One. 2013; 8(2):e47234.
    View in: PubMed
  30. Leibowitz MS, Srivastava RM, Andrade Filho PA, Egloff AM, Wang L, Seethala RR, Ferrone S, Ferris RL. SHP2 is overexpressed and inhibits pSTAT1-mediated APM component expression, T-cell attracting chemokine secretion, and CTL recognition in head and neck cancer cells. Clin Cancer Res. 2013 Feb 15; 19(4):798-808.
    View in: PubMed
  31. Loustau M, Wiendl H, Ferrone S, Carosella ED. HLA-G 2012 conference: the 15-year milestone update. Tissue Antigens. 2013 Mar; 81(3):127-36.
    View in: PubMed
  32. Sabbatino F, Ferrone S. Can the "right" EGFR-specific mAb dramatically improve EGFR-targeted therapy? Clin Cancer Res. 2013 Mar 1; 19(5):958-60.
    View in: PubMed
  33. Sabbatino F, Schwab JH, Ferrone S, Ferrone CR. Evolution of studies of HLA class I antigen processing machinery (APM) components in malignant cells. Clin Transpl. 2013; 453-63.
    View in: PubMed
  34. Whiteside TL, Ferrone S. IGKC and prognosis in breast cancer--response to Schmidt. Clin Cancer Res. 2013 Jan 1; 19(1):305.
    View in: PubMed
  35. Ferrone S. A tribute to Edgardo Carosella on the occasion of the 6th International Conference on HLA-G held in Paris, France, July 9-11, 2012. Hum Immunol. 2013 Apr; 74(4):405.
    View in: PubMed
  36. Wastowski IJ, Simões RT, Yaghi L, Donadi EA, Pancoto JT, Poras I, Lechapt-Zalcman E, Bernaudin M, Valable S, Carlotti CG, Flajollet S, Jensen SS, Ferrone S, Carosella ED, Kristensen BW, Moreau P. Human leukocyte antigen-G is frequently expressed in glioblastoma and may be induced in vitro by combined 5-aza-2'-deoxycytidine and interferon-? treatments: results from a multicentric study. Am J Pathol. 2013 Feb; 182(2):540-52.
    View in: PubMed
  37. Sconocchia G, Arriga R, Tornillo L, Terracciano L, Ferrone S, Spagnoli GC. Melanoma cells inhibit NK cell functions. Cancer Res. 2012 Oct 15; 72(20):5428-9; author reply 5430.
    View in: PubMed
  38. Fauci JM, Straughn JM, Ferrone S, Buchsbaum DJ. A review of B7-H3 and B7-H4 immune molecules and their role in ovarian cancer. Gynecol Oncol. 2012 Nov; 127(2):420-5.
    View in: PubMed
  39. Rivera Z, Ferrone S, Wang X, Jube S, Yang H, Pass HI, Kanodia S, Gaudino G, Carbone M. CSPG4 as a target of antibody-based immunotherapy for malignant mesothelioma. Clin Cancer Res. 2012 Oct 1; 18(19):5352-63.
    View in: PubMed
  40. Ascierto PA, Grimaldi AM, Curti B, Faries MB, Ferrone S, Flaherty K, Fox BA, Gajewski TF, Gershenwald JE, Gogas H, Grossmann K, Hauschild A, Hodi FS, Kefford R, Kirkwood JM, Leachmann S, Maio M, Marais R, Palmieri G, Morton DL, Ribas A, Stroncek DF, Stewart R, Wang E, Mozzillo N, Marincola FM. Future perspectives in melanoma research. Meeting report from the "Melanoma research: a bridge from Naples to the World. Napoli, December 5th-6th 2011". J Transl Med. 2012; 10:83.
    View in: PubMed
  41. Kirkwood JM, Butterfield LH, Tarhini AA, Zarour H, Kalinski P, Ferrone S. Immunotherapy of cancer in 2012. CA Cancer J Clin. 2012 Sep-Oct; 62(5):309-35.
    View in: PubMed
  42. Tassi E, Zanon M, Vegetti C, Molla A, Bersani I, Perotti V, Pennati M, Zaffaroni N, Milella M, Ferrone S, Carlo-Stella C, Gianni AM, Mortarini R, Anichini A. Role of Apollon in human melanoma resistance to antitumor agents that activate the intrinsic or the extrinsic apoptosis pathways. Clin Cancer Res. 2012 Jun 15; 18(12):3316-27.
    View in: PubMed
  43. Campoli M, Fitzpatrick JE, High W, Ferrone S. HLA antigen expression in melanocytic lesions: is acquisition of HLA antigen expression a biomarker of atypical (dysplastic) melanocytes? J Am Acad Dermatol. 2012 Jun; 66(6):911-6, 916.e1-8.
    View in: PubMed
  44. Whiteside TL, Ferrone S. For breast cancer prognosis, immunoglobulin kappa chain surfaces to the top. Clin Cancer Res. 2012 May 1; 18(9):2417-9.
    View in: PubMed
  45. Favole A, Cascio P, Cerruti F, Sereno A, Tursi M, Tomatis A, Della Beffa C, Ferrone S, Bollo E. MHC class I-related antigen-processing machinery component defects in feline mammary carcinoma. Transl Oncol. 2012 Feb; 5(1):48-55.
    View in: PubMed
  46. Sakaizawa K, Goto Y, Kiniwa Y, Uchiyama A, Harada K, Shimada S, Saida T, Ferrone S, Takata M, Uhara H, Okuyama R. Mutation analysis of BRAF and KIT in circulating melanoma cells at the single cell level. Br J Cancer. 2012 Feb 28; 106(5):939-46.
    View in: PubMed
  47. Andersson E, Villabona L, Bergfeldt K, Carlson JW, Ferrone S, Kiessling R, Seliger B, Masucci GV. Correlation of HLA-A02* genotype and HLA class I antigen down-regulation with the prognosis of epithelial ovarian cancer. Cancer Immunol Immunother. 2012 Aug; 61(8):1243-53.
    View in: PubMed
  48. Price MA, Colvin Wanshura LE, Yang J, Carlson J, Xiang B, Li G, Ferrone S, Dudek AZ, Turley EA, McCarthy JB. CSPG4, a potential therapeutic target, facilitates malignant progression of melanoma. Pigment Cell Melanoma Res. 2011 Dec; 24(6):1148-57.
    View in: PubMed
  49. Tanaka K, Tsuchikawa T, Miyamoto M, Maki T, Ichinokawa M, Kubota KC, Shichinohe T, Hirano S, Ferrone S, Dosaka-Akita H, Matsuno Y, Kondo S. Down-regulation of Human Leukocyte Antigen class I heavy chain in tumors is associated with a poor prognosis in advanced esophageal cancer patients. Int J Oncol. 2012 Apr; 40(4):965-74.
    View in: PubMed
  50. Khoury T, Ademuyiwa FO, Chandrasekhar R, Chandraseekhar R, Jabbour M, Deleo A, Ferrone S, Wang Y, Wang X. Aldehyde dehydrogenase 1A1 expression in breast cancer is associated with stage, triple negativity, and outcome to neoadjuvant chemotherapy. Mod Pathol. 2012 Mar; 25(3):388-97.
    View in: PubMed
  51. Liu Y, Komohara Y, Domenick N, Ohno M, Ikeura M, Hamilton RL, Horbinski C, Wang X, Ferrone S, Okada H. Expression of antigen processing and presenting molecules in brain metastasis of breast cancer. Cancer Immunol Immunother. 2012 Jun; 61(6):789-801.
    View in: PubMed
  52. Wang X, Katayama A, Wang Y, Yu L, Favoino E, Sakakura K, Favole A, Tsuchikawa T, Silver S, Watkins SC, Kageshita T, Ferrone S. Functional characterization of an scFv-Fc antibody that immunotherapeutically targets the common cancer cell surface proteoglycan CSPG4. Cancer Res. 2011 Dec 15; 71(24):7410-22.
    View in: PubMed
  53. Ferrone S. Hidden immunotherapy targets challenge dogma. Sci Transl Med. 2011 Sep 7; 3(99):99ps38.
    View in: PubMed
  54. Visus C, Wang Y, Lozano-Leon A, Ferris RL, Silver S, Szczepanski MJ, Brand RE, Ferrone CR, Whiteside TL, Ferrone S, DeLeo AB, Wang X. Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8? T cells. Clin Cancer Res. 2011 Oct 1; 17(19):6174-84.
    View in: PubMed
  55. Lee SC, Srivastava RM, López-Albaitero A, Ferrone S, Ferris RL. Natural killer (NK): dendritic cell (DC) cross talk induced by therapeutic monoclonal antibody triggers tumor antigen-specific T cell immunity. Immunol Res. 2011 Aug; 50(2-3):248-54.
    View in: PubMed
  56. Morandi F, Corrias MV, Levreri I, Scaruffi P, Raffaghello L, Carlini B, Bocca P, Prigione I, Stigliani S, Amoroso L, Ferrone S, Pistoia V. Serum levels of cytoplasmic melanoma-associated antigen at diagnosis may predict clinical relapse in neuroblastoma patients. Cancer Immunol Immunother. 2011 Oct; 60(10):1485-95.
    View in: PubMed
  57. Cooney CA, Jousheghany F, Yao-Borengasser A, Phanavanh B, Gomes T, Kieber-Emmons AM, Siegel ER, Suva LJ, Ferrone S, Kieber-Emmons T, Monzavi-Karbassi B. Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells. Breast Cancer Res. 2011; 13(3):R58.
    View in: PubMed
  58. Zarour HM, Ferrone S. Cancer immunotherapy: Progress and challenges in the clinical setting. Eur J Immunol. 2011 Jun; 41(6):1510-5.
    View in: PubMed
  59. Latzka J, Gaier S, Hofstetter G, Balazs N, Smole U, Ferrone S, Scheiner O, Breiteneder H, Pehamberger H, Wagner S. Specificity of mimotope-induced anti-high molecular weight-melanoma associated antigen (HMW-MAA) antibodies does not ensure biological activity. PLoS One. 2011; 6(5):e19383.
    View in: PubMed
  60. Campoli M, Ferrone S. HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisition. Semin Immunopathol. 2011 Jul; 33(4):321-34.
    View in: PubMed
  61. Mayayo SL, Prestigio S, Maniscalco L, La Rosa G, Aricò A, De Maria R, Cavallo F, Ferrone S, Buracco P, Iussich S. Chondroitin sulfate proteoglycan-4: a biomarker and a potential immunotherapeutic target for canine malignant melanoma. Vet J. 2011 Nov; 190(2):e26-30.
    View in: PubMed
  62. Ascierto PA, De Maio E, Bertuzzi S, Palmieri G, Halaban R, Hendrix M, Kashani-sabet M, Ferrone S, Wang E, Cochran A, Rivoltini L, Lee PP, Fox BA, Kirkwood JM, Ullmann CD, Lehmann FF, Sznol M, Schwartzentruber DJ, Maio M, Flaherty K, Galon J, Ribas A, Yang J, Stroncek DF, Mozzillo N, Marincola FM. Future perspectives in melanoma research. Meeting report from the "Melanoma Research: a bridge Naples-USA. Naples, December 6th-7th 2010". J Transl Med. 2011; 9:32.
    View in: PubMed
  63. Chikamatsu K, Takahashi G, Sakakura K, Ferrone S, Masuyama K. Immunoregulatory properties of CD44+ cancer stem-like cells in squamous cell carcinoma of the head and neck. Head Neck. 2011 Feb; 33(2):208-15.
    View in: PubMed
  64. Respa A, Bukur J, Ferrone S, Pawelec G, Zhao Y, Wang E, Marincola FM, Seliger B. Association of IFN-gamma signal transduction defects with impaired HLA class I antigen processing in melanoma cell lines. Clin Cancer Res. 2011 May 1; 17(9):2668-78.
    View in: PubMed
  65. Leibowitz MS, Andrade Filho PA, Ferrone S, Ferris RL. Deficiency of activated STAT1 in head and neck cancer cells mediates TAP1-dependent escape from cytotoxic T lymphocytes. Cancer Immunol Immunother. 2011 Apr; 60(4):525-35.
    View in: PubMed
  66. Amiot L, Ferrone S, Grosse-Wilde H, Seliger B. Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention? Cell Mol Life Sci. 2011 Feb; 68(3):417-31.
    View in: PubMed
  67. Sconocchia G, Zlobec I, Lugli A, Calabrese D, Iezzi G, Karamitopoulou E, Patsouris ES, Peros G, Horcic M, Tornillo L, Zuber M, Droeser R, Muraro MG, Mengus C, Oertli D, Ferrone S, Terracciano L, Spagnoli GC. Tumor infiltration by Fc?RIII (CD16)+ myeloid cells is associated with improved survival in patients with colorectal carcinoma. Int J Cancer. 2011 Jun 1; 128(11):2663-72.
    View in: PubMed
  68. Brady MT, Lee J, Ferrone S, Wang ES, Wetzler M. Interferon-? secretion by t(9;22) acute lymphoblastic leukemia-derived dendritic cells. Leuk Res. 2011 Feb; 35(2):275-7.
    View in: PubMed
  69. Sharafinski ME, Ferris RL, Ferrone S, Grandis JR. Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neck. Head Neck. 2010 Oct; 32(10):1412-21.
    View in: PubMed
  70. Wang X, Osada T, Wang Y, Yu L, Sakakura K, Katayama A, McCarthy JB, Brufsky A, Chivukula M, Khoury T, Hsu DS, Barry WT, Lyerly HK, Clay TM, Ferrone S. CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancer. J Natl Cancer Inst. 2010 Oct 6; 102(19):1496-512.
    View in: PubMed
  71. Michel S, Linnebacher M, Alcaniz J, Voss M, Wagner R, Dippold W, Becker C, von Knebel Doeberitz M, Ferrone S, Kloor M. Lack of HLA class II antigen expression in microsatellite unstable colorectal carcinomas is caused by mutations in HLA class II regulatory genes. Int J Cancer. 2010 Aug 15; 127(4):889-98.
    View in: PubMed
  72. Ferris RL, Jaffee EM, Ferrone S. Tumor antigen-targeted, monoclonal antibody-based immunotherapy: clinical response, cellular immunity, and immunoescape. J Clin Oncol. 2010 Oct 1; 28(28):4390-9.
    View in: PubMed
  73. Wang X, Wang Y, Yu L, Sakakura K, Visus C, Schwab JH, Ferrone CR, Favoino E, Koya Y, Campoli MR, McCarthy JB, DeLeo AB, Ferrone S. CSPG4 in cancer: multiple roles. Curr Mol Med. 2010 Jun; 10(4):419-29.
    View in: PubMed
  74. Mine T, Matsueda S, Gao H, Li Y, Wong KK, Peoples GE, Ferrone S, Ioannides CG. Created Gli-1 duplex short-RNA (i-Gli-RNA) eliminates CD44 Hi progenitors of taxol-resistant ovarian cancer cells. Oncol Rep. 2010 Jun; 23(6):1537-43.
    View in: PubMed
  75. Burns WR, Zhao Y, Frankel TL, Hinrichs CS, Zheng Z, Xu H, Feldman SA, Ferrone S, Rosenberg SA, Morgan RA. A high molecular weight melanoma-associated antigen-specific chimeric antigen receptor redirects lymphocytes to target human melanomas. Cancer Res. 2010 Apr 15; 70(8):3027-33.
    View in: PubMed
  76. Cairo MS, Jordan CT, Maley CC, Chao C, Melnick A, Armstrong SA, Shlomchik W, Molldrem J, Ferrone S, Mackall C, Zitvogel L, Bishop MR, Giralt SA, June CH. NCI first International Workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on the biological considerations of hematological relapse following allogeneic stem cell transplantation unrelated to graft-versus-tumor effects: state of the science. Biol Blood Marrow Transplant. 2010 Jun; 16(6):709-28.
    View in: PubMed
  77. Karyampudi L, Formicola C, Erskine CL, Maurer MJ, Ingle JN, Krco CJ, Wettstein PJ, Kalli KR, Fikes JD, Beebe M, Hartmann LC, Disis ML, Ferrone S, Ishioka G, Knutson KL. A degenerate HLA-DR epitope pool of HER-2/neu reveals a novel in vivo immunodominant epitope, HER-2/neu88-102. Clin Cancer Res. 2010 Feb 1; 16(3):825-34.
    View in: PubMed
  78. Di Tomaso T, Mazzoleni S, Wang E, Sovena G, Clavenna D, Franzin A, Mortini P, Ferrone S, Doglioni C, Marincola FM, Galli R, Parmiani G, Maccalli C. Immunobiological characterization of cancer stem cells isolated from glioblastoma patients. Clin Cancer Res. 2010 Feb 1; 16(3):800-13.
    View in: PubMed
  79. Meyer Zu Horste G, Heidenreich H, Lehmann HC, Ferrone S, Hartung HP, Wiendl H, Kieseier BC. Expression of antigen processing and presenting molecules by Schwann cells in inflammatory neuropathies. Glia. 2010 Jan 1; 58(1):80-92.
    View in: PubMed
  80. Campoli M, Ferrone S, Wang X. Functional and clinical relevance of chondroitin sulfate proteoglycan 4. Adv Cancer Res. 2010; 109:73-121.
    View in: PubMed
  81. Campoli M, Ferris R, Ferrone S, Wang X. Immunotherapy of malignant disease with tumor antigen-specific monoclonal antibodies. Clin Cancer Res. 2010 Jan 1; 16(1):11-20.
    View in: PubMed
  82. Racanelli V, Leone P, Frassanito MA, Brunetti C, Perosa F, Ferrone S, Dammacco F. Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma. Blood. 2010 Feb 11; 115(6):1185-93.
    View in: PubMed
  83. Seliger B, Stoehr R, Handke D, Mueller A, Ferrone S, Wullich B, Tannapfel A, Hofstaedter F, Hartmann A. Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer. Cancer Immunol Immunother. 2010 Apr; 59(4):529-40.
    View in: PubMed
  84. Cathro HP, Smolkin ME, Theodorescu D, Jo VY, Ferrone S, Frierson HF. Relationship between HLA class I antigen processing machinery component expression and the clinicopathologic characteristics of bladder carcinomas. Cancer Immunol Immunother. 2010 Mar; 59(3):465-72.
    View in: PubMed
  85. Lin J, Takata M, Murata H, Goto Y, Kido K, Ferrone S, Saida T. Polyclonality of BRAF mutations in acquired melanocytic nevi. J Natl Cancer Inst. 2009 Oct 21; 101(20):1423-7.
    View in: PubMed
  86. Yang J, Price MA, Li GY, Bar-Eli M, Salgia R, Jagedeeswaran R, Carlson JH, Ferrone S, Turley EA, McCarthy JB. Melanoma proteoglycan modifies gene expression to stimulate tumor cell motility, growth, and epithelial-to-mesenchymal transition. Cancer Res. 2009 Oct 1; 69(19):7538-47.
    View in: PubMed
  87. Sconocchia G, Spagnoli GC, Del Principe D, Ferrone S, Anselmi M, Wongsena W, Cervelli V, Schultz-Thater E, Wyler S, Carafa V, Moch H, Terracciano L, Tornillo L. Defective infiltration of natural killer cells in MICA/B-positive renal cell carcinoma involves beta(2)-integrin-mediated interaction. Neoplasia. 2009 Jul; 11(7):662-71.
    View in: PubMed
  88. López-Albaitero A, Mailliard R, Hackman T, Andrade Filho PA, Wang X, Gooding W, Ferrone S, Kalinski P, Ferris RL. Maturation pathways of dendritic cells determine TAP1 and TAP2 levels and cross-presenting function. J Immunother. 2009 Jun; 32(5):465-73.
    View in: PubMed
  89. Shen Y, Xia M, Zhang J, Xu L, Yang J, Chen A, Miao F, Ferrone S, Xie W. IRF-1 and p65 mediate upregulation of constitutive HLA-A antigen expression by hepatocellular carcinoma cells. Mol Immunol. 2009 Jun; 46(10):2045-53.
    View in: PubMed
  90. Fourcade J, Kudela P, Sun Z, Shen H, Land SR, Lenzner D, Guillaume P, Luescher IF, Sander C, Ferrone S, Kirkwood JM, Zarour HM. PD-1 is a regulator of NY-ESO-1-specific CD8+ T cell expansion in melanoma patients. J Immunol. 2009 May 1; 182(9):5240-9.
    View in: PubMed
  91. La Rocca R, Fulciniti M, Lakshmikanth T, Mesuraca M, Ali TH, Mazzei V, Amodio N, Catalano L, Rotoli B, Ouerfelli O, Grieco M, Gulletta E, Bond HM, Morrone G, Ferrone S, Carbone E. Early hematopoietic zinc finger protein prevents tumor cell recognition by natural killer cells. J Immunol. 2009 Apr 15; 182(8):4529-37.
    View in: PubMed
  92. Lakshmikanth T, Burke S, Ali TH, Kimpfler S, Ursini F, Ruggeri L, Capanni M, Umansky V, Paschen A, Sucker A, Pende D, Groh V, Biassoni R, Höglund P, Kato M, Shibuya K, Schadendorf D, Anichini A, Ferrone S, Velardi A, Kärre K, Shibuya A, Carbone E, Colucci F. NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo. J Clin Invest. 2009 May; 119(5):1251-63.
    View in: PubMed
  93. López-Albaitero A, Lee SC, Morgan S, Grandis JR, Gooding WE, Ferrone S, Ferris RL. Role of polymorphic Fc gamma receptor IIIa and EGFR expression level in cetuximab mediated, NK cell dependent in vitro cytotoxicity of head and neck squamous cell carcinoma cells. Cancer Immunol Immunother. 2009 Nov; 58(11):1853-64.
    View in: PubMed
  94. Weiner LM, Dhodapkar MV, Ferrone S. Monoclonal antibodies for cancer immunotherapy. Lancet. 2009 Mar 21; 373(9668):1033-40.
    View in: PubMed
  95. Santisteban M, Reiman JM, Asiedu MK, Behrens MD, Nassar A, Kalli KR, Haluska P, Ingle JN, Hartmann LC, Manjili MH, Radisky DC, Ferrone S, Knutson KL. Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells. Cancer Res. 2009 Apr 1; 69(7):2887-95.
    View in: PubMed
  96. Kitago M, Koyanagi K, Nakamura T, Goto Y, Faries M, O'Day SJ, Morton DL, Ferrone S, Hoon DS. mRNA expression and BRAF mutation in circulating melanoma cells isolated from peripheral blood with high molecular weight melanoma-associated antigen-specific monoclonal antibody beads. Clin Chem. 2009 Apr; 55(4):757-64.
    View in: PubMed
  97. Paul AK, Ciesielski MJ, Sajjad M, Wang X, Ferrone S, Abdel-Nabi H, Fenstermaker RA. Expression of HMP/AN2, a melanoma associated antigen, in murine cerebral gliomas: potential for radioimmunotargeting. J Neurooncol. 2009 Aug; 94(1):21-30.
    View in: PubMed
  98. Tosello V, Zamarchi R, Merlo A, Gorza M, Piovan E, Mandruzzato S, Bronte V, Wang X, Ferrone S, Amadori A, Zanovello P. Differential expression of constitutive and inducible proteasome subunits in human monocyte-derived DC differentiated in the presence of IFN-alpha or IL-4. Eur J Immunol. 2009 Jan; 39(1):56-66.
    View in: PubMed
  99. Mine T, Matsueda S, Li Y, Tokumitsu H, Gao H, Danes C, Wong KK, Wang X, Ferrone S, Ioannides CG. Breast cancer cells expressing stem cell markers CD44+ CD24 lo are eliminated by Numb-1 peptide-activated T cells. Cancer Immunol Immunother. 2009 Aug; 58(8):1185-94.
    View in: PubMed
  100. Seliger B, Marincola FM, Ferrone S, Abken H. The complex role of B7 molecules in tumor immunology. Trends Mol Med. 2008 Dec; 14(12):550-9.
    View in: PubMed
  101. Goto Y, Arigami T, Kitago M, Nguyen SL, Narita N, Ferrone S, Morton DL, Irie RF, Hoon DS. Activation of Toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors. Mol Cancer Ther. 2008 Nov; 7(11):3642-53.
    View in: PubMed
  102. Wongsena W, Sconocchia G, Cho HS, Chang CC, Wang X, Klumkrathok K, Ferrone S, Leelayuwat C. Production and characterization of monoclonal antibodies against major histocompatibility complex class I chain-related gene A. Tissue Antigens. 2008 Nov; 72(5):431-40.
    View in: PubMed
  103. Verheyden S, Ferrone S, Mulder A, Claas FH, Schots R, De Moerloose B, Benoit Y, Demanet C. Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells. Cancer Immunol Immunother. 2009 Jun; 58(6):855-65.
    View in: PubMed
  104. Campoli M, Ferrone S. HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance. Oncogene. 2008 Oct 6; 27(45):5869-85.
    View in: PubMed
  105. Maciag PC, Seavey MM, Pan ZK, Ferrone S, Paterson Y. Cancer immunotherapy targeting the high molecular weight melanoma-associated antigen protein results in a broad antitumor response and reduction of pericytes in the tumor vasculature. Cancer Res. 2008 Oct 1; 68(19):8066-75.
    View in: PubMed
  106. Tourkova IL, Shurin GV, Ferrone S, Shurin MR. Interferon regulatory factor 8 mediates tumor-induced inhibition of antigen processing and presentation by dendritic cells. Cancer Immunol Immunother. 2009 Apr; 58(4):567-74.
    View in: PubMed
  107. Hsieh CH, Hsu YJ, Chang CC, Liu HC, Chuang KL, Chuang CK, Pang ST, Hasumi K, Ferrone S, Liao SK. Total HLA class I loss in a sarcomatoid renal carcinoma cell line caused by the coexistence of distinct mutations in the two encoding beta2-microglobulin genes. Cancer Immunol Immunother. 2009 Mar; 58(3):395-408.
    View in: PubMed
  108. Campoli M, Ferrone S. Tumor escape mechanisms: potential role of soluble HLA antigens and NK cells activating ligands. Tissue Antigens. 2008 Oct; 72(4):321-34.
    View in: PubMed
  109. Drake AS, Brady MT, Wang XH, Sait SJ, Earp JC, Ghoshal Gupta S, Ferrone S, Wang ES, Wetzler M. Targeting 11q23 positive acute leukemia cells with high molecular weight-melanoma associated antigen-specific monoclonal antibodies. Cancer Immunol Immunother. 2009 Mar; 58(3):415-27.
    View in: PubMed
  110. Schwab JH, Boland PJ, Agaram NP, Socci ND, Guo T, O'Toole GC, Wang X, Ostroumov E, Hunter CJ, Block JA, Doty S, Ferrone S, Healey JH, Antonescu CR. Chordoma and chondrosarcoma gene profile: implications for immunotherapy. Cancer Immunol Immunother. 2009 Mar; 58(3):339-49.
    View in: PubMed
  111. Wondimu A, Zhang T, Kieber-Emmons T, Gimotty P, Sproesser K, Somasundaram R, Ferrone S, Tsao CY, Herlyn D. Peptides mimicking GD2 ganglioside elicit cellular, humoral and tumor-protective immune responses in mice. Cancer Immunol Immunother. 2008 Jul; 57(7):1079-89.
    View in: PubMed
  112. Han LY, Fletcher MS, Urbauer DL, Mueller P, Landen CN, Kamat AA, Lin YG, Merritt WM, Spannuth WA, Deavers MT, De Geest K, Gershenson DM, Lutgendorf SK, Ferrone S, Sood AK. HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma. Clin Cancer Res. 2008 Jun 1; 14(11):3372-9.
    View in: PubMed
  113. Goto Y, Ferrone S, Arigami T, Kitago M, Tanemura A, Sunami E, Nguyen SL, Turner RR, Morton DL, Hoon DS. Human high molecular weight-melanoma-associated antigen: utility for detection of metastatic melanoma in sentinel lymph nodes. Clin Cancer Res. 2008 Jun 1; 14(11):3401-7.
    View in: PubMed
  114. Vujanovic L, Whiteside TL, Potter DM, Chu J, Ferrone S, Butterfield LH. Regulation of antigen presentation machinery in human dendritic cells by recombinant adenovirus. Cancer Immunol Immunother. 2009 Jan; 58(1):121-33.
    View in: PubMed
  115. Schwenkert M, Birkholz K, Schwemmlein M, Kellner C, Kügler M, Peipp M, Nettelbeck DM, Schuler-Thurner B, Schaft N, Dörrie J, Ferrone S, Kämpgen E, Fey GH. A single chain immunotoxin, targeting the melanoma-associated chondroitin sulfate proteoglycan, is a potent inducer of apoptosis in cultured human melanoma cells. Melanoma Res. 2008 Apr; 18(2):73-84.
    View in: PubMed
  116. Morandi F, Raffaghello L, Bianchi G, Meloni F, Salis A, Millo E, Ferrone S, Barnaba V, Pistoia V. Immunogenicity of human mesenchymal stem cells in HLA-class I-restricted T-cell responses against viral or tumor-associated antigens. Stem Cells. 2008 May; 26(5):1275-87.
    View in: PubMed
  117. Belicha-Villanueva A, McEvoy S, Cycon K, Ferrone S, Gollnick SO, Bangia N. Differential contribution of TAP and tapasin to HLA class I antigen expression. Immunology. 2008 May; 124(1):112-20.
    View in: PubMed
  118. Ferrone S, Whiteside TL. Tumor microenvironment and immune escape. Surg Oncol Clin N Am. 2007 Oct; 16(4):755-74, viii.
    View in: PubMed
  119. Signorino E, Brusa D, Granata R, Malavasi F, Ferrone S, Matera L. Contribution of dendritic cells' FcgammaRI and FcgammaRIII to cross-presentation of tumor cells opsonized with the anti-MHC class I monoclonal antibodies. Cancer Biol Ther. 2007 Dec; 6(12):1932-7.
    View in: PubMed
  120. Tsuda N, Chang DZ, Mine T, Efferson C, García-Sastre A, Wang X, Ferrone S, Ioannides CG. Taxol increases the amount and T cell activating ability of self-immune stimulatory multimolecular complexes found in ovarian cancer cells. Cancer Res. 2007 Sep 1; 67(17):8378-87.
    View in: PubMed
  121. Connolly N, Riddler S, Stanson J, Gooding W, Rinaldo CR, Ferrone S, Whiteside TL. Levels of antigen processing machinery components in dendritic cells generated for vaccination of HIV-1+ subjects. AIDS. 2007 Aug 20; 21(13):1683-92.
    View in: PubMed
  122. Ko E, Luo W, Peng L, Wang X, Ferrone S. Mouse dendritic-endothelial cell hybrids and 4-1BB costimulation elicit antitumor effects mediated by broad antiangiogenic immunity. Cancer Res. 2007 Aug 15; 67(16):7875-84.
    View in: PubMed
  123. Pistoia V, Morandi F, Wang X, Ferrone S. Soluble HLA-G: Are they clinically relevant? Semin Cancer Biol. 2007 Dec; 17(6):469-79.
    View in: PubMed
  124. Mehta AM, Jordanova ES, Kenter GG, Ferrone S, Fleuren GJ. Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma. Cancer Immunol Immunother. 2008 Feb; 57(2):197-206.
    View in: PubMed
  125. Morandi F, Levreri I, Bocca P, Galleni B, Raffaghello L, Ferrone S, Prigione I, Pistoia V. Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release. Cancer Res. 2007 Jul 1; 67(13):6433-41.
    View in: PubMed
  126. Oflazoglu E, Elliott M, Takita H, Ferrone S, Henderson RA, Repasky EA. Adoptively transferred human lung tumor specific cytotoxic T cells can control autologous tumor growth and shape tumor phenotype in a SCID mouse xenograft model. J Transl Med. 2007; 5:29.
    View in: PubMed
  127. Ogino T, Moriai S, Ishida Y, Ishii H, Katayama A, Miyokawa N, Harabuchi Y, Ferrone S. Association of immunoescape mechanisms with Epstein-Barr virus infection in nasopharyngeal carcinoma. Int J Cancer. 2007 Jun 1; 120(11):2401-10.
    View in: PubMed
  128. Raffaghello L, Nozza P, Morandi F, Camoriano M, Wang X, Garrè ML, Cama A, Basso G, Ferrone S, Gambini C, Pistoia V. Expression and functional analysis of human leukocyte antigen class I antigen-processing machinery in medulloblastoma. Cancer Res. 2007 Jun 1; 67(11):5471-8.
    View in: PubMed
  129. Mehling M, Simon P, Mittelbronn M, Meyermann R, Ferrone S, Weller M, Wiendl H. WHO grade associated downregulation of MHC class I antigen-processing machinery components in human astrocytomas: does it reflect a potential immune escape mechanism? Acta Neuropathol. 2007 Aug; 114(2):111-9.
    View in: PubMed
  130. Theurillat JP, Zürrer-Härdi U, Varga Z, Storz M, Probst-Hensch NM, Seifert B, Fehr MK, Fink D, Ferrone S, Pestalozzi B, Jungbluth AA, Chen YT, Jäger D, Knuth A, Moch H. NY-BR-1 protein expression in breast carcinoma: a mammary gland differentiation antigen as target for cancer immunotherapy. Cancer Immunol Immunother. 2007 Nov; 56(11):1723-31.
    View in: PubMed
  131. Vermeulen CF, Jordanova ES, ter Haar NT, Kolkman-Uljee SM, de Miranda NF, Ferrone S, Peters AA, Fleuren GJ. Expression and genetic analysis of transporter associated with antigen processing in cervical carcinoma. Gynecol Oncol. 2007 Jun; 105(3):593-9.
    View in: PubMed
  132. Wang W, Edington HD, Rao UN, Jukic DM, Land SR, Ferrone S, Kirkwood JM. Modulation of signal transducers and activators of transcription 1 and 3 signaling in melanoma by high-dose IFNalpha2b. Clin Cancer Res. 2007 Mar 1; 13(5):1523-31.
    View in: PubMed
  133. Dierssen JW, de Miranda NF, Ferrone S, van Puijenbroek M, Cornelisse CJ, Fleuren GJ, van Wezel T, Morreau H. HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression. BMC Cancer. 2007; 7:33.
    View in: PubMed
  134. Almeciga I, Wang ZC, Zúñiga J, Fernandez-Viña M, Clavijo O, Araujo H, Romero V, Henry J, Ferrone S, Yunis EJ. Allorecognition of an HLA-A*01 aberrant allele by an HLA identical family member carrying the HLA-A*0101 allele. J Immunol. 2006 Dec 15; 177(12):8643-9.
    View in: PubMed
  135. Ogino T, Shigyo H, Ishii H, Katayama A, Miyokawa N, Harabuchi Y, Ferrone S. HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker. Cancer Res. 2006 Sep 15; 66(18):9281-9.
    View in: PubMed
  136. Sabbatini P, Dupont J, Aghajanian C, Derosa F, Poynor E, Anderson S, Hensley M, Livingston P, Iasonos A, Spriggs D, McGuire W, Reinartz S, Schneider S, Grande C, Lele S, Rodabaugh K, Kepner J, Ferrone S, Odunsi K. Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer. Clin Cancer Res. 2006 Sep 15; 12(18):5503-10.
    View in: PubMed
  137. Leys CM, Nomura S, LaFleur BJ, Ferrone S, Kaminishi M, Montgomery E, Goldenring JR. Expression and prognostic significance of prothymosin-alpha and ERp57 in human gastric cancer. Surgery. 2007 Jan; 141(1):41-50.
    View in: PubMed
  138. Chang CC, Ferrone S. NK cell activating ligands on human malignant cells: molecular and functional defects and potential clinical relevance. Semin Cancer Biol. 2006 Oct; 16(5):383-92.
    View in: PubMed
  139. Petti C, Molla A, Vegetti C, Ferrone S, Anichini A, Sensi M. Coexpression of NRASQ61R and BRAFV600E in human melanoma cells activates senescence and increases susceptibility to cell-mediated cytotoxicity. Cancer Res. 2006 Jul 1; 66(13):6503-11.
    View in: PubMed
  140. Ferris RL, Whiteside TL, Ferrone S. Immune escape associated with functional defects in antigen-processing machinery in head and neck cancer. Clin Cancer Res. 2006 Jul 1; 12(13):3890-5.
    View in: PubMed
  141. Reynolds SR, Vergilis IJ, Szarek M, Ferrone S, Bystryn JC. Cytoplasmic melanoma-associated antigen (CYT-MAA) serum level in patients with melanoma: a potential marker of response to immunotherapy? Int J Cancer. 2006 Jul 1; 119(1):157-61.
    View in: PubMed
  142. Chang CC, Ferrone S. Immune selective pressure and HLA class I antigen defects in malignant lesions. Cancer Immunol Immunother. 2007 Feb; 56(2):227-36.
    View in: PubMed
  143. Anichini A, Mortarini R, Nonaka D, Molla A, Vegetti C, Montaldi E, Wang X, Ferrone S. Association of antigen-processing machinery and HLA antigen phenotype of melanoma cells with survival in American Joint Committee on Cancer stage III and IV melanoma patients. Cancer Res. 2006 Jun 15; 66(12):6405-11.
    View in: PubMed
  144. Luo W, Ko E, Hsu JC, Wang X, Ferrone S. Targeting melanoma cells with human high molecular weight-melanoma associated antigen-specific antibodies elicited by a peptide mimotope: functional effects. J Immunol. 2006 May 15; 176(10):6046-54.
    View in: PubMed
  145. Luo W, Wang X, Kageshita T, Wakasugi S, Karpf AR, Ferrone S. Regulation of high molecular weight-melanoma associated antigen (HMW-MAA) gene expression by promoter DNA methylation in human melanoma cells. Oncogene. 2006 May 11; 25(20):2873-84.
    View in: PubMed
  146. Chang CC, Ogino T, Mullins DW, Oliver JL, Yamshchikov GV, Bandoh N, Slingluff CL, Ferrone S. Defective human leukocyte antigen class I-associated antigen presentation caused by a novel beta2-microglobulin loss-of-function in melanoma cells. J Biol Chem. 2006 Jul 7; 281(27):18763-73.
    View in: PubMed
  147. Slingluff CL, Engelhard VH, Ferrone S. Peptide and dendritic cell vaccines. Clin Cancer Res. 2006 Apr 1; 12(7 Pt 2):2342s-2345s.
    View in: PubMed
  148. López-Albaitero A, Nayak JV, Ogino T, Machandia A, Gooding W, DeLeo AB, Ferrone S, Ferris RL. Role of antigen-processing machinery in the in vitro resistance of squamous cell carcinoma of the head and neck cells to recognition by CTL. J Immunol. 2006 Mar 15; 176(6):3402-9.
    View in: PubMed
  149. Peng L, Ko E, Luo W, Wang X, Shrikant PA, Ferrone S. CD4-dependent potentiation of a high molecular weight-melanoma-associated antigen-specific CTL response elicited in HLA-A2/Kb transgenic mice. J Immunol. 2006 Feb 15; 176(4):2307-15.
    View in: PubMed
  150. Seliger B, Ritz U, Ferrone S. Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformation. Int J Cancer. 2006 Jan 1; 118(1):129-38.
    View in: PubMed
  151. Bangia N, Ferrone S. Antigen presentation machinery (APM) modulation and soluble HLA molecules in the tumor microenvironment: do they provide tumor cells with escape mechanisms from recognition by cytotoxic T lymphocytes? Immunol Invest. 2006; 35(3-4):485-503.
    View in: PubMed
  152. Facoetti A, Nano R, Zelini P, Morbini P, Benericetti E, Ceroni M, Campoli M, Ferrone S. Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors. Clin Cancer Res. 2005 Dec 1; 11(23):8304-11.
    View in: PubMed
  153. Albers A, Abe K, Hunt J, Wang J, Lopez-Albaitero A, Schaefer C, Gooding W, Whiteside TL, Ferrone S, DeLeo A, Ferris RL. Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck. Cancer Res. 2005 Dec 1; 65(23):11146-55.
    View in: PubMed
  154. Rouas-Freiss N, Moreau P, Ferrone S, Carosella ED. HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism? Cancer Res. 2005 Nov 15; 65(22):10139-44.
    View in: PubMed
  155. Raffaghello L, Prigione I, Airoldi I, Camoriano M, Morandi F, Bocca P, Gambini C, Ferrone S, Pistoia V. Mechanisms of immune evasion of human neuroblastoma. Cancer Lett. 2005 Oct 18; 228(1-2):155-61.
    View in: PubMed
  156. Chang CC, Hernandez-Guzman FG, Luo W, Wang X, Ferrone S, Ghosh D. Structural basis of antigen mimicry in a clinically relevant melanoma antigen system. J Biol Chem. 2005 Dec 16; 280(50):41546-52.
    View in: PubMed
  157. Ramnath N, Tan D, Li Q, Hylander BL, Bogner P, Ryes L, Ferrone S. Is downregulation of MHC class I antigen expression in human non-small cell lung cancer associated with prolonged survival? Cancer Immunol Immunother. 2006 Aug; 55(8):891-9.
    View in: PubMed
  158. Tourkova IL, Shurin GV, Chatta GS, Perez L, Finke J, Whiteside TL, Ferrone S, Shurin MR. Restoration by IL-15 of MHC class I antigen-processing machinery in human dendritic cells inhibited by tumor-derived gangliosides. J Immunol. 2005 Sep 1; 175(5):3045-52.
    View in: PubMed
  159. Bandoh N, Ogino T, Cho HS, Hur SY, Shen J, Wang X, Kato S, Miyokawa N, Harabuchi Y, Ferrone S. Development and characterization of human constitutive proteasome and immunoproteasome subunit-specific monoclonal antibodies. Tissue Antigens. 2005 Sep; 66(3):185-94.
    View in: PubMed
  160. Vergilis IJ, Szarek M, Ferrone S, Reynolds SR. Presence and prognostic significance of melanoma-associated antigens CYT-MAA and HMW-MAA in serum of patients with melanoma. J Invest Dermatol. 2005 Sep; 125(3):526-31.
    View in: PubMed
  161. Wang X, Ko EC, Peng L, Gillies SD, Ferrone S. Human high molecular weight melanoma-associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: enhancement of immunogenicity of anti-idiotypic monoclonal antibody MK2-23 by fusion with interleukin 2. Cancer Res. 2005 Aug 1; 65(15):6976-83.
    View in: PubMed
  162. Sconocchia G, Lau M, Provenzano M, Rezvani K, Wongsena W, Fujiwara H, Hensel N, Melenhorst J, Li J, Ferrone S, Barrett AJ. The antileukemia effect of HLA-matched NK and NK-T cells in chronic myelogenous leukemia involves NKG2D-target-cell interactions. Blood. 2005 Nov 15; 106(10):3666-72.
    View in: PubMed
  163. Kawano K, Ferrone S, Ioannides CG. Functional idiotopes: tumor antigen-directed expression of CD8+ T-cell epitopes nested in unique NH2-terminal VH sequence of antiidiotypic antibodies? Cancer Res. 2005 Jul 15; 65(14):6001-4.
    View in: PubMed
  164. Kloor M, Becker C, Benner A, Woerner SM, Gebert J, Ferrone S, von Knebel Doeberitz M. Immunoselective pressure and human leukocyte antigen class I antigen machinery defects in microsatellite unstable colorectal cancers. Cancer Res. 2005 Jul 15; 65(14):6418-24.
    View in: PubMed
  165. Claus JA, Brady MT, Lee J, Donohue KA, Sait SN, Ferrone S, Wetzler M. T-Cell activation by t(9;22) acute lymphoblastic leukemia-derived dendritic-like cells is associated with increased tapasin expression. Cancer Immunol Immunother. 2006 Feb; 55(2):160-5.
    View in: PubMed
  166. Raffaghello L, Prigione I, Bocca P, Morandi F, Camoriano M, Gambini C, Wang X, Ferrone S, Pistoia V. Multiple defects of the antigen-processing machinery components in human neuroblastoma: immunotherapeutic implications. Oncogene. 2005 Jul 7; 24(29):4634-44.
    View in: PubMed
  167. Yan WH, Lin AF, Chang CC, Ferrone S. Induction of HLA-G expression in a melanoma cell line OCM-1A following the treatment with 5-aza-2'-deoxycytidine. Cell Res. 2005 Jul; 15(7):523-31.
    View in: PubMed
  168. Yamshchikov GV, Mullins DW, Chang CC, Ogino T, Thompson L, Presley J, Galavotti H, Aquila W, Deacon D, Ross W, Patterson JW, Engelhard VH, Ferrone S, Slingluff CL. Sequential immune escape and shifting of T cell responses in a long-term survivor of melanoma. J Immunol. 2005 Jun 1; 174(11):6863-71.
    View in: PubMed
  169. Luo W, Hsu JC, Tsao CY, Ko E, Wang X, Ferrone S. Differential immunogenicity of two peptides isolated by high molecular weight-melanoma-associated antigen-specific monoclonal antibodies with different affinities. J Immunol. 2005 Jun 1; 174(11):7104-10.
    View in: PubMed
  170. Kageshita T, Ishihara T, Campoli M, Ferrone S. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions. Tissue Antigens. 2005 May; 65(5):419-28.
    View in: PubMed
  171. Bolesta E, Kowalczyk A, Wierzbicki A, Rotkiewicz P, Bambach B, Tsao CY, Horwacik I, Kolinski A, Rokita H, Brecher M, Wang X, Ferrone S, Kozbor D. DNA vaccine expressing the mimotope of GD2 ganglioside induces protective GD2 cross-reactive antibody responses. Cancer Res. 2005 Apr 15; 65(8):3410-8.
    View in: PubMed
  172. Hafner C, Breiteneder H, Ferrone S, Thallinger C, Wagner S, Schmidt WM, Jasinska J, Kundi M, Wolff K, Zielinski CC, Scheiner O, Wiedermann U, Pehamberger H. Suppression of human melanoma tumor growth in SCID mice by a human high molecular weight-melanoma associated antigen (HMW-MAA) specific monoclonal antibody. Int J Cancer. 2005 Apr 10; 114(3):426-32.
    View in: PubMed
  173. Meissner M, Reichert TE, Kunkel M, Gooding W, Whiteside TL, Ferrone S, Seliger B. Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome. Clin Cancer Res. 2005 Apr 1; 11(7):2552-60.
    View in: PubMed
  174. Wang X, Campoli M, Cho HS, Ogino T, Bandoh N, Shen J, Hur SY, Kageshita T, Ferrone S. A method to generate antigen-specific mAb capable of staining formalin-fixed, paraffin-embedded tissue sections. J Immunol Methods. 2005 Apr; 299(1-2):139-51.
    View in: PubMed
  175. Chang CC, Campoli M, Restifo NP, Wang X, Ferrone S. Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy. J Immunol. 2005 Feb 1; 174(3):1462-71.
    View in: PubMed
  176. Wagner S, Hafner C, Allwardt D, Jasinska J, Ferrone S, Zielinski CC, Scheiner O, Wiedermann U, Pehamberger H, Breiteneder H. Vaccination with a human high molecular weight melanoma-associated antigen mimotope induces a humoral response inhibiting melanoma cell growth in vitro. J Immunol. 2005 Jan 15; 174(2):976-82.
    View in: PubMed
  177. Luo W, Hsu JC, Kieber-Emmons T, Wang X, Ferrone S. Human tumor associated antigen mimicry by xenoantigens, anti-idiotypic antibodies and peptide mimics: implications for immunotherapy of malignant diseases. Cancer Chemother Biol Response Modif. 2005; 22:769-87.
    View in: PubMed
  178. Campoli M, Ferrone S, Zea AH, Rodriguez PC, Ochoa AC. Mechanisms of tumor evasion. Cancer Treat Res. 2005; 123:61-88.
    View in: PubMed
  179. Vitale M, Pelusi G, Taroni B, Gobbi G, Micheloni C, Rezzani R, Donato F, Wang X, Ferrone S. HLA class I antigen down-regulation in primary ovary carcinoma lesions: association with disease stage. Clin Cancer Res. 2005 Jan 1; 11(1):67-72.
    View in: PubMed
  180. Ferris RL, Hunt JL, Ferrone S. Human leukocyte antigen (HLA) class I defects in head and neck cancer: molecular mechanisms and clinical significance. Immunol Res. 2005; 33(2):113-33.
    View in: PubMed
  181. Chang CC, Campoli M, Ferrone S. Classical and nonclassical HLA class I antigen and NK Cell-activating ligand changes in malignant cells: current challenges and future directions. Adv Cancer Res. 2005; 93:189-234.
    View in: PubMed
  182. Prigione I, Corrias MV, Airoldi I, Raffaghello L, Morandi F, Bocca P, Cocco C, Ferrone S, Pistoia V. Immunogenicity of human neuroblastoma. Ann N Y Acad Sci. 2004 Dec; 1028:69-80.
    View in: PubMed
  183. Chang CC, Campoli M, Luo W, Zhao W, Zaenker KS, Ferrone S. Immunotherapy of melanoma targeting human high molecular weight melanoma-associated antigen: potential role of nonimmunological mechanisms. Ann N Y Acad Sci. 2004 Dec; 1028:340-50.
    View in: PubMed
  184. Wang X, Campoli M, Ko E, Luo W, Ferrone S. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies. J Immunol Methods. 2004 Nov; 294(1-2):23-35.
    View in: PubMed
  185. Chang CC, Campoli M, Ferrone S. HLA class I antigen expression in malignant cells: why does it not always correlate with CTL-mediated lysis? Curr Opin Immunol. 2004 Oct; 16(5):644-50.
    View in: PubMed
  186. Ferrone S. Immunotherapy dispenses with tumor antigens. Nat Biotechnol. 2004 Sep; 22(9):1096-8.
    View in: PubMed
  187. Raffaghello L, Prigione I, Airoldi I, Camoriano M, Levreri I, Gambini C, Pende D, Steinle A, Ferrone S, Pistoia V. Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma. Neoplasia. 2004 Sep-Oct; 6(5):558-68.
    View in: PubMed
  188. Murray JL, Gillogly M, Kawano K, Efferson CL, Lee JE, Ross M, Wang X, Ferrone S, Ioannides CG. Fine specificity of high molecular weight-melanoma-associated antigen-specific cytotoxic T lymphocytes elicited by anti-idiotypic monoclonal antibodies in patients with melanoma. Cancer Res. 2004 Aug 1; 64(15):5481-8.
    View in: PubMed
  189. Whiteside TL, Stanson J, Shurin MR, Ferrone S. Antigen-processing machinery in human dendritic cells: up-regulation by maturation and down-regulation by tumor cells. J Immunol. 2004 Aug 1; 173(3):1526-34.
    View in: PubMed
  190. Yang J, Price MA, Neudauer CL, Wilson C, Ferrone S, Xia H, Iida J, Simpson MA, McCarthy JB. Melanoma chondroitin sulfate proteoglycan enhances FAK and ERK activation by distinct mechanisms. J Cell Biol. 2004 Jun 21; 165(6):881-91.
    View in: PubMed
  191. Campoli M, Ferrone S. T-cell-based immunotherapy of melanoma: what have we learned and how can we improve? Expert Rev Vaccines. 2004 Apr; 3(2):171-87.
    View in: PubMed
  192. Atkins D, Breuckmann A, Schmahl GE, Binner P, Ferrone S, Krummenauer F, Störkel S, Seliger B. MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma. Int J Cancer. 2004 Mar 20; 109(2):265-73.
    View in: PubMed
  193. Atkins D, Ferrone S, Schmahl GE, Störkel S, Seliger B. Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma? J Urol. 2004 Feb; 171(2 Pt 1):885-9.
    View in: PubMed
  194. Campoli MR, Chang CC, Kageshita T, Wang X, McCarthy JB, Ferrone S. Human high molecular weight-melanoma-associated antigen (HMW-MAA): a melanoma cell surface chondroitin sulfate proteoglycan (MSCP) with biological and clinical significance. Crit Rev Immunol. 2004; 24(4):267-96.
    View in: PubMed
  195. Campoli M, Chang CC, Oldford SA, Edgecombe AD, Drover S, Ferrone S. HLA antigen changes in malignant tumors of mammary epithelial origin: molecular mechanisms and clinical implications. Breast Dis. 2004; 20:105-25.
    View in: PubMed
  196. Demanet C, Mulder A, Deneys V, Worsham MJ, Maes P, Claas FH, Ferrone S. Down-regulation of HLA-A and HLA-Bw6, but not HLA-Bw4, allospecificities in leukemic cells: an escape mechanism from CTL and NK attack? Blood. 2004 Apr 15; 103(8):3122-30.
    View in: PubMed
  197. Ko EC, Wang X, Ferrone S. Immunotherapy of malignant diseases. Challenges and strategies. Int Arch Allergy Immunol. 2003 Dec; 132(4):294-309.
    View in: PubMed
  198. Chang CC, Campoli M, Ferrone S. HLA class I defects in malignant lesions: what have we learned? Keio J Med. 2003 Dec; 52(4):220-9.
    View in: PubMed
  199. Marincola FM, Ferrone S. Immunotherapy of melanoma: the good news, the bad ones and what to do next. Semin Cancer Biol. 2003 Dec; 13(6):387-9.
    View in: PubMed
  200. Ogino T, Wang X, Kato S, Miyokawa N, Harabuchi Y, Ferrone S. Endoplasmic reticulum chaperone-specific monoclonal antibodies for flow cytometry and immunohistochemical staining. Tissue Antigens. 2003 Nov; 62(5):385-93.
    View in: PubMed
  201. Chang CC, Murphy SP, Ferrone S. Differential in vivo and in vitro HLA-G expression in melanoma cells: potential mechanisms. Hum Immunol. 2003 Nov; 64(11):1057-63.
    View in: PubMed
  202. Chang CC, Ferrone S. HLA-G in melanoma: can the current controversies be solved? Semin Cancer Biol. 2003 Oct; 13(5):361-9.
    View in: PubMed
  203. Ogino T, Bandoh N, Hayashi T, Miyokawa N, Harabuchi Y, Ferrone S. Association of tapasin and HLA class I antigen down-regulation in primary maxillary sinus squamous cell carcinoma lesions with reduced survival of patients. Clin Cancer Res. 2003 Sep 15; 9(11):4043-51.
    View in: PubMed
  204. Perosa F, Luccarelli G, Prete M, Favoino E, Ferrone S, Dammacco F. Beta 2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide. J Immunol. 2003 Aug 15; 171(4):1918-26.
    View in: PubMed
  205. Dissemond J, Goette P, Moers J, Lindeke A, Goos M, Ferrone S, Wagner SN. Immunoproteasome subunits LMP2 and LMP7 downregulation in primary malignant melanoma lesions: association with lack of spontaneous regression. Melanoma Res. 2003 Aug; 13(4):371-7.
    View in: PubMed
  206. Wang X, Liang B, Rebmann V, Lu J, Celis E, Kageshita T, Grosse-Wilde H, Ferrone S. Specificity and functional characteristics of anti-HLA-A mAbs LGIII-147.4.1 and LGIII-220.6.2. Tissue Antigens. 2003 Aug; 62(2):139-48.
    View in: PubMed
  207. Ogino T, Wang X, Ferrone S. Modified flow cytometry and cell-ELISA methodology to detect HLA class I antigen processing machinery components in cytoplasm and endoplasmic reticulum. J Immunol Methods. 2003 Jul; 278(1-2):33-44.
    View in: PubMed
  208. Dissemond J, Götte P, Mörs J, Lindeke A, Goos M, Ferrone S, Wagner SN. Association of TAP1 downregulation in human primary melanoma lesions with lack of spontaneous regression. Melanoma Res. 2003 Jun; 13(3):253-8.
    View in: PubMed
  209. Marincola FM, Wang E, Herlyn M, Seliger B, Ferrone S. Tumors as elusive targets of T-cell-based active immunotherapy. Trends Immunol. 2003 Jun; 24(6):335-42.
    View in: PubMed
  210. Seliger B, Atkins D, Bock M, Ritz U, Ferrone S, Huber C, Störkel S. Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation. Clin Cancer Res. 2003 May; 9(5):1721-7.
    View in: PubMed
  211. Weinman EC, Roche PC, Kasperbauer JL, Cha SS, Sargent DJ, Cheville J, Murphy LM, Chen L, Wettstein PJ, Gostout B, Ferrone S, Strome SE. Characterization of antigen processing machinery and Survivin expression in tonsillar squamous cell carcinoma. Cancer. 2003 May 1; 97(9):2203-11.
    View in: PubMed
  212. Wetzler M, McElwain BK, Stewart CC, Blumenson L, Mortazavi A, Ford LA, Slack JL, Barcos M, Ferrone S, Baer MR. HLA-DR antigen-negative acute myeloid leukemia. Leukemia. 2003 Apr; 17(4):707-15.
    View in: PubMed
  213. Yang T, McNally BA, Ferrone S, Liu Y, Zheng P. A single-nucleotide deletion leads to rapid degradation of TAP-1 mRNA in a melanoma cell line. J Biol Chem. 2003 Apr 25; 278(17):15291-6.
    View in: PubMed
  214. Seliger B, Abken H, Ferrone S. HLA-G and MIC expression in tumors and their role in anti-tumor immunity. Trends Immunol. 2003 Feb; 24(2):82-7.
    View in: PubMed
  215. Contini P, Ghio M, Poggi A, Filaci G, Indiveri F, Ferrone S, Puppo F. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur J Immunol. 2003 Jan; 33(1):125-34.
    View in: PubMed
  216. Campoli M, Chang CC, Ferrone S. HLA class I antigen loss, tumor immune escape and immune selection. Vaccine. 2002 Dec 19; 20 Suppl 4:A40-5.
    View in: PubMed
  217. Pende D, Rivera P, Marcenaro S, Chang CC, Biassoni R, Conte R, Kubin M, Cosman D, Ferrone S, Moretta L, Moretta A. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Cancer Res. 2002 Nov 1; 62(21):6178-86.
    View in: PubMed
  218. Ferrone S. Changes in serum ganglioside and antibody levels in soft tissue sarcoma: are they the cause or the effect of tumor progression? Cancer J. 2002 Sep-Oct; 8(5):369-70.
    View in: PubMed
  219. Wang ZC, Smith AG, Yunis EJ, Selvakumar A, Ferrone S, McKinney S, Lee JH, Fernandez-Vina M, Hansen JA. Molecular characterization of the HLA-Cw*0409N allele. Hum Immunol. 2002 Apr; 63(4):295-300.
    View in: PubMed
  220. Seliger B, Cabrera T, Garrido F, Ferrone S. HLA class I antigen abnormalities and immune escape by malignant cells. Semin Cancer Biol. 2002 Feb; 12(1):3-13.
    View in: PubMed
  221. Noronha EJ, Wang X, Ferrone S. Isolation of human tumor-associated cell surface antigen-binding scFvs. Methods Mol Biol. 2002; 178:227-33.
    View in: PubMed
  222. Rothenfusser S, Buchwald A, Kock S, Ferrone S, Fisch P. Missing HLA class I expression on Daudi cells unveils cytotoxic and proliferative responses of human gammadelta T lymphocytes. Cell Immunol. 2002 Jan; 215(1):32-44.
    View in: PubMed
  223. Seliger B, Ritz U, Abele R, Bock M, Tampé R, Sutter G, Drexler I, Huber C, Ferrone S. Immune escape of melanoma: first evidence of structural alterations in two distinct components of the MHC class I antigen processing pathway. Cancer Res. 2001 Dec 15; 61(24):8647-50.
    View in: PubMed
  224. Ericsson C, Seregard S, Bartolazzi A, Levitskaya E, Ferrone S, Kiessling R, Larsson O. Association of HLA class I and class II antigen expression and mortality in uveal melanoma. Invest Ophthalmol Vis Sci. 2001 Sep; 42(10):2153-6.
    View in: PubMed
  225. Ugurel S, Rebmann V, Ferrone S, Tilgen W, Grosse-Wilde H, Reinhold U. Soluble human leukocyte antigen--G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy. Cancer. 2001 Jul 15; 92(2):369-76.
    View in: PubMed
  226. Herlyn M, Ferrone S, Ronai Z, Finerty J, Pelroy R, Mohla S. Melanoma biology and progression. Cancer Res. 2001 Jun 1; 61(11):4642-3.
    View in: PubMed
  227. Kamarashev J, Ferrone S, Seifert B, Böni R, Nestle FO, Burg G, Dummer R. TAP1 down-regulation in primary melanoma lesions: an independent marker of poor prognosis. Int J Cancer. 2001 Jan 20; 95(1):23-8.
    View in: PubMed
  228. Wetzler M, Baer MR, Stewart SJ, Donohue K, Ford L, Stewart CC, Repasky EA, Ferrone S. HLA class I antigen cell surface expression is preserved on acute myeloid leukemia blasts at diagnosis and at relapse. Leukemia. 2001 Jan; 15(1):128-33.
    View in: PubMed
  229. Ferrone S, Wang X. Active specific immunotherapy of malignant melanoma and peptide mimics of the human high-molecular-weight melanoma-associated antigen. Recent Results Cancer Res. 2001; 158:231-5.
    View in: PubMed
  230. Wang X, Luo W, Foon KA, Ferrone S. Tumor associated antigen (TAA) mimicry and immunotherapy of malignant diseases from anti-idiotypic antibodies to peptide mimics. Cancer Chemother Biol Response Modif. 2001; 19:309-26.
    View in: PubMed
  231. Paul P, Rouas-Freiss N, Moreau P, Cabestre FA, Menier C, Khalil-Daher I, Pangault C, Onno M, Fauchet R, Martinez-Laso J, Morales P, Villena AA, Giacomini P, Natali PG, Frumento G, Ferrara GB, McMaster M, Fisher S, Schust D, Ferrone S, Dausset J, Geraghty D, Carosella ED. HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression. Hum Immunol. 2000 Nov; 61(11):1177-95.
    View in: PubMed
  232. Desai SA, Wang X, Noronha EJ, Zhou Q, Rebmann V, Grosse-Wilde H, Moy FJ, Powers R, Ferrone S. Structural relatedness of distinct determinants recognized by monoclonal antibody TP25.99 on beta 2-microglobulin-associated and beta 2-microglobulin-free HLA class I heavy chains. J Immunol. 2000 Sep 15; 165(6):3275-83.
    View in: PubMed
  233. Kiessling R, Pawelec G, Welsh RM, Barry JD, Ferrone S. Have tumor cells learnt from microorganisms how to fool the immune system? Escape from immune surveillance of tumors and microorganisms: emerging mechanisms and shared strategies. Mol Med Today. 2000 Sep; 6(9):344-6.
    View in: PubMed
  234. Seliger B, Maeurer MJ, Ferrone S. Antigen-processing machinery breakdown and tumor growth. Immunol Today. 2000 Sep; 21(9):455-64.
    View in: PubMed
  235. Moy FJ, Desai SA, Wang X, Noronha EJ, Zhou Q, Ferrone S, Powers R. Analysis by NMR spectroscopy of the structural homology between the linear and the cyclic peptide recognized by anti-human leukocyte antigen class I monoclonal antibody TP25.99*. J Biol Chem. 2000 Aug 11; 275(32):24679-85.
    View in: PubMed
  236. Kageshita T, Hamby CV, Hirai S, Kimura T, Ono T, Ferrone S. Alpha(v)beta3 expression on blood vessels and melanoma cells in primary lesions: differential association with tumor progression and clinical prognosis. Cancer Immunol Immunother. 2000 Aug; 49(6):314-8.
    View in: PubMed
  237. Puppo F, Brenci S, Contini P, Bignardi D, Hamby CV, Filaci G, Ghio M, Scudeletti M, Picciotto A, Indiveri F, Ferrone S. Increased beta2-microglobulin-free HLA class I heavy chain serum levels in the course of immune responses to viral antigens and to mismatched HLA antigens. Tissue Antigens. 2000 Apr; 55(4):333-41.
    View in: PubMed
  238. Kageshita T, Hamby CV, Hirai S, Kimura T, Ono T, Ferrone S. Differential clinical significance of alpha(v)Beta(3) expression in primary lesions of acral lentiginous melanoma and of other melanoma histotypes. Int J Cancer. 2000 Mar 20; 89(2):153-9.
    View in: PubMed
  239. Puppo F, Contini P, Ghio M, Brenci S, Scudeletti M, Filaci G, Ferrone S, Indiveri F. Soluble human MHC class I molecules induce soluble Fas ligand secretion and trigger apoptosis in activated CD8(+) Fas (CD95)(+) T lymphocytes. Int Immunol. 2000 Feb; 12(2):195-203.
    View in: PubMed
  240. Ferrone S, Finerty JF, Jaffee EM, Nabel GJ. How much longer will tumour cells fool the immune system? Immunol Today. 2000 Feb; 21(2):70-2.
    View in: PubMed
  241. Marincola FM, Jaffee EM, Hicklin DJ, Ferrone S. Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. Adv Immunol. 2000; 74:181-273.
    View in: PubMed
  242. Wang X, Luo W, Ferrone S. Immunotherapy of melanoma: peptide mimics of a human high molecular weight-melanoma associated antigen. Medicina (B Aires). 2000; 60 Suppl 2:48-50.
    View in: PubMed
  243. Perosa F, Prete M, Luccarelli G, Favoino B, Ferrone S, Dammacco F. Serum levels of beta-2-microglobulin-free heavy chain of HLA class I antigen in healthy individuals: relationship to their class I allotype. Hum Immunol. 1999 Nov; 60(11):1058-66.
    View in: PubMed
  244. Perosa F, Luccarelli G, Prete M, Ferrone S, Dammacco F. Increased serum levels of beta2m-free HLA class I heavy chain in multiple myeloma. Br J Haematol. 1999 Sep; 106(4):987-94.
    View in: PubMed
  245. Wang Z, Marincola FM, Rivoltini L, Parmiani G, Ferrone S. Selective histocompatibility leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells. J Exp Med. 1999 Jul 19; 190(2):205-15.
    View in: PubMed
  246. Reinhold U, Liu L, Lüdtke-Handjery HC, Heuser C, Hombach A, Wang X, Tilgen W, Ferrone S, Abken H. Specific lysis of melanoma cells by receptor grafted T cells is enhanced by anti-idiotypic monoclonal antibodies directed to the scFv domain of the receptor. J Invest Dermatol. 1999 May; 112(5):744-50.
    View in: PubMed
  247. Finke J, Ferrone S, Frey A, Mufson A, Ochoa A. Where have all the T cells gone? Mechanisms of immune evasion by tumors. Immunol Today. 1999 Apr; 20(4):158-60.
    View in: PubMed
  248. Hicklin DJ, Marincola FM, Ferrone S. HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story. Mol Med Today. 1999 Apr; 5(4):178-86.
    View in: PubMed
  249. Cormier JN, Panelli MC, Hackett JA, Bettinotti MP, Mixon A, Wunderlich J, Parker LL, Restifo NP, Ferrone S, Marincola FM. Natural variation of the expression of HLA and endogenous antigen modulates CTL recognition in an in vitro melanoma model. Int J Cancer. 1999 Mar 1; 80(5):781-90.
    View in: PubMed
  250. Kageshita T, Hirai S, Ono T, Hicklin DJ, Ferrone S. Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression. Am J Pathol. 1999 Mar; 154(3):745-54.
    View in: PubMed
  251. Puppo F, Bignardi D, Contini P, Hamby CV, Brenci S, Lanza L, Ghio M, Scudeletti M, Indiveri F, Ferrone S. Beta2-micro-free HLA class I heavy chain levels in sera of healthy individuals. Lack of association with beta2-micro-associated HLA class I heavy chain levels and HLA phenotype. Tissue Antigens. 1999 Mar; 53(3):253-62.
    View in: PubMed
  252. Willers J, Lucchese A, Kanduc D, Ferrone S. Molecular mimicry of phage displayed peptides mimicking GD3 ganglioside. Peptides. 1999; 20(9):1021-6.
    View in: PubMed
  253. Rebmann V, Pfeiffer K, Pässler M, Ferrone S, Maier S, Weiss E, Grosse-Wilde H. Detection of soluble HLA-G molecules in plasma and amniotic fluid. Tissue Antigens. 1999 Jan; 53(1):14-22.
    View in: PubMed
  254. Burlingham WJ, Jankowska-Gan E, DeVito-Haynes L, Fechner JH, Hogan KT, Claas FH, Mulder A, Wang X, Ferrone S. HLA (A*0201) mimicry by anti-idiotypic monoclonal antibodies. J Immunol. 1998 Dec 15; 161(12):6705-14.
    View in: PubMed
  255. Hamby CV, Chinol M, Palestro CJ, Manzo C, Ferrone S. Improved tumor targeting of rhenium-186-labeled anti-human high-m.w. melanoma-associated antigen monoclonal antibody 763.74 following purification with anti-idiotypic monoclonal antibody MK2-23. Int J Cancer. 1998 Nov 9; 78(4):486-90.
    View in: PubMed
  256. Noronha EJ, Wang X, Desai SA, Kageshita T, Ferrone S. Limited diversity of human scFv fragments isolated by panning a synthetic phage-display scFv library with cultured human melanoma cells. J Immunol. 1998 Sep 15; 161(6):2968-76.
    View in: PubMed
  257. Fayen J, Huang JH, Ferrone S, Tykocinski ML. Negative signaling by anti-HLA class I antibodies is dependent upon two triggering events. Int Immunol. 1998 Sep; 10(9):1347-58.
    View in: PubMed
  258. Wang Z, Arienti F, Parmiani G, Ferrone S. Induction and functional characterization of beta2-microglobulin (beta2-mu)-free HLA class I heavy chains expressed by beta2-mu-deficient human FO-1 melanoma cells. Eur J Immunol. 1998 Sep; 28(9):2817-26.
    View in: PubMed
  259. Bresciani A, Pirozzi G, Spera M, Lombardi ML, Ambrosone L, Migliaresi S, Ferrone S, Manzo C. Increased level of serum HLA class I antigens in patients with systemic lupus in patients with systemic lupus erythematosus. Correlation with disease activity. Tissue Antigens. 1998 Jul; 52(1):44-50.
    View in: PubMed
  260. Chatterjee-Kishore M, Kishore R, Hicklin DJ, Marincola FM, Ferrone S. Different requirements for signal transducer and activator of transcription 1alpha and interferon regulatory factor 1 in the regulation of low molecular mass polypeptide 2 and transporter associated with antigen processing 1 gene expression. J Biol Chem. 1998 Jun 26; 273(26):16177-83.
    View in: PubMed
  261. Hicklin DJ, Wang Z, Arienti F, Rivoltini L, Parmiani G, Ferrone S. beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma. J Clin Invest. 1998 Jun 15; 101(12):2720-9.
    View in: PubMed
  262. Desai SA, Wang X, Noronha EJ, Kageshita T, Ferrone S. Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library. Cancer Res. 1998 Jun 1; 58(11):2417-25.
    View in: PubMed
  263. Wang Z, Seliger B, Mike N, Momburg F, Knuth A, Ferrone S. Molecular analysis of the HLA-A2 antigen loss by melanoma cells SK-MEL-29.1.22 and SK-MEL-29.1.29. Cancer Res. 1998 May 15; 58(10):2149-57.
    View in: PubMed
  264. Völk H, Charlemagne J, Tournefier A, Ferrone S, Jost R, Parisot R, Kaufman J. Wide tissue distribution of axolotl class II molecules occurs independently of thyroxin. Immunogenetics. 1998 Apr; 47(5):339-49.
    View in: PubMed
  265. Vitale M, Rezzani R, Rodella L, Zauli G, Grigolato P, Cadei M, Hicklin DJ, Ferrone S. HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions. Cancer Res. 1998 Feb 15; 58(4):737-42.
    View in: PubMed
  266. Kishore R, Hicklin DJ, Dellaratta DV, Golde U, Kageshita T, Seliger B, Ferrone S. Development and characterization of mouse anti-human LMP2, LMP7, TAP1 and TAP2 monoclonal antibodies. Tissue Antigens. 1998 Feb; 51(2):129-40.
    View in: PubMed
  267. Perosa F, Luccarelli G, Neri M, De Pinto V, Ferrone S, Dammacco F. Evaluation of biotinylated cells as a source of antigens for characterization of their molecular profile. Int J Clin Lab Res. 1998; 28(4):246-51.
    View in: PubMed
  268. Abken H, Hombach A, Reinhold U, Ferrone S. Can combined T-cell- and antibody-based immunotherapy outsmart tumor cells? Immunol Today. 1998 Jan; 19(1):2-5.
    View in: PubMed
  269. Dellaratta DV, Hicklin DJ, Kishore R, Kageshita T, Ferrone S. Characterization of rabbit antisera elicited with human LMP2- and LMP7-specific peptides and recombinant proteins. Tissue Antigens. 1997 Dec; 50(6):567-75.
    View in: PubMed
  270. Fisch P, Meuer E, Pende D, Rothenfusser S, Viale O, Kock S, Ferrone S, Fradelizi D, Klein G, Moretta L, Rammensee HG, Boon T, Coulie P, van der Bruggen P. Control of B cell lymphoma recognition via natural killer inhibitory receptors implies a role for human Vgamma9/Vdelta2 T cells in tumor immunity. Eur J Immunol. 1997 Dec; 27(12):3368-79.
    View in: PubMed
  271. Hicklin DJ, Dellaratta DV, Kishore R, Liang B, Kageshita T, Ferrone S. Beta2-microglobulin gene mutations in human melanoma cells: molecular characterization and implications for immune surveillance. Melanoma Res. 1997 Aug; 7 Suppl 2:S67-74.
    View in: PubMed
  272. Zhu X, Bavari S, Ulrich R, Sadegh-Nasseri S, Ferrone S, McHugh L, Mage M. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens. Eur J Immunol. 1997 Aug; 27(8):1933-41.
    View in: PubMed
  273. Mutz M, Hawthorne T, Ferrone S, Pluschke G. Titration calorimetry study of an anti-idiotypic antibody cascade in a human melanoma-associated antigen system. Mol Immunol. 1997 Jul; 34(10):695-707.
    View in: PubMed
  274. Turco MC, Romano MF, Lamberti A, Petrella A, Bisogni R, Sun SC, Ferrone S, Bonelli P, Cerra M, Venuta S. Induction of nuclear factor kappa B/Rel nuclear activity in human peripheral blood T lymphocytes by anti-HLA class I monoclonal antibodies. Tissue Antigens. 1997 Jul; 50(1):1-7.
    View in: PubMed
  275. Seliger B, Maeurer MJ, Ferrone S. TAP off--tumors on. Immunol Today. 1997 Jun; 18(6):292-9.
    View in: PubMed
  276. Natali PG, Hamby CV, Felding-Habermann B, Liang B, Nicotra MR, Di Filippo F, Giannarelli D, Temponi M, Ferrone S. Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions. Cancer Res. 1997 Apr 15; 57(8):1554-60.
    View in: PubMed
  277. Puppo F, Indiveri F, Scudeletti M, Ferrone S. Soluble HLA antigens: new roles and uses. Immunol Today. 1997 Apr; 18(4):154-5.
    View in: PubMed
  278. Hamby CV, Chinol M, Manzo C, Ferrone S. Purification by affinity chromatography with anti-idiotypic monoclonal antibodies of immunoreactive monoclonal antibodies following labeling with 188Re. Hybridoma. 1997 Feb; 16(1):27-31.
    View in: PubMed
  279. Merimsky O, Shoenfeld Y, Baharav E, Altomonte M, Chaitchik S, Maio M, Ferrone S, Fishman P. Melanoma-associated hypopigmentation: where are the antibodies? Am J Clin Oncol. 1996 Dec; 19(6):613-8.
    View in: PubMed
  280. Reisfeld RA, Ferrone S. International Conference on the Biology of Melanoma. Aviano, Italy, 24-26 September 1995. Melanoma Res. 1996 Dec; 6(6):447-56.
    View in: PubMed
  281. Hicklin DJ, Kageshita T, Ferrone S. Development and characterization of rabbit antisera to human MHC-linked transporters associated with antigen processing. Tissue Antigens. 1996 Jul; 48(1):38-46.
    View in: PubMed
  282. Boccaletti V, Temponi M, Wang Z, Manganoni AM, Marcelli M, Maio M, Ferrone S, De Panfilis G. The vitronectin receptor alpha-V beta-3, contrary to ICAM-1, is not modulated by interferon-gamma and tumour necrosis factor-alpha on melanoma cell lines. Acta Derm Venereol. 1996 Jul; 76(4):269-73.
    View in: PubMed
  283. Wang Z, Margulies L, Hicklin DJ, Ferrone S. Molecular and functional phenotypes of melanoma cells with abnormalities in HLA class I antigen expression. Tissue Antigens. 1996 May; 47(5):382-90.
    View in: PubMed
  284. Puppo F, Brenci S, Ghio M, Bignardi D, Contini P, Bacigalupo A, Van Lint MT, Scudeletti M, Ferrone S, Indiveri F. Serum HLA class I antigen levels in allogeneic bone marrow transplantation: a possible marker of acute GVHD. Bone Marrow Transplant. 1996 May; 17(5):753-8.
    View in: PubMed
  285. Ferrone S. Anti-idiotypic monoclonal antibodies as therapeutic vaccines. Melanoma Res. 1996 Apr; 6(2):179.
    View in: PubMed
  286. Ban N, Day J, Wang X, Ferrone S, McPherson A. Crystal structure of an anti-anti-idiotype shows it to be self-complementary. J Mol Biol. 1996 Feb 2; 255(4):617-27.
    View in: PubMed
  287. Baharav E, Merimsky O, Altomonte M, Shoenfeld Y, Pavlovic M, Maio M, Ferrone S, Fishman P. Anti-tyrosinase antibodies participate in the immune response to vaccination with anti-idiotypic antibodies mimicking the high-molecular-weight melanoma-associated antigen. Melanoma Res. 1995 Oct; 5(5):337-43.
    View in: PubMed
  288. Ferrone S, Marincola FM. Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol Today. 1995 Oct; 16(10):487-94.
    View in: PubMed
  289. Mittelman A, Chen GZ, Wong GY, Liu C, Hirai S, Ferrone S. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma. Clin Cancer Res. 1995 Jul; 1(7):705-13.
    View in: PubMed
  290. Arkin S, Ferrone S, Lipton JM. Modulation of adhesion molecule CD54 expression on CD34+ hematopoietic progenitors. Exp Hematol. 1995 Jul; 23(7):588-96.
    View in: PubMed
  291. Mittelman A, Wang X, Matsumoto K, Ferrone S. Antiantiidiotypic response and clinical course of the disease in patients with malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23. Hybridoma. 1995 Apr; 14(2):175-81.
    View in: PubMed
  292. Puppo F, Scudeletti M, Indiveri F, Ferrone S. Serum HLA class I antigens: markers and modulators of an immune response? Immunol Today. 1995 Mar; 16(3):124-7.
    View in: PubMed
  293. Kageshita T, Hirai S, Ono T, Ferrone S. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic MAb MK2-23. Immunohistochemical analysis of the reactivity of anti-anti-idiotypic MAb with surgically removed melanoma lesions. Int J Cancer. 1995 Jan 27; 60(3):334-40.
    View in: PubMed
  294. Iwasaki Y, Takabatake H, Monestier M, Ferrone S. Idiotypic diversity and variable region gene usage by mouse anti-HLA-DQ3 mAb. Immunogenetics. 1995; 42(2):90-100.
    View in: PubMed
  295. Iwasaki Y, Takabatake H, Shinji T, Monestier M, Ferrone S. Structural profile of idiotype, anti-idiotype and anti-anti-idiotype monoclonal antibodies in the HLA-DQ3 antigenic system. Eur J Immunol. 1994 Nov; 24(11):2874-81.
    View in: PubMed
  296. Shoenfeld Y, Amital H, Ferrone S, Kennedy RC. Anti-idiotypes and their application under autoimmune, neoplastic, and infectious conditions. Int Arch Allergy Immunol. 1994 Nov; 105(3):211-23.
    View in: PubMed
  297. Castagnoli C, Stella M, Magliacani G, Ferrone S, Richiardi PM. Similar ectopic expression of ICAM-1 and HLA class II molecules in hypertrophic scars following thermal injury. Burns. 1994 Oct; 20(5):430-3.
    View in: PubMed
  298. Resnicoff M, Coppola D, Sell C, Rubin R, Ferrone S, Baserga R. Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor. Cancer Res. 1994 Sep 15; 54(18):4848-50.
    View in: PubMed
  299. May LT, Patel K, García D, Ndubuisi MI, Ferrone S, Mittelman A, Mackiewicz A, Sehgal PB. Sustained high levels of circulating chaperoned interleukin-6 after active specific cancer immunotherapy. Blood. 1994 Sep 15; 84(6):1887-95.
    View in: PubMed
  300. Puppo F, Brenci S, Lanza L, Bosco O, Imro MA, Scudeletti M, Indiveri F, Ferrone S. Increased level of serum HLA class I antigens in HIV infection. Correlation with disease progression. Hum Immunol. 1994 Aug; 40(4):259-66.
    View in: PubMed
  301. Ferrone S. Melanoma, immune surveillance, and immunotherapy. J Clin Invest. 1994 Apr; 93(4):1351-2.
    View in: PubMed
  302. Kageshita T, Kimura T, Yoshi A, Hirai S, Ono T, Ferrone S. Antigenic profile of mucosal melanoma lesions. Int J Cancer. 1994 Feb 1; 56(3):370-4.
    View in: PubMed
  303. Takamiya Y, Schönbach C, Nokihara K, Yamaguchi M, Ferrone S, Kano K, Egawa K, Takiguchi M. HLA-B*3501-peptide interactions: role of anchor residues of peptides in their binding to HLA-B*3501 molecules. Int Immunol. 1994 Feb; 6(2):255-61.
    View in: PubMed
  304. Mittelman A, Chen ZJ, Liu CC, Hirai S, Ferrone S. Kinetics of the immune response and regression of metastatic lesions following development of humoral anti-high molecular weight-melanoma associated antigen immunity in three patients with advanced malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23. Cancer Res. 1994 Jan 15; 54(2):415-21.
    View in: PubMed
  305. Gattoni-Celli S, Byers RH, Calorini L, Ferrone S. Organ-specific metastases in melanoma: experimental animal models. Pigment Cell Res. 1993 Dec; 6(6):381-4.
    View in: PubMed
  306. Di Rosa F, D'Oro U, Ruggiero G, Racioppi L, Acquaviva A, Ferrone S, Fontana S, Zappacosta S. HLA class II molecules transduce accessory signals affecting the CD3 but not the interleukin-2 activation pathway in T blasts. Hum Immunol. 1993 Dec; 38(4):251-60.
    View in: PubMed
  307. Kageshita T, Yoshii A, Kimura T, Kuriya N, Ono T, Tsujisaki M, Imai K, Ferrone S. Clinical relevance of ICAM-1 expression in primary lesions and serum of patients with malignant melanoma. Cancer Res. 1993 Oct 15; 53(20):4927-32.
    View in: PubMed
  308. Fishman P, Azizi E, Shoenfeld Y, Sredni B, Yecheskel G, Ferrone S, Zigelman R, Chaitchik S, Floro S, Djaldetti M. Vitiligo autoantibodies are effective against melanoma. Cancer. 1993 Oct 15; 72(8):2365-9.
    View in: PubMed
  309. Ferrone S. Anti-idiotypes in melanoma. Hybridoma. 1993 Oct; 12(5):509-14.
    View in: PubMed
  310. Wang Z, Hu XZ, Tatake RJ, Yang SY, Zeff RA, Ferrone S. Differential effect of human and mouse beta 2-microglobulin on the induction and the antigenic profile of endogenous HLA-A and -B antigens synthesized by beta 2-microglobulin gene-null FO-1 melanoma cells. Cancer Res. 1993 Sep 15; 53(18):4303-9.
    View in: PubMed
  311. Ferrone S, Kageshita T, Hirai S. Active specific immunotherapy of malignant melanoma with anti-idiotypic monoclonal antibodies. J Dermatol. 1993 Sep; 20(9):533-9.
    View in: PubMed
  312. Ferrone S. Human tumor-associated antigen mimicry by anti-idiotypic antibodies. Immunogenicity and clinical trials in patients with solid tumors. Ann N Y Acad Sci. 1993 Aug 12; 690:214-24.
    View in: PubMed
  313. Chen ZJ, Ferrone S. Comparison of the binding parameters to melanoma cells of antihuman high molecular weight-melanoma associated antigen (HMW-MAA) monoclonal antibodies (mAb) and syngeneic anti-anti-idiotypic (anti-anti-id) mAb. Ann N Y Acad Sci. 1993 Aug 12; 690:398-401.
    View in: PubMed
  314. Gattoni-Celli S, Calorini L, Simile MM, Ferrone S. Modulation by MHC class I antigens of the biology of melanoma cells. Non-immunological mechanisms. Melanoma Res. 1993 Aug; 3(4):285-9.
    View in: PubMed
  315. Tedesco F, Narchi G, Radillo O, Meri S, Ferrone S, Betterle C. Susceptibility of human trophoblast to killing by human complement and the role of the complement regulatory proteins. J Immunol. 1993 Aug 1; 151(3):1562-70.
    View in: PubMed
  316. Altomonte M, Gloghini A, Bertola G, Gasparollo A, Carbone A, Ferrone S, Maio M. Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells. Cancer Res. 1993 Jul 15; 53(14):3343-8.
    View in: PubMed
  317. Kageshita T, Wang Z, Calorini L, Yoshii A, Kimura T, Ono T, Gattoni-Celli S, Ferrone S. Selective loss of human leukocyte class I allospecificities and staining of melanoma cells by monoclonal antibodies recognizing monomorphic determinants of class I human leukocyte antigens. Cancer Res. 1993 Jul 15; 53(14):3349-54.
    View in: PubMed
  318. Yang H, Chen ZJ, Kageshita T, Yamada M, Ferrone S. Idiotypic cascade in the human high molecular weight melanoma-associated antigen system: fine specificity and idiotypic profile of anti-anti-idiotypic monoclonal antibodies. Eur J Immunol. 1993 Jul; 23(7):1671-7.
    View in: PubMed
  319. Pouletty P, Ferrone S, Amesland F, Cohen N, Westhoff U, Charron D, Shimizu RM, Grosse-Wilde H. Summary report from the first international workshop on soluble HLA antigens. Paris, August 1992. Tissue Antigens. 1993 Jul; 42(1):45-54.
    View in: PubMed
  320. Pouletty P, Chang C, Kalil J, Atwood E, Ferrone S, Shimizu B, Howson W, Mazaheri R, Del Villano B, Grumet C. Typing of serum-soluble HLA-B27 antigen by ELISA. Tissue Antigens. 1993 Jul; 42(1):14-9.
    View in: PubMed
  321. Yang YM, Rutberg SE, Luo FC, Spratt TE, Halaban R, Ferrone S, Ronai Z. A transcriptional inhibitor induced in human melanoma cells upon ultraviolet irradiation. Cell Growth Differ. 1993 Jul; 4(7):595-602.
    View in: PubMed
  322. Kageshita T, Kuriya N, Ono T, Horikoshi T, Takahashi M, Wong GY, Ferrone S. Association of high molecular weight melanoma-associated antigen expression in primary acral lentiginous melanoma lesions with poor prognosis. Cancer Res. 1993 Jun 15; 53(12):2830-3.
    View in: PubMed
  323. Temponi M, Kekish U, Hamby CV, Nielsen H, Marboe CC, Ferrone S. Characterization of anti-HLA class II monoclonal antibody LGII-612.14 reacting with formalin fixed tissues. J Immunol Methods. 1993 May 26; 161(2):239-56.
    View in: PubMed
  324. Mariani SM, Armandola EA, Ferrone S. Preferential selection of a subset of anti-HLA-DR monoclonal antibodies by a syngeneic antiidiotypic monoclonal antibody. Transplantation. 1993 May; 55(5):1176-81.
    View in: PubMed
  325. Gattoni-Celli S, Calorini L, Byers HR, Etoh T, Wang Z, Ferrone S. Abnormalities in HLA class I antigen expression by melanoma cells: structural characterization and functional implications. J Invest Dermatol. 1993 Feb; 100(2 Suppl):226S-230S.
    View in: PubMed
  326. Ferrone S, Chen ZJ, Liu CC, Hirai S, Kageshita T, Mittelman A. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibodies MK2-23. Experimental studies and clinical trials in patients with malignant melanoma. Pharmacol Ther. 1993 Feb-Mar; 57(2-3):259-90.
    View in: PubMed
  327. Armandola EA, Mariani SM, Ferrone S. Serological and molecular characterization of mouse anti-idiotypic monoclonal antibodies elicited with the syngeneic anti-HLA-A2,28 monoclonal antibody CR11-351. Mol Immunol. 1993 Feb; 30(3):287-300.
    View in: PubMed
  328. Wang Z, Cao Y, Albino AP, Zeff RA, Houghton A, Ferrone S. Lack of HLA class I antigen expression by melanoma cells SK-MEL-33 caused by a reading frameshift in beta 2-microglobulin messenger RNA. J Clin Invest. 1993 Feb; 91(2):684-92.
    View in: PubMed
  329. Quagliata F, Schenkelaars EJ, Ferrone S. Immunotherapeutic approach to rheumatoid arthritis with anti-idiotypic antibodies to HLA-DR4. Isr J Med Sci. 1993 Feb-Mar; 29(2-3):154-9.
    View in: PubMed
  330. Chen ZJ, Yang H, Liu CC, Hirai S, Ferrone S. Modulation by adjuvants and carriers of the immunogenicity in xenogeneic hosts of mouse anti-idiotypic monoclonal antibody MK2-23, an internal image of human high molecular weight-melanoma associated antigen. Cancer Res. 1993 Jan 1; 53(1):112-9.
    View in: PubMed
  331. Mariani SM, Armandola EA, Ferrone S. Diversity of anti-HLA-DR antibodies elicited by distinct anti-idiotypic monoclonal antibodies recognizing idiotopes co-expressed by the immunizing monoclonal antibody. Immunology. 1992 Dec; 77(4):597-603.
    View in: PubMed
  332. Mariani SM, Armandola EA, Ferrone S. Heterogeneity in the anti-HLA-DR immune response elicited by the antiidiotypic monoclonal antibody F5-444. Analysis at the clonal level. Transplantation. 1992 Dec; 54(6):1078-84.
    View in: PubMed
  333. Armandola EA, Mariani SM, Zwickl M, Hardman N, Ferrone S. Molecular analysis of anti-idiotypic monoclonal antibodies in the HLA-DR antigenic system. Eur J Immunol. 1992 Nov; 22(11):2893-9.
    View in: PubMed
  334. Wang Z, Cao Y, D'Urso CM, Ferrone S. Differential susceptibility of cultured human melanoma cell lines to enhancement by retinoic acid of intercellular adhesion molecule 1 expression. Cancer Res. 1992 Sep 1; 52(17):4766-72.
    View in: PubMed
  335. Tatake RJ, Ferrone S, Zeff RA. The role of beta-2 microglobulin in temperature-sensitive and interferon-gamma-induced exocytosis of HLA class I molecules. Transplantation. 1992 Sep; 54(3):395-403.
    View in: PubMed
  336. Cozzi E, Ferrone S. Immunotherapeutic approaches with monoclonal antibodies to immunological diseases. Recenti Prog Med. 1992 Sep; 83(9):528-33.
    View in: PubMed
  337. Kageshita T, Ono T, Hirai S, Yoshii A, Kimura T, Nakakuma H, Horikawa K, Takatsuki K, Ferrone S. Ganglioside, adhesion molecule, and HLA antigen expression in basal cell carcinoma lesions. Cancer Res. 1992 Jun 1; 52(11):3201-7.
    View in: PubMed
  338. Tanabe M, Sekimata M, Ferrone S, Takiguchi M. Structural and functional analysis of monomorphic determinants recognized by monoclonal antibodies reacting with the HLA class I alpha 3 domain. J Immunol. 1992 May 15; 148(10):3202-9.
    View in: PubMed
  339. Temponi M, Gold AM, Ferrone S. Binding parameters and idiotypic profile of the whole immunoglobulin and Fab' fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen. Cancer Res. 1992 May 1; 52(9):2497-503.
    View in: PubMed
  340. Dal Canton A, Fuiano G, Sepe V, Caglioti A, Ferrone S. Mesangial expression of intercellular adhesion molecule-1 in primary glomerulosclerosis. Kidney Int. 1992 Apr; 41(4):951-5.
    View in: PubMed
  341. Sakaguchi K, Koide N, Takenami T, Matsushima H, Takabatake H, Ferrone S, Tsuji T. Soluble HLA class I antigens in sera of patients with chronic hepatitis. Gastroenterol Jpn. 1992 Apr; 27(2):206-11.
    View in: PubMed
  342. Matsui M, Yoshimura S, Nakanishi T, Ferrone S. Effect of tumor size on the enhancement by gamma interferon of the localization of radiolabeled F(ab')2 fragments of anti-intercellular adhesion molecule-1 monoclonal antibodies in human colon carcinoma cells grafted in nude mice. Cancer Res. 1992 Mar 1; 52(5):1309-13.
    View in: PubMed
  343. Mittelman A, Chen ZJ, Yang H, Wong GY, Ferrone S. Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma. Proc Natl Acad Sci U S A. 1992 Jan 15; 89(2):466-70.
    View in: PubMed
  344. Kageshita T, Yamada M, Arao T, Ferrone S. Expression of high molecular weight-melanoma associated antigen (HMW-MAA) in primary ALM lesions is associated with a poor prognosis. Pigment Cell Res. 1992; Suppl 2:132-5.
    View in: PubMed
  345. Guarini L, Graham GM, Jiang H, Ferrone S, Zucker S, Fisher PB. Modulation of the antigenic phenotype of human melanoma cells by differentiation-inducing and growth-suppressing agents. Pigment Cell Res. 1992; Suppl 2:123-31.
    View in: PubMed
  346. Chen ZJ, Yang H, Liu CC, Mittelman A, Ferrone S. Association between induction of anti high molecular weight-melanoma associated antigen (HMW-MAA) immunity with mouse antiidiotypic monoclonal antibody (MoAb) MK2-23 and prolongation of survival in patients with melanoma. Pigment Cell Res. 1992; Suppl 2:113-22.
    View in: PubMed
  347. Perosa F, Ferrone S, Dammacco F. Anti-idiotypic monoclonal antibodies reacting with idiotope on isolated-denatured chains of an anti-CD4 monoclonal antibody. Immunology. 1991 Dec; 74(4):748-50.
    View in: PubMed
  348. Chattopadhyay P, Kaveri SV, Byars N, Starkey J, Ferrone S, Raychaudhuri S. Human high molecular weight-melanoma associated antigen mimicry by an anti-idiotypic antibody: characterization of the immunogenicity and the immune response to the mouse monoclonal antibody IMel-1. Cancer Res. 1991 Nov 15; 51(22):6045-51.
    View in: PubMed
  349. Shoenfeld Y, Ferrone S, Bombardieri S. New aspects in the treatment of immunomediated diseases. Clin Exp Rheumatol. 1991 Nov-Dec; 9(6):663-73.
    View in: PubMed
  350. Temponi M, Fawwaz RA, Kekish U, Wang TS, Ferrone S. Improvement by affinity chromatography on antiidiotypic monoclonal antibodies (MAbs) of immunoreactivity and in vivo targeting of radiolabelled anti-HMW-MAA MAb TP61.5 in nude mice bearing human melanoma lesions. Int J Cancer. 1991 Oct 21; 49(4):624-30.
    View in: PubMed
  351. Turco MC, Alfinito F, De Felice M, Lamberti A, Ferrone S, Venuta S. T-cell malignancies with mature phenotypes: altered cell cycle regulation by HLA class I molecules. Blood. 1991 Oct 15; 78(8):2045-52.
    View in: PubMed
  352. Reddy PG, Graham GM, Datta S, Guarini L, Moulton TA, Jiang HP, Gottesman MM, Ferrone S, Fisher PB. Effect of recombinant fibroblast interferon and recombinant immune interferon on growth and the antigenic phenotype of multidrug-resistant human glioblastoma multiforme cells. J Natl Cancer Inst. 1991 Sep 18; 83(18):1307-15.
    View in: PubMed
  353. Chen ZJ, Yang H, Kageshita T, Ferrone S. Human high-molecular-weight melanoma-associated antigen mimicry by mouse antiidiotypic monoclonal antibody TK7-371. Cancer Res. 1991 Sep 15; 51(18):4790-7.
    View in: PubMed
  354. Moolenaar W, Bruijn JA, Schrama E, Ferrone S, Daha MR, Zwinderman AH, Hoedemaeker PJ, van Es LA, van der Woude FJ. T-cell receptors and ICAM-1 expression in renal allografts during rejection. Transpl Int. 1991 Sep; 4(3):140-5.
    View in: PubMed
  355. Mariani SM, Armandola EA, Ferrone S. Diversity in the fine specificity and idiotypic profile of mouse anti-HLA-DR monoclonal antibody elicited with the syngeneic anti-idiotypic monoclonal antibody F5-830. J Immunol. 1991 Aug 15; 147(4):1322-30.
    View in: PubMed
  356. Chen ZJ, Yang H, Ferrone S. Human high molecular weight melanoma-associated antigen mimicry by mouse antiidiotypic monoclonal antibody MK2-23. Characterization of the immunogenicity in syngeneic hosts. J Immunol. 1991 Aug 1; 147(3):1082-90.
    View in: PubMed
  357. Hayashibe K, Mishima Y, Ferrone S. Cloning and in vitro expression of a melanoma-associated antigen immunogenic in patients with melanoma. J Immunol. 1991 Aug 1; 147(3):1098-104.
    View in: PubMed
  358. Maio M, Altomonte M, Tatake R, Zeff RA, Ferrone S. Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m gene. J Clin Invest. 1991 Jul; 88(1):282-9.
    View in: PubMed
  359. Kageshita T, Nakamura T, Yamada M, Kuriya N, Arao T, Ferrone S. Differential expression of melanoma associated antigens in acral lentiginous melanoma and in nodular melanoma lesions. Cancer Res. 1991 Mar 15; 51(6):1726-32.
    View in: PubMed
  360. Arkin S, Naprstek B, Guarini L, Ferrone S, Lipton JM. Expression of intercellular adhesion molecule-1 (CD54) on hematopoietic progenitors. Blood. 1991 Mar 1; 77(5):948-53.
    View in: PubMed
  361. Mariani SM, Armandola EA, Ferrone S. Diversity in the fine specificity of anti-HLA-DR monoclonal antibodies elicited with syngeneic antiidiotypic monoclonal antibodies. Transplant Proc. 1991 Feb; 23(1 Pt 1):455-6.
    View in: PubMed
  362. D'Errico A, Facchini A, Meliconi R, Grigioni FW, Ferrone S. Reactivity of monoclonal antibody (mAb) GD9 with a cytoplasmic antigen preserved in formalin-fixed, paraffin-embedded gastrointestinal tumors. Hybridoma. 1991 Feb; 10(1):113-9.
    View in: PubMed
  363. Ruiter DJ, Mattijssen V, Broecker EB, Ferrone S. MHC antigens in human melanomas. Semin Cancer Biol. 1991 Feb; 2(1):35-45.
    View in: PubMed
  364. Wang ZG, Cao Y, D'Urso C, Houghton AN, Ferrone S. Molecular abnormalities in the expression of HLA class-I antigens by melanoma cells. Int J Cancer Suppl. 1991; 6:101-5.
    View in: PubMed
  365. Graham GM, Guarini L, Moulton TA, Datta S, Ferrone S, Giacomini P, Kerbel RS, Fisher PB. Potentiation of growth suppression and modulation of the antigenic phenotype in human melanoma cells by the combination of recombinant human fibroblast and immune interferons. Cancer Immunol Immunother. 1991; 32(6):382-90.
    View in: PubMed
  366. Perosa F, Dannecker G, Ferrone S, Dammacco F. Immunochemical and functional characterization of anti-idiotypic antibodies to a mouse anti-CD4 monoclonal antibody. Int J Clin Lab Res. 1991; 21(2):179-85.
    View in: PubMed
  367. Ghose T, Ferrone S, Blair AH, Kralovec Y, Temponi M, Singh M, Mammen M. Regression of human melanoma xenografts in nude mice injected with methotrexate linked to monoclonal antibody 225.28 to human high molecular weight-melanoma associated antigen. Cancer Immunol Immunother. 1991; 34(2):90-6.
    View in: PubMed
  368. D'Urso CM, Wang ZG, Cao Y, Tatake R, Zeff RA, Ferrone S. Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression. J Clin Invest. 1991 Jan; 87(1):284-92.
    View in: PubMed
  369. Coli A, Bigotti G, Ferrone S. Histiocytosis X arising in Hodgkin's disease: immunophenotypic characterization with a panel of monoclonal antibodies. Virchows Arch A Pathol Anat Histopathol. 1991; 418(4):369-73.
    View in: PubMed
  370. Ruggiero G, Racioppi L, Manzo C, Pirozzi G, D'Oro U, Ferrone S, Zappacosta S, Fontana S. HLA class II molecules on monocytes regulate T cell proliferation through physical interaction in the CD3 activation pathway. Eur J Immunol. 1991 Jan; 21(1):29-33.
    View in: PubMed
  371. Guarini L, Temponi M, Bruce JN, Bollon AP, Duigou GJ, Moulton TA, Ferrone S, Fisher PB. Expression and modulation by cytokines of the intercellular adhesion molecule-1 (ICAM-1) in human central nervous system tumor cell cultures. Int J Cancer. 1990 Dec 15; 46(6):1041-7.
    View in: PubMed
  372. Ferrone S. Monoclonal antibodies and tumor vaccines. Curr Opin Oncol. 1990 Dec; 2(6):1146-51.
    View in: PubMed
  373. Racioppi L, Moscarella A, Ruggiero G, Manzo C, Ferrone S, Fontana S, Zappacosta S. Inhibition by anti-HLA class II monoclonal antibodies of monoclonal antibody OKT3-induced T cell proliferation. Studies at the mRNA level. J Immunol. 1990 Dec 1; 145(11):3635-40.
    View in: PubMed
  374. De Felice M, Giarrusso PC, Lamberti A, Turco MC, Valerio G, van Lier RA, Yang SY, Ferrone S, Venuta S. Mitogenic activity of anti-CD28 MoAb CLB-CD28/1 on peripheral blood mononuclear cells and its cooperation with other anti-T cells MoAb in the activation of purified T lymphocytes. Tissue Antigens. 1990 Jul; 36(1):12-8.
    View in: PubMed
  375. Schlingemann RO, Rietveld FJ, de Waal RM, Ferrone S, Ruiter DJ. Expression of the high molecular weight melanoma-associated antigen by pericytes during angiogenesis in tumors and in healing wounds. Am J Pathol. 1990 Jun; 136(6):1393-405.
    View in: PubMed
  376. Shinji T, Ono R, Ferrone S. Fine specificity and idiotype diversity of a murine anti-HLA-DQw3 monoclonal antibody elicited with a syngeneic antiidiotypic monoclonal antibody. J Immunol. 1990 Jun 1; 144(11):4291-7.
    View in: PubMed
  377. Flajnik MF, Ferrone S, Cohen N, Du Pasquier L. Evolution of the MHC: antigenicity and unusual tissue distribution of Xenopus (frog) class II molecules. Mol Immunol. 1990 May; 27(5):451-62.
    View in: PubMed
  378. De Felice M, Turco MC, Costanzo F, Corbo L, Ferrone S, Venuta S. Inhibition by anti-HLA class I mAb of IL-2 and IL-2 receptor synthesis in lymphocytes stimulated with PHA-P. Cell Immunol. 1990 Apr 1; 126(2):420-7.
    View in: PubMed
  379. Perosa F, Carbone R, Ferrone S, Dammacco F. Purification of human immunoglobulins by sequential precipitation with caprylic acid and ammonium sulphate. J Immunol Methods. 1990 Mar 27; 128(1):9-16.
    View in: PubMed
  380. Kaufman J, Ferrone S, Flajnik M, Kilb M, Völk H, Parisot R. MHC-like molecules in some nonmammalian vertebrates can be detected by some cross-reactive monoclonal antibodies. J Immunol. 1990 Mar 15; 144(6):2273-80.
    View in: PubMed
  381. Rosenberg CD, Ferrone S, Hamby CV, Mancino V, Graf LH. Interspecific DNA-mediated transfer and amplification of a gene specifying a Mr 100,000 human melanoma-associated cell surface glycoprotein. Cancer Res. 1990 Mar 1; 50(5):1559-65.
    View in: PubMed
  382. Natali P, Nicotra MR, Cavaliere R, Bigotti A, Romano G, Temponi M, Ferrone S. Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions. Cancer Res. 1990 Feb 15; 50(4):1271-8.
    View in: PubMed
  383. Temponi M, Pupa S, Ferrone S. Purification of immunoreactive radiolabeled monoclonal antibodies with anti-idiotypic monoclonal antibodies. J Immunol Methods. 1990 Feb 9; 126(2):223-9.
    View in: PubMed
  384. Schenkelaars EJ, Bonta IL, Ferrone S, Quagliata F. Macrophage function during the development of adjuvant disease. Agents Actions. 1990 Jan; 29(1-2):111-3.
    View in: PubMed
  385. Siccardi AG, Buraggi GL, Natali PG, Scassellati GA, Viale G, Ferrone S. European multicentre study on melanoma immunoscintigraphy by means of 99mTc-labelled monoclonal antibody fragments. The European Multicentre Study Group. Eur J Nucl Med. 1990; 16(4-6):317-23.
    View in: PubMed
  386. Manzo C, Ruggiero G, del Vecchio L, Racioppi L, Pirozzi G, Temponi M, Ferrone S, Fontana S, Zappacosta S. Monoclonal antibody OKT3-induced T cell proliferation: differential role of HLA class II determinants expressed by T cells and monocytes. Cell Immunol. 1990 Jan; 125(1):79-91.
    View in: PubMed
  387. Kusama M, Kageshita T, Chen ZJ, Ferrone S. Characterization of syngeneic antiidiotypic monoclonal antibodies to murine anti-human high molecular weight melanoma-associated antigen monoclonal antibodies. J Immunol. 1989 Dec 1; 143(11):3844-52.
    View in: PubMed
  388. Turco MC, De Felice M, Alfinito F, Lamberti A, Costanzo F, Giordano M, Martinelli V, Rotoli B, Ferrone S, Venuta S. Proliferative pathways in CD1- CD3+ CD4+ CD8+ T-prolymphocytic leukemic cells: analysis with monoclonal antibodies and cytokines. Blood. 1989 Oct; 74(5):1651-7.
    View in: PubMed
  389. Ono R, Sakaguchi K, Ferrone S. Modulation by antiidiotypic monoclonal antibodies of immune lysis mediated by anti-HLA monoclonal antibodies. J Immunol. 1989 Sep 15; 143(6):1921-9.
    View in: PubMed
  390. Maio M, Gulwani B, Morgano A, Ferrone S. Differential modulation by tumor necrosis factor and immune interferon of HLA class-II antigens expressed by melanoma cells. Int J Cancer. 1989 Sep 15; 44(3):554-9.
    View in: PubMed
  391. Perosa F, Ferrone S. Murine antiidiotypic monoclonal antibodies that bear the internal image of HLA-DR allospecificities. J Clin Invest. 1989 Sep; 84(3):907-14.
    View in: PubMed
  392. Gilliland LK, Norris NA, Grosmaire LS, Ferrone S, Gladstone P, Ledbetter JA. Signal transduction in lymphocyte activation through crosslinking of HLA class I molecules. Hum Immunol. 1989 Aug; 25(4):269-89.
    View in: PubMed
  393. De Felice M, Turco MC, Corbo L, Carandente Giarrusso P, Lamberti A, Valerio G, Temponi M, Costanzo F, Ferrone S, Venuta S. Lack of a role of monocytes in the inhibition by monoclonal antibodies to monomorphic and polymorphic determinants of HLA class I antigens of PHA-P-induced peripheral blood mononuclear cell proliferation. Cell Immunol. 1989 Aug; 122(1):164-77.
    View in: PubMed
  394. Komura A, Tokuhisa T, Nakagawa T, Sasase A, Ichihashi M, Ferrone S, Mishima Y. Specific killing of human melanoma cells with an efficient 10B-compound on monoclonal antibodies. Pigment Cell Res. 1989 Jul-Aug; 2(4):259-63.
    View in: PubMed
  395. Maio M, Tessitori G, Pinto A, Temponi M, Colombatti A, Ferrone S. Differential role of distinct determinants of intercellular adhesion molecule-1 in immunologic phenomena. J Immunol. 1989 Jul 1; 143(1):181-8.
    View in: PubMed
  396. Maio M, Gulwani B, Langer JA, Kerbel RS, Duigou GJ, Fisher PB, Ferrone S. Modulation by interferons of HLA antigen, high-molecular-weight melanoma associated antigen, and intercellular adhesion molecule 1 expression by cultured melanoma cells with different metastatic potential. Cancer Res. 1989 Jun 1; 49(11):2980-7.
    View in: PubMed
  397. Scambia G, Benedetti Panici P, Baiocchi G, Coli A, Ferrone S, Natali PG, Mancuso S. A primary amelanotic melanoma of the vagina diagnosed by immunocytochemistry. Int J Gynaecol Obstet. 1989 Jun; 29(2):159-64.
    View in: PubMed
  398. Matzku S, Kirchgessner H, Schmid U, Temponi M, Ferrone S. Melanoma targeting with a cocktail of monoclonal antibodies to distinct determinants of the human HMW-MAA. J Nucl Med. 1989 Mar; 30(3):390-7.
    View in: PubMed
  399. Natali PG, Bigotti A, Nicotra MR, Nardi RM, Delovu A, Segatto O, Ferrone S. Analysis of the antigenic profile of uveal melanoma lesions with anti-cutaneous melanoma-associated antigen and anti-HLA monoclonal antibodies. Cancer Res. 1989 Mar 1; 49(5):1269-74.
    View in: PubMed
  400. Kumari HL, Shuler CF, Lehman T, Ferrone S, Milo GE. Development of neoplastic phenotype following transfection of HNF cells with sarcoma DNA. Carcinogenesis. 1989 Feb; 10(2):401-4.
    View in: PubMed
  401. Ziai MR, Hamby CV, Reddy R, Hayashibe K, Ferrone S. Rapid purification of plasmid DNA following acid precipitation of bacterial proteins. Biotechniques. 1989 Feb; 7(2):147.
    View in: PubMed
  402. Temponi M, Kageshita T, Perosa F, Ono R, Okada H, Ferrone S. Purification of murine IgG monoclonal antibodies by precipitation with caprylic acid: comparison with other methods of purification. Hybridoma. 1989 Feb; 8(1):85-95.
    View in: PubMed
  403. Graf LH, Ferrone S. Human melanoma-associated antigens. Immunol Ser. 1989; 43:643-79.
    View in: PubMed
  404. Guarini L, Temponi M, Edwalds GM, Vita JR, Fisher PB, Ferrone S. In vitro differentiation and antigenic changes in human melanoma cell lines. Cancer Immunol Immunother. 1989; 30(5):262-8.
    View in: PubMed
  405. O'Connell MJ, Chen ZJ, Yang H, Yamada M, Massaro M, Mittelman A, Ferrone S. Active specific immunotherapy with antiidiotypic antibodies in patients with solid tumors. Semin Surg Oncol. 1989; 5(6):441-7.
    View in: PubMed
  406. Perosa F, Kageshita T, Ono R, Ferrone S. Serological methods to detect anti-idiotypic antibodies. Methods Enzymol. 1989; 178:74-90.
    View in: PubMed
  407. Natali PG, Fawwaz R, Ruiter DJ, Bigotti A, Kageshita T, Temponi M, Ferrone S. Immunodiagnostic and immunotherapeutic applications of anti human melanoma associated antigen monoclonal antibodies. Carcinog Compr Surv. 1989; 11:133-63.
    View in: PubMed
  408. Maio M, Gulwani B, Tombesi S, Ferrone S. Modulation by cytokines of HLA antigens, intercellular adhesion molecule 1 and high molecular weight melanoma associated antigen expression and of immune lysis of clones derived from the melanoma cell line MeM 50-10. Cancer Immunol Immunother. 1989; 30(1):34-42.
    View in: PubMed
  409. Ziai MR, Ferrone S. Specific phosphorylation by calcium-EGTA complex of a 75 kDa human tumor plasma membrane protein (pp75). Int J Biochem. 1989; 21(7):731-8.
    View in: PubMed
  410. Perosa F, Ferrone S. Syngeneic antiidiotypic monoclonal antibodies to the murine anti-HLA-DR,DP monoclonal antibody CR11-462. Hum Immunol. 1988 Dec; 23(4):255-69.
    View in: PubMed
  411. Temponi M, Romano G, D'Urso CM, Wang Z, Kekish U, Ferrone S. Profile of intercellular adhesion molecule-1 (ICAM-1) synthesized by human melanoma cell lines. Semin Oncol. 1988 Dec; 15(6):595-607.
    View in: PubMed
  412. Ferrone S, Kageshita T. Human high molecular weight-melanoma associated antigen as a target for active specific immunotherapy--a phase I clinical trial with murine antiidiotypic monoclonal antibodies. J Dermatol. 1988 Dec; 15(6):457-65.
    View in: PubMed
  413. Temponi M, Kekish U, Ferrone S. Immunoreactivity and affinity of murine IgG monoclonal antibodies purified by caprylic acid precipitation. J Immunol Methods. 1988 Nov 25; 115(1):151-2.
    View in: PubMed
  414. Santoli D, Radka SF, Kreider BL, Ferrone S. Regulatory role of monomorphic and polymorphic determinants of HLA class I antigens in the proliferation of T cells stimulated by autologous and allogeneic B and T lymphoid cells. Cell Immunol. 1988 Oct 15; 116(2):263-73.
    View in: PubMed
  415. Turco MC, de Felice M, Corbo L, Giarrusso PC, Yang SY, Ferrone S, Venuta S. Enhancing effect of anti-HLA class I monoclonal antibodies on T cell proliferation induced via CD2 molecule. J Immunol. 1988 Oct 1; 141(7):2275-81.
    View in: PubMed
  416. Cordiali-Fei P, Mottolese M, Tecce R, Natali P, Ferrone S. Accessory cell function of human melanoma cells in mitogen-induced T cell proliferation. Cell Immunol. 1988 Oct 1; 116(1):149-62.
    View in: PubMed
  417. Matsui M, Nakanishi T, Noguchi T, Ferrone S. Synergistic in vitro and in vivo anti-tumor effect of daunomycin-anti-96-kDa melanoma-associated antigen monoclonal antibody CL 207 conjugate and recombinant IFN-gamma. J Immunol. 1988 Aug 15; 141(4):1410-7.
    View in: PubMed
  418. Graf LH, Rosenberg CD, Mancino V, Ferrone S. Transfer and co-amplification of a gene encoding a 96-kDa immune IFN-inducible human melanoma-associated antigen. Preferential expression by mouse melanoma host cells. J Immunol. 1988 Aug 1; 141(3):1054-60.
    View in: PubMed
  419. Maio M, Gulwani B, Tombesi S, Langer JA, Duigou GJ, Kerbel RS, Fisher PB, Ferrone S. Differential induction by immune interferon of the gene products of the HLA-D region on the melanoma cell line MeWo and its metastatic variant MeM 50-10. J Immunol. 1988 Aug 1; 141(3):913-20.
    View in: PubMed
  420. Milo GE, Casto B, Ferrone S. Comparison of features of carcinogen-transformed human cells in vitro with sarcoma-derived cells. Mutat Res. 1988 Jun; 199(2):387-98.
    View in: PubMed
  421. Ziai MR, Giordano A, Armandola E, Ferrone S. Purification by ammonium sulfate precipitation of bacteriophage lambda gt11 DNA for restriction analysis of cloned cDNA inserts. Anal Biochem. 1988 May 15; 171(1):192-6.
    View in: PubMed
  422. van Vreeswijk H, Ruiter DJ, Bröcker EB, Welvaart K, Ferrone S. Differential expression of HLA-DR, DQ, and DP antigens in primary and metastatic melanoma. J Invest Dermatol. 1988 May; 90(5):755-60.
    View in: PubMed
  423. Okada H, Ono R, Addonizio JC, Nagamatsu GR, Ferrone S. A solid-phase immunoassay to screen anti-HLA monoclonal antibodies. J Immunol Methods. 1988 Mar 16; 107(2):179-87.
    View in: PubMed
  424. Sakaguchi K, Ono R, Tsujisaki M, Richiardi P, Carbonara A, Park MS, Tonai R, Terasaki PI, Ferrone S. Anti-HLA-B7,B27,Bw42,Bw54,Bw55,Bw56, Bw67,Bw73 monoclonal antibodies: specificity, idiotypes, and application for a double determinant immunoassay. Hum Immunol. 1988 Mar; 21(3):193-207.
    View in: PubMed
  425. Tsujisaki M, Sakaguchi K, Igarashi M, Richiardi P, Perosa F, Ferrone S. Fine specificity and idiotype diversity of the murine anti-HLA-A2, A28 monoclonal antibodies CR11-351 and KS1. Transplantation. 1988 Mar; 45(3):632-9.
    View in: PubMed
  426. van Duinen SG, Ruiter DJ, Broecker EB, van der Velde EA, Sorg C, Welvaart K, Ferrone S. Level of HLA antigens in locoregional metastases and clinical course of the disease in patients with melanoma. Cancer Res. 1988 Feb 15; 48(4):1019-25.
    View in: PubMed
  427. Graf LH, Matsui M, Temponi M, Romano G, Rosenberg CD, Natali PG, Ferrone S. Immunological and structural profile of a 96 kD human melanoma associated antigen with preferential distribution in metastases. Adv Exp Med Biol. 1988; 233:341-9.
    View in: PubMed
  428. Sieratzki J, Thung SN, Gerber MA, Ferrone S, Schaffner F. Major histocompatibility antigen expression in the liver in acquired immunodeficiency syndrome. Arch Pathol Lab Med. 1987 Nov; 111(11):1045-9.
    View in: PubMed
  429. Ruggiero G, Manzo C, Fontana S, Scala G, Pirozzi G, Ferrone S, Zappacosta S. Inhibition by anti-HLA class II monoclonal antibodies of monocyte-dependent T cell proliferation induced by monoclonal antibody OKT3. Eur J Immunol. 1987 Nov; 17(11):1585-92.
    View in: PubMed
  430. De Felice M, Turco MC, Giarrusso PC, Corbo L, Pizzano R, Martinelli V, Ferrone S, Venuta S. Differential regulatory role of monomorphic and polymorphic determinants of histocompatibility leukocyte antigen class I antigens in monoclonal antibody OKT3-induced T cell proliferation. J Immunol. 1987 Oct 15; 139(8):2683-9.
    View in: PubMed
  431. Hamby CV, Liao SK, Kanamaru T, Ferrone S. Immunogenicity of human melanoma-associated antigens defined by murine monoclonal antibodies in allogeneic and xenogeneic hosts. Cancer Res. 1987 Oct 15; 47(20):5284-9.
    View in: PubMed
  432. Gulwani B, Maio M, Imberti L, Melamede RJ, Ferrone S. Immunosuppressive activity of T cell clones generated from human T cells stimulated with autologous TPHA cells. J Immunol. 1987 Oct 1; 139(7):2130-6.
    View in: PubMed
  433. Giacomini P, Viora M, Tecce R, Knowles DM, Natali PG, Ferrone S. A cytoplasmic human melanoma associated antigen as a marker of activation in lymphoid cells. Cancer Res. 1987 Oct 1; 47(19):5175-80.
    View in: PubMed
  434. Liao SK, Smith JW, Kwong PC, Natali PG, Kusama M, Hamby CV, Ferrone S. Cross-reactivity of murine anti-human high molecular weight-melanoma associated antigen monoclonal antibodies with guinea pig melanoma cells. Cancer Res. 1987 Sep 15; 47(18):4835-41.
    View in: PubMed
  435. Matsui M, Temponi M, Ferrone S. Characterization of a monoclonal antibody-defined human melanoma-associated antigen susceptible to induction by immune interferon. J Immunol. 1987 Sep 15; 139(6):2088-95.
    View in: PubMed
  436. Perosa F, Ferrone S. Syngeneic anti-idiotypic antisera to murine anti-HLA class II monoclonal antibodies. J Immunol. 1987 Aug 15; 139(4):1232-9.
    View in: PubMed
  437. Kusama M, Kageshita T, Tsujisaki M, Perosa F, Ferrone S. Syngeneic antiidiotypic antisera to murine antihuman high-molecular-weight melanoma-associated antigen monoclonal antibodies. Cancer Res. 1987 Aug 15; 47(16):4312-7.
    View in: PubMed
  438. Giudizi MG, Biagiotti R, Almerigogna F, Alessi A, Tiri A, Del Prete GF, Ferrone S, Romagnani S. Role of HLA class I and class II antigens in activation and differentiation of B cells. Cell Immunol. 1987 Aug; 108(1):97-108.
    View in: PubMed
  439. Russo C, Nepo A, Lanza E, Igarashi M, Ferrone S. Antibody-induced association between discrete regions of HLA class I and II antigens. J Immunol. 1987 May 15; 138(10):3152-8.
    View in: PubMed
  440. Russo C, Fotino M, Carbonara A, Ferrone S. A double determinant immunoassay for HLA class I typing using serum as an antigen source. Hum Immunol. 1987 May; 19(1):69-77.
    View in: PubMed
  441. Ziai MR, Imberti L, Nicotra MR, Badaracco G, Segatto O, Natali PG, Ferrone S. Analysis with monoclonal antibodies of the molecular and cellular heterogeneity of human high molecular weight melanoma associated antigen. Cancer Res. 1987 May 1; 47(9):2474-80.
    View in: PubMed
  442. Perosa F, Tsujisaki M, Ferrone S. Syngeneic anti-idiotypic antisera to murine monoclonal antibodies to monomorphic and polymorphic determinants of HLA class I antigens. J Immunol. 1987 Apr 1; 138(7):2202-7.
    View in: PubMed
  443. Igarashi M, Suciu-Foca N, Ferrone S. Differential expression of HLA-DR allospecificities on antigen specific T cell clones. Tissue Antigens. 1987 Mar; 29(3):160-7.
    View in: PubMed
  444. Tsujisaki M, Igarashi M, Sakaguchi K, Eisinger M, Herlyn M, Ferrone S. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes. J Immunol. 1987 Feb 15; 138(4):1310-6.
    View in: PubMed
  445. van den Ingh HF, Ruiter DJ, Griffioen G, van Muijen GN, Ferrone S. HLA antigens in colorectal tumours--low expression of HLA class I antigens in mucinous colorectal carcinomas. Br J Cancer. 1987 Feb; 55(2):125-30.
    View in: PubMed
  446. Natali PG, Roberts JT, Difilippo F, Bigotti A, Dent PB, Ferrone S, Liao SK. Immunohistochemical detection of antigen in human primary and metastatic melanomas by the monoclonal antibody 140.240 and its possible prognostic significance. Cancer. 1987 Jan 1; 59(1):55-63.
    View in: PubMed
  447. Tsujisaki M, Kusama M, Sakaguchi K, Perosa F, Ferrone S. A sandwich assay to detect and characterize syngeneic anti-idiotypic antibodies to murine anti-HLA and tumor associated antigen monoclonal antibodies. J Immunol Methods. 1986 Dec 4; 95(1):47-55.
    View in: PubMed
  448. Ziai MR, Imberti L, Kobayashi M, Perussia B, Trinchieri G, Ferrone S. Distinct functional domains on the recombinant human immune interferon molecule. Cancer Res. 1986 Dec; 46(12 Pt 1):6187-90.
    View in: PubMed
  449. Slovin SF, Lackman RD, Ferrone S, Kiely PE, Mastrangelo MJ. Cellular immune response to human sarcomas: cytotoxic T cell clones reactive with autologous sarcomas. I. Development, phenotype, and specificity. J Immunol. 1986 Nov 1; 137(9):3042-8.
    View in: PubMed
  450. Scudeletti M, Indiveri F, Pierri I, Picciotto A, Ferrone S. T cells from patients with chronic liver diseases: abnormalities in PHA-induced expression of HLA class II antigens and in autologous mixed-lymphocyte reactions. Cell Immunol. 1986 Oct 1; 102(1):227-33.
    View in: PubMed
  451. Kantor RR, Albino AP, Ng AK, Ferrone S. Biosynthesis and intracellular processing of four human melanoma associated antigens. Cancer Res. 1986 Oct; 46(10):5223-8.
    View in: PubMed
  452. Igarashi M, Gebhard DH, Chen YX, Safai B, Evans RL, Ferrone S. Identification with the monoclonal antibody 26.163 of a determinant shared by the beta chains of the gene products of the HLA-DR, DQ, and DP loci. Hum Immunol. 1986 Aug; 16(4):347-55.
    View in: PubMed
  453. van Duinen SG, Ruitter DJ, Ferrone S. Associated expression of HLA class I and class II antigens on melanoma cells in surgically removed metastases. J Pathol. 1986 Aug; 149(4):339-48.
    View in: PubMed
  454. Crepaldi T, Crump A, Newman M, Ferrone S, Antczak DF. Equine T lymphocytes express MHC class II antigens. J Immunogenet. 1986 Aug; 13(4):349-60.
    View in: PubMed
  455. Santoli D, Radka SF, Igarashi M, Kreider BL, Ferrone S. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules. J Immunol. 1986 Jul 15; 137(2):400-7.
    View in: PubMed
  456. Pende D, Indiveri F, Pierri I, Criscuolo D, Ferrone S. In vitro enhancement of the proliferative response of human T cells to autologous non-T cells by hydralazine. Immunopharmacology. 1986 Jun; 11(3):183-7.
    View in: PubMed
  457. Fukusato T, Gerber MA, Thung SN, Ferrone S, Schaffner F. Expression of HLA class I antigens on hepatocytes in liver disease. Am J Pathol. 1986 May; 123(2):264-70.
    View in: PubMed
  458. Ruiter DJ, Bröcker EB, Ferrone S. Expression and susceptibility to modulation by interferons of HLA class I and II antigens on melanoma cells. Immunohistochemical analysis and clinical relevance. J Immunogenet. 1986 Apr-Jun; 13(2-3):229-34.
    View in: PubMed
  459. Allen JI, Ferrone S, Boue D, Kay NE. The monoclonal antibody CJA3 down-regulates the susceptibility of human tumor cell lines to natural cell-mediated cytotoxicity. J Immunol. 1986 Mar 15; 136(6):2318-22.
    View in: PubMed
  460. Natali P, Bigotti A, Cavalieri R, Nicotra MR, Tecce R, Manfredi D, Chen YX, Nadler LM, Ferrone S. Gene products of the HLA-D region in normal and malignant tissues of nonlymphoid origin. Hum Immunol. 1986 Feb; 15(2):220-33.
    View in: PubMed
  461. Taramelli D, Fossati G, Mazzocchi A, Delia D, Ferrone S, Parmiani G. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions. Cancer Res. 1986 Jan; 46(1):433-9.
    View in: PubMed
  462. Indiveri F, Pierri I, Rogna S, Poggi A, Romano R, Tavano A, Ratto G, Motta G, Ferrone S. Abnormalities of T cells isolated from mediastinal lymph nodes and peripheral blood of patients with lung carcinoma: deficit in PHA-induced expression of HLA class II antigens and in autologous mixed lymphocyte reactions. Cancer Immunol Immunother. 1986; 22(3):232-5.
    View in: PubMed
  463. Indiveri F, Scudeletti M, Pierri I, Traverso A, Cerri C, Ferrone S. PHA-T cells in systemic lupus erythematosus and in rheumatoid arthritis: abnormalities in HLA class II antigen induction and in autologous mixed lymphocyte reactions. Cell Immunol. 1986 Jan; 97(1):197-203.
    View in: PubMed
  464. Giacomini P, Aguzzi A, Ferrone S. Differential susceptibility to modulation by recombinant immune interferon of HLA-DR and -DQ antigens synthesized by melanoma COLO 38 cells. Hybridoma. 1986; 5(4):277-88.
    View in: PubMed
  465. Buraggi G, Turrin A, Cascinelli N, Attili A, Gasparini M, Callegaro L, Ferrone S, Seregni E, Bombardieri E, Belli F. Radioimmunodetection of melanoma: preliminary results of a prospective study. Int J Biol Markers. 1986 Jan-Apr; 1(1):47-54.
    View in: PubMed
  466. Quagliata F, Ferrone S, Taranta A. In vivo and in vitro antiinflammatory and immunoregulating properties of streptococcal mitogen: effects on adjuvant disease in the rat, on homograft rejection in the mouse, and on the appearance of Ia antigens on human T lymphocytes. Agents Actions. 1986 Jan; 17(3-4):377-8.
    View in: PubMed
  467. Ziai MR, Imberti L, Tongson A, Ferrone S. Differential modulation by recombinant immune interferon of the expression and shedding of HLA antigens and melanoma associated antigens by a melanoma cell line resistant to the antiproliferative activity of immune interferon. Cancer Res. 1985 Nov; 45(11 Pt 2):5877-82.
    View in: PubMed
  468. Ziai MR, Imberti L, Ferrone S. An enzyme-linked double antibody immunoassay to measure murine immunoglobulins--its application to determine the specific activity of radiolabeled monoclonal antibodies. J Immunol Methods. 1985 Oct 10; 82(2):233-41.
    View in: PubMed
  469. Natali P, Bigotti A, Cavalieri R, Wakabayaski S, Taniguchi M, Ferrone S. Distribution of a cross-species melanoma-associated antigen in normal and neoplastic human tissues. J Invest Dermatol. 1985 Oct; 85(4):340-6.
    View in: PubMed
  470. Turco MC, De Felice M, Corbo L, Morrone G, Mertelsmann R, Ferrone S, Venuta S. Regulatory role of a monomorphic determinant of HLA Class I antigens in T cell proliferation. J Immunol. 1985 Oct; 135(4):2268-73.
    View in: PubMed
  471. Giacomini P, Imberti L, Aguzzi A, Fisher PB, Trinchieri G, Ferrone S. Immunochemical analysis of the modulation of human melanoma-associated antigens by DNA recombinant immune interferon. J Immunol. 1985 Oct; 135(4):2887-94.
    View in: PubMed
  472. Indiveri F, Pierri I, Rogna S, Poggi A, Montaldo P, Romano R, Pende A, Morgano A, Barabino A, Ferrone S. Circadian variations of autologous mixed lymphocyte reactions and endogenous cortisol. J Immunol Methods. 1985 Sep 3; 82(1):17-24.
    View in: PubMed
  473. Giacomini P, Aguzzi A, Tecce R, Fisher PB, Ferrone S. A third polypeptide associated with heavy and light chain subunits of class I HLA antigens in immune interferon-treated human melanoma cells. Eur J Immunol. 1985 Sep; 15(9):946-51.
    View in: PubMed
  474. Giacomini P, Natali P, Ferrone S. Analysis of the interaction between a human high molecular weight melanoma-associated antigen and the monoclonal antibodies to three distinct antigenic determinants. J Immunol. 1985 Jul; 135(1):696-702.
    View in: PubMed
  475. Crepaldi T, Richiardi P, Malavasi F, Carbonara AO, Igarashi M, Ferrone S. The monoclonal antibody AC1.59 defines a new polymorphic determinant on HLA-DR molecules. Tissue Antigens. 1985 Jul; 26(1):25-34.
    View in: PubMed
  476. Mottolese M, Natali PG, Atlante G, Cavallari A, DiFilippo F, Ferrone S. Antigenic profile and functional characterization of human peritoneal macrophages. J Immunol. 1985 Jul; 135(1):200-6.
    View in: PubMed
  477. Natali P, Bigotti A, Cavaliere R, Liao SK, Taniguchi M, Matsui M, Ferrone S. Heterogeneous expression of melanoma-associated antigens and HLA antigens by primary and multiple metastatic lesions removed from patients with melanoma. Cancer Res. 1985 Jun; 45(6):2883-9.
    View in: PubMed
  478. Fawwaz RA, Wang TS, Estabrook A, Rosen JM, Hardy MA, Alderson PO, Srivastava SC, Richards P, Ferrone S. Immunoreactivity and biodistribution of indium-111-labeled monoclonal antibody to a human high molecular weight-melanoma associated antigen. J Nucl Med. 1985 May; 26(5):488-92.
    View in: PubMed
  479. Indiveri F, Scudeletti M, Pende D, Piccardo C, Pierri I, Ferrone S. Analysis of the role of xenogeneic antigens in the proliferation of human T cells stimulated with autologous non-T cells and phytohemagglutinin-activated T cells. Cell Immunol. 1985 May; 92(2):210-7.
    View in: PubMed
  480. Akiyama Y, Zicht R, Ferrone S, Bonnard GD, Herberman RB. Effect of monoclonal antibodies (MoAb) to class I and class II HLA antigens on lectin- and MoAb OKT3-induced lymphocyte proliferation. Cell Immunol. 1985 Apr 1; 91(2):477-91.
    View in: PubMed
  481. Matsui M, Nakanishi T, Noguchi T, Imai K, Yachi A, Ferrone S. Suppression of human melanoma growth in nude mice injected with anti high-molecular-weight melanoma-associated antigen monoclonal antibody 225.28S conjugated to purothionin. Jpn J Cancer Res. 1985 Feb; 76(2):119-23.
    View in: PubMed
  482. Quagliata F, Ferrone S, Taranta A. In vivo and in vitro immunomodulatory ability of streptococcal mitogen: effects on adjuvant disease in the rat; on homograft rejection in the mouse; and on the appearance of Ia antigens on human T lymphocytes. Drugs Exp Clin Res. 1985; 11(2):75-81.
    View in: PubMed
  483. Uadia P, Blair AH, Ghose T, Ferrone S. Uptake of methotrexate linked to polyclonal and monoclonal antimelanoma antibodies by a human melanoma cell line. J Natl Cancer Inst. 1985 Jan; 74(1):29-35.
    View in: PubMed
  484. Ghose T, Blair AH, Uadia P, Kulkarni PN, Goundalkar A, Mezei M, Ferrone S. Antibodies as carriers of cancer chemotherapeutic agents. Ann N Y Acad Sci. 1985; 446:213-27.
    View in: PubMed
  485. Romagnani S, Almerigogna F, Biagiotti R, Giudizi MG, Alessi A, Damiani G, Ricci M, Ferrone S. Role of class II histocompatibility antigens in Staphylococcus aureus protein A-induced activation of human T lymphocytes. Cell Immunol. 1985 Jan; 90(1):52-64.
    View in: PubMed
  486. Quagliata F, Ferrone S. Appearance of Ia antigens on T lymphocytes stimulated by streptococcal mitogen as an in vitro model of autoimmunity. Int J Tissue React. 1985; 7(1):47-53.
    View in: PubMed
  487. Greiner JW, Schlom J, Pestka S, Langer JA, Giacomini P, Kusama M, Ferrone S, Fisher PB. Modulation of tumor associated antigen expression and shedding by recombinant human leukocyte and fibroblast interferons. Pharmacol Ther. 1985; 31(3):209-36.
    View in: PubMed
  488. Marder P, Hinson A, Russo C, Ferrone S, Ades E. Heterogeneity of human peripheral blood mononuclear cells detected by monoclonal antibodies to monomorphic determinants of human Ia antigens. Immunobiology. 1984 Dec; 167(5):483-94.
    View in: PubMed
  489. Lordon RE, Stelzer GT, Garrison RN, Ferrone S. Early determination of renal allograft survival: a correlation between cytotoxic antibodies in recipient sera, renal pathology, and response to antirejection therapy. Transplant Proc. 1984 Dec; 16(6):1588-90.
    View in: PubMed
  490. Lordon RE, Stelzer GT, Ferrone S. The early posttransplant prognosis of acute renal allograft rejection as determined by detection of cytotoxic antibodies to lymphoid B cell lines. Transplantation. 1984 Nov; 38(5):493-7.
    View in: PubMed
  491. Scudeletti M, Torrielli F, Pende D, Piccardo C, Indiveri F, Ferrone S. Human T cells in cord blood: abnormalities in IA antigens induction by phytohemagglutinin and in autologous mixed lymphocyte reactions. Cell Immunol. 1984 Oct 15; 88(2):521-30.
    View in: PubMed
  492. Spooner RL, Ferrone S. Cross reaction of monoclonal antibodies to human MHC class I and class II products with bovine lymphocyte subpopulations. Tissue Antigens. 1984 Oct; 24(4):270-7.
    View in: PubMed
  493. Russo C, Flomenberg N, Dupont B, Ferrone S. Reactivity patterns with HLA-A2 variants indicate lack of identity between determinants defined by monoclonal antibodies and cytotoxic-T-cell clones. Cell Immunol. 1984 Oct 1; 88(1):228-32.
    View in: PubMed
  494. Natali PG, Bigotti A, Nicotra MR, Viora M, Manfredi D, Ferrone S. Distribution of human Class I (HLA-A,B,C) histocompatibility antigens in normal and malignant tissues of nonlymphoid origin. Cancer Res. 1984 Oct; 44(10):4679-87.
    View in: PubMed
  495. Ruiter DJ, Bergman W, Welvaart K, Scheffer E, van Vloten WA, Russo C, Ferrone S. Immunohistochemical analysis of malignant melanomas and nevocellular nevi with monoclonal antibodies to distinct monomorphic determinants of HLA antigens. Cancer Res. 1984 Sep; 44(9):3930-5.
    View in: PubMed
  496. Giacomini P, Aguzzi A, Pestka S, Fisher PB, Ferrone S. Modulation by recombinant DNA leukocyte (alpha) and fibroblast (beta) interferons of the expression and shedding of HLA- and tumor-associated antigens by human melanoma cells. J Immunol. 1984 Sep; 133(3):1649-55.
    View in: PubMed
  497. Wang TS, Srivastava SC, Fawwaz RA, Giacomini P, Ferrone S, Richards P, Hardy M, Alderson PO. A comparison of the cyclic anhydride and mixed anhydride methods for 111In-DTPA chelation to monoclonal antibodies. Nuklearmedizin. 1984 Aug; 23(4):193-5.
    View in: PubMed
  498. Natali PG, Bigotti A, Cavaliere R, Nicotra MR, Ferrone S. Phenotyping of lesions of melanocyte origin with monoclonal antibodies to melanoma-associated antigens and to HLA antigens. J Natl Cancer Inst. 1984 Jul; 73(1):13-24.
    View in: PubMed
  499. Fawwaz RA, Wang TS, Srivastava SC, Rosen JM, Ferrone S, Hardy MA, Alderson PO. Potential of palladium-109-labeled antimelanoma monoclonal antibody for tumor therapy. J Nucl Med. 1984 Jul; 25(7):796-9.
    View in: PubMed
  500. Glassy MC, Ferrone S. Ia antigen expression is increased on tunicamycin-resistant human B-lymphoid cells. Clin Immunol Immunopathol. 1984 Jul; 32(1):90-100.
    View in: PubMed
  501. Russo C, Pellegrino MA, Ferrone S. Analysis of the repertoire of anti-HLA antibodies with anti-idiotypes to a murine anti-HLA-A2,A28 monoclonal antibody. Hum Immunol. 1984 May; 10(1):57-67.
    View in: PubMed
  502. Fitchen JH, Russo C, Ferrone S. Complement-dependent killing of human hematopoietic progenitor cells with noncomplement-fixing monoclonal antibodies in an antiglobulin assay. Blood. 1984 Apr; 63(4):873-7.
    View in: PubMed
  503. Giacomini P, Veglia F, Cordiali Fei P, Rehle T, Natali PG, Ferrone S. Level of a membrane-bound high-molecular-weight melanoma-associated antigen and a cytoplasmic melanoma-associated antigen in surgically removed tissues and in sera from patients with melanoma. Cancer Res. 1984 Mar; 44(3):1281-7.
    View in: PubMed
  504. Zweig SE, Ferrone S, Shevach EM. Monoclonal antibodies directed against human Ia antigens detect an evolutionary conserved epitope on guinea pig Ia antigens with unique functional properties. J Leukoc Biol. 1984 Jan; 35(1):101-13.
    View in: PubMed
  505. Flomenberg N, Russo C, Ferrone S, Dupont B. HLA class I specific T lymphocyte clones with dual alloreactive functions. Immunogenetics. 1984; 19(1):39-51.
    View in: PubMed
  506. Igarashi M, Obata F, Yoshii M, Kashiwagi N, Ferrone S. Structural polymorphism of human Ia antigens recognized by the monoclonal antibody I2 and by cross-reacting I-Ek-specific alloantibodies. Immunogenetics. 1984; 19(3):249-55.
    View in: PubMed
  507. Natali PG, Segatto O, Ferrone S, Tosi R, Corte G. Differential tissue distribution and ontogeny of DC-1 and HLA-DR antigens. Immunogenetics. 1984; 19(2):109-16.
    View in: PubMed
  508. Russo C, Callegaro L, Lanza E, Ferrone S. Re.: Purification of IgG monoclonal antibody by caprylic acid precipitation. J Immunol Methods. 1983 Dec 16; 65(1-2):269-71.
    View in: PubMed
  509. Natali PG, Aguzzi A, Veglia F, Imai K, Burlage RS, Giacomini P, Ferrone S. The impact of monoclonal antibodies on the study of human malignant melanoma. J Cutan Pathol. 1983 Dec; 10(6):514-28.
    View in: PubMed
  510. Natali PG, Segatto O, Zupi G, Cavaliere R, Giacomini P, Ferrone S. Isolation of viable melanoma cells from surgically removed lesions using dishes coated with monoclonal antibody to a high molecular weight melanoma associated antigen. J Immunol Methods. 1983 Sep 16; 62(3):337-46.
    View in: PubMed
  511. Indiveri F, Scudeletti M, Pende D, Barabino A, Russo C, Pellegrino MA, Ferrone S. Inhibitory effect of a low dose of prednisone on PHA-induced Ia antigen expression by human T cells and on proliferation of T cells stimulated with autologous PHA-T cells. Cell Immunol. 1983 Sep; 80(2):320-8.
    View in: PubMed
  512. Natali PG, Viora M, Nicotra MR, Giacomini P, Bigotti A, Ferrone S. Antigenic heterogeneity of skin tumors of nonmelanocyte origin: analysis with monoclonal antibodies to tumor-associated antigens and to histocompatibility antigens. J Natl Cancer Inst. 1983 Sep; 71(3):439-47.
    View in: PubMed
  513. Giacomini P, Ng AK, Kantor RR, Natali PG, Ferrone S. Double determinant immunoassay to measure a human high-molecular-weight melanoma-associated antigen. Cancer Res. 1983 Aug; 43(8):3586-90.
    View in: PubMed
  514. Natali PG, Giacomini P, Russo C, Steinbach G, Fenoglio C, Ferrone S. Antigenic profile of human melanoma cells. Analysis with monoclonal antibodies to histocompatibility antigens and to melanoma-associated antigens. J Cutan Pathol. 1983 Aug; 10(4):225-37.
    View in: PubMed
  515. Indiveri F, Scudeletti M, Pende D, Barabino A, Russo C, Pellegrino MA, Ferrone S. Role of distinct domains of Ia antigens in autologous and allogeneic mixed lymphocyte reactions. Behring Inst Mitt. 1983 May; (72):95-100.
    View in: PubMed
  516. Indiveri F, Pierri I, Viglione D, Pende D, Russo C, Pellegrino MA, Ferrone S. Human T lymphocytes in aging and malignancy: abnormalities in PHA-induced Ia antigen expression and in functional activity in autologous and allogeneic MLR. Cell Immunol. 1983 Mar; 76(2):224-31.
    View in: PubMed
  517. Natali PG, Cavaliere R, Bigotti A, Nicotra MR, Russo C, Ng AK, Giacomini P, Ferrone S. Antigenic heterogeneity of surgically removed primary and autologous metastatic human melanoma lesions. J Immunol. 1983 Mar; 130(3):1462-6.
    View in: PubMed
  518. Natali PG, Giacomini P, Bigotti A, Imai K, Nicotra MR, Ng AK, Ferrone S. Heterogeneity in the expression of HLA and tumor-associated antigens by surgically removed and cultured breast carcinoma cells. Cancer Res. 1983 Feb; 43(2):660-8.
    View in: PubMed
  519. Thorsby E, Ferrone S, Nousiainen H, Hirschberg H. HLA-D restriction of antigen-specific proliferative T cell responses. Inhibitory activity of antisera against HLA determinants or stimulatory antigen. Tissue Antigens. 1983 Feb; 21(2):148-58.
    View in: PubMed
  520. Russo C, Ng AK, Pellegrino MA, Ferrone S. The monoclonal antibody CR11-351 discriminates HLA-A2 variants identified by T cells. Immunogenetics. 1983; 18(1):23-35.
    View in: PubMed
  521. Ng AK, Imai K, Pellegrino MA, Vitiello A, Indiveri F, Wilson BS, Ferrone S. Modulation of immune lysis of tumor cells by interferon. Biomembranes. 1983; 11:313-39.
    View in: PubMed
  522. Imai K, Nakanishi T, Noguchi T, Yachi A, Ferrone S. Selective in vitro toxicity of purothionin conjugated to the monoclonal antibody 225.28S to a human high-molecular-weight melanoma-associated antigen. Cancer Immunol Immunother. 1983; 15(3):206-9.
    View in: PubMed
  523. Imai K, Sasanami T, Fujita H, Moriya Y, Tsujisaki M, Kawaharada M, Ferrone S, Yachi A. Antibody-dependent cell-mediated cytotoxicity using monoclonal antibodies reacting with CEA. Ann N Y Acad Sci. 1983; 417:443-51.
    View in: PubMed
  524. Ng AK, Giacomini P, Ferrone S. Monoclonal antibodies and immunologic approaches to malignant tumors. Adv Intern Med. 1983; 28:253-76.
    View in: PubMed
  525. Wilson BS, Ruberto G, Ferrone S. Immunochemical characterization of a human high molecular weight--melanoma associated antigen identified with monoclonal antibodies. Cancer Immunol Immunother. 1983; 14(3):196-201.
    View in: PubMed
  526. Ng AK, Giacomini P, Kantor R, Ferrone S. Molecular heterogeneity and shedding of a high-molecular-mass melanoma-associated antigen identified with monoclonal antibodies. Clin Chem. 1982 Dec; 28(12):2347-50.
    View in: PubMed
  527. Natali PG, Russo C, Ng AK, Nicotra MR, Apollonj C, Pellegrino MA, Ferrone S. Ontogeny of human Ia antigens. Cell Immunol. 1982 Nov 1; 73(2):385-96.
    View in: PubMed
  528. Wilson BS, Giacomini P, Imai K, Natali PG, Nakanishi T, Ruberto G, Ferrone S. Human melanoma-associated antigens identified with monoclonal antibodies. Ric Clin Lab. 1982 Oct-Dec; 12(4):517-38.
    View in: PubMed
  529. Ghose T, Ferrone S, Imai K, Norvell ST, Luner SJ, Martin RH, Blair AH. Imaging of human melanoma xenografts in nude mice with a radiolabeled monoclonal antibody. J Natl Cancer Inst. 1982 Oct; 69(4):823-6.
    View in: PubMed
  530. Glassy MC, Ferrone S. Differential segregation patterns of human chromosomes in somatic cell hybrids constructed with human B-lymphocytes and human melanoma cells. Cancer Res. 1982 Oct; 42(10):3971-3.
    View in: PubMed
  531. Burchiel SW, Martin JC, Imai K, Ferrone S, Warner NL. Heterogeneity of HLA-A,B, Ia-like, and melanoma-associated antigen expression by human melanoma cell lines analyzed with monoclonal antibodies and flow cytometry. Cancer Res. 1982 Oct; 42(10):4110-5.
    View in: PubMed
  532. Imai K, Pellegrino MA, Wilson BS, Ferrone S. Higher cytolytic efficiency of an IgG2 alpha than of an IgG1 monoclonal antibody reacting with the same (or spatially close) determinant on a human high-molecular-weight melanoma-associated antigen. Cell Immunol. 1982 Sep 15; 72(2):239-47.
    View in: PubMed
  533. Allen RW, Ferrone S, Hoch JA. Characterization of antigens on human lymphocytes coded by messenger RNA translated in vitro. Mol Immunol. 1982 Sep; 19(9):1127-38.
    View in: PubMed
  534. Pellegrino MA, Ng AK, Russo C, Ferrone S. Heterogeneous distribution of the determinants defined by monoclonal antibodies on HLA-A and B antigens bearing molecules. Transplantation. 1982 Jul; 34(1):18-23.
    View in: PubMed
  535. Fitchen JH, Hays EF, Ferrone S. Expression of the H-2 antigenic complex on murine haematopoietic stem cells. Scand J Immunol. 1982 Jun; 15(6):547-51.
    View in: PubMed
  536. Imai K, Wilson BS, Bigotti A, Natali PG, Ferrone S. A 94,000-dalton glycoprotein expressed by human melanoma and carcinoma cells. J Natl Cancer Inst. 1982 May; 68(5):761-9.
    View in: PubMed
  537. Pellegrino MA, Indiveri F, Fagiolo U, Antonello A, Ferrone S. Immunogenicity of serum HLA antigens in allogeneic combinations. Transplantation. 1982 May; 33(5):530-3.
    View in: PubMed
  538. Quagliata F, Beckerdite Quagliata S, Alsobrook RA, Russo C, Indiveri F, Pellegrino MA, Ferrone S. Functional and immunological characterization of the stimulation of human lymphocytes with a mitogen from group A streptococci (SM). Cell Immunol. 1982 Mar 15; 68(1):146-54.
    View in: PubMed
  539. Pellegrino M, Russo C, Ng AK, Pellegrino AG, Ferrone S. An antiglobulin microcytotoxicity assay to analyze non-complement fixing monoclonal antibodies to human histocompatibility antigens. J Immunol Methods. 1982 Mar 12; 49(2):119-28.
    View in: PubMed
  540. Natali PG, Wilson BS, Imai K, Bigotti A, Ferrone S. Tissue distribution, molecular profile, and shedding of a cytoplasmic antigen identified by the monoclonal antibody 465.12S to human melanoma cells. Cancer Res. 1982 Feb; 42(2):583-9.
    View in: PubMed
  541. Wolf PL, Ferrone S. A radioimmunoassay and biological profile of Ia-like antigens on human melanoma cells. Clin Biochem. 1982 Feb; 15(1):24-7.
    View in: PubMed
  542. Wilson BS, Kay NE, Imai K, Ferrone S. Heterogeneity of human melanoma-associated antigens defined by monoclonal antibodies and conventional xenoantisera. Cancer Immunol Immunother. 1982; 13(1):69-74.
    View in: PubMed
  543. Kantor RR, Ng AK, Giacomini P, Ferrone S. Analysis of the NIH workshop monoclonal antibodies to human melanoma antigens. Hybridoma. 1982; 1(4):473-82.
    View in: PubMed
  544. Fitchen JH, Le Fèvre C, Ferrone S, Cline MJ. Expression of Ia-like and HLA-A,B antigens on human multipotential hematopoietic progenitor cells. Blood. 1982 Jan; 59(1):188-90.
    View in: PubMed
  545. Ng AK, Zhang YH, Russo C, Ferrone S. Immunochemical and functional analysis of Ia-like antigens on human monocyte-macrophages with monoclonal antibodies. Cell Immunol. 1982 Jan 1; 66(1):78-87.
    View in: PubMed
  546. Pellegrino MA, Weaver JF, Nelson-Rees WA, Ferrone S. Ia-like and HLA-A,B antigens on tumor cells in long-term culture. Transplant Proc. 1981 Dec; 13(4):1935-8.
    View in: PubMed
  547. Nathanson SD, Pellegrino MA, Ferrone S. Serum HLA-A and B alloantigens in patients with malignant melanoma. Transplant Proc. 1981 Dec; 13(4):1939-41.
    View in: PubMed
  548. Cordiali-Fei P, Natali PG, Pecci G, Pellegrino MA, Ferrone S. Levels of Ia-like antigen bearing lymphocytes in patients with solid primary tumors. J Clin Lab Immunol. 1981 Nov; 6(3):197-9.
    View in: PubMed
  549. Imai K, Pellegrino MA, Ng AK, Ferrone S. Role of antigen density in immune lysis of interferon-treated human lymphoid cells: analysis with monoclonal antibodies to the HLA-A,B antigenic molecular complex and to Ia-like antigens. Scand J Immunol. 1981 Nov; 14(5):529-35.
    View in: PubMed
  550. Imai K, Ng AK, Glassy MC, Ferrone S. ADCC of cultured human melanoma cells: analysis with monoclonal antibodies to human melanoma-associated antigens. Scand J Immunol. 1981 Oct; 14(4):369-77.
    View in: PubMed
  551. Lordon RE, Wilson RL, Shield CF, Ferrone S. Humoral immunity in renal transplantation Detection of cytotoxic antibodies to lymphocyte antigens other than HLA-A,B,C and Ia-like antigens in patients with vascular graft rejection. Transplantation. 1981 Oct; 32(4):286-90.
    View in: PubMed
  552. Natali PG, Russo C, Apollonj C, Pellegrino MA, Ferrone S. Human Ia-like antigens (Analysis of the tissue distribution and immunochemical profile with monoclonal antibodies). Ric Clin Lab. 1981 Oct-Dec; 11(4):287-300.
    View in: PubMed
  553. Wilson BS, Imai K, Natali PG, Ferrone S. Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies. Int J Cancer. 1981 Sep 15; 28(3):293-300.
    View in: PubMed
  554. Natali PG, Imai K, Wilson BS, Bigotti A, Cavaliere R, Pellegrino MA, Ferrone S. Structural properties and tissue distribution of the antigen recognized by the monoclonal antibody 653.40S to human melanoma cells. J Natl Cancer Inst. 1981 Sep; 67(3):591-601.
    View in: PubMed
  555. Ng AK, Indiveri F, Russo C, Quaranta V, Pellegrino MA, Ferrone S. Characterization of human null cells isolated from peripheral lymphocytes by a simultaneous double-rosetting procedure. Scand J Immunol. 1981 Sep; 14(3):225-31.
    View in: PubMed
  556. Wilson BS, Ruberto G, Ferrone S. Sulfation and molecular weight of fibronectin shed by human melanoma cells. Biochem Biophys Res Commun. 1981 Aug 14; 101(3):1047-51.
    View in: PubMed
  557. Indiveri F, Russo C, Quaranta V, Pellegrino MA, Ferrone S. HLA-DR antigens and mitogenic factors released by PWM-stimulated T lymphocytes share the framework determinant recognized by the monoclonal antibody Q5/13. Cell Immunol. 1981 Aug; 62(2):406-11.
    View in: PubMed
  558. Wilson BS, Glassy MC, Quaranta V, Ng AK, Ferrone S. Effect of tunicamycin on the assembly and antigenicity of HLA antigens: analysis with monoclonal antibodies. Scand J Immunol. 1981 Aug; 14(2):201-5.
    View in: PubMed
  559. Curtoni ES, Pellegrino MA, Indiveri F, Borelli I, Ferrone S. Persistence of cytotoxic antibodies to HLA-A,B,C antigens and to Ia-like antigens in parous women. J Immunogenet. 1981 Aug; 8(4):281-5.
    View in: PubMed
  560. Ng AK, Pellegrino MA, Imai K, Ferrone S. HLA-A,B antigens Ia-like antigens, and tumor-associated antigens on prostate carcinoma cell lines: serologic and immunochemical analysis with monoclonal antibodies. J Immunol. 1981 Aug; 127(2):443-7.
    View in: PubMed
  561. Imai K, Ng AK, Glassy MC, Ferrone S. Differential effect of interferon on the expression of tumor-associated antigens and histocompatibility antigens on human melanoma cells: relationship to susceptibility to immune lysis mediated by monoclonal antibodies. J Immunol. 1981 Aug; 127(2):505-9.
    View in: PubMed
  562. Slovin SF, Glassy MC, Dambaugh T, Catalano MA, Curry RA, Ferrone S, Kieff E, Vaughan JH, Carson DA. Discordant expression of 2 Epstein-Barr virus-associated antigens, EBNA and RANA, in man-rodent somatic cell hybrids. J Immunol. 1981 Aug; 127(2):585-90.
    View in: PubMed
  563. Seeger RC, Rosenblatt HM, Imai K, Ferrone S. Common antigenic determinants on human melanoma, glioma, neuroblastoma, and sarcoma cells defined with monoclonal antibodies. Cancer Res. 1981 Jul; 41(7):2714-7.
    View in: PubMed
  564. Natali PG, De Martino C, Marcellini M, Quaranta V, Ferrone S. Expression of Ia-like antigens on the vasculature of human kidney. Clin Immunol Immunopathol. 1981 Jul; 20(1):11-20.
    View in: PubMed
  565. Belzer MB, Fitchen JH, Ferrone S, Foon KA, Billing RJ, Golde DW. Expression of Ia-like antigens in human erythroid progenitor cells as determined by monoclonal antibodies and heteroantiserum to Ia-like antigens. Clin Immunol Immunopathol. 1981 Jul; 20(1):111-5.
    View in: PubMed
  566. Pellegrino MA, Richiardi P, Ferrone S. 8th international histocompatibility workshop analysis of a goat antiserum to HLA-B15 allospecificity. Tissue Antigens. 1981 May; 17(5):542-5.
    View in: PubMed
  567. Natali PG, Cordiali-Fei P, Cavaliere R, Di Filippo F, Quaranta V, Pellegrino MA, Ferrone S. Ia-like antigens on freshly explanted human melanoma. Clin Immunol Immunopathol. 1981 May; 19(2):250-9.
    View in: PubMed
  568. Tsoukas CD, Fox RI, Slovin SF, Carson DA, Pellegrino M, Fong S, Pasquali JL, Ferrone S, Kung P, Vaughan JH. T lymphocyte-mediated cytotoxicity against autologous EBV-genome-bearing B cells. J Immunol. 1981 May; 126(5):1742-6.
    View in: PubMed
  569. Howe AJ, Seeger RC, Molinaro GA, Ferrone S. Analysis of human tumor cells for Ia-like antigens with monoclonal antibodies. J Natl Cancer Inst. 1981 May; 66(5):827-9.
    View in: PubMed
  570. Glassy MC, Ferrone S. Ultrastructural alterations in human lymphoblastoid B cell lines treated with tunicamycin. Am J Pathol. 1981 Apr; 103(1):1-9.
    View in: PubMed
  571. Eskinazi DP, Molinaro GA, Reisfeld RA, Ferrone S. Cellular and molecular heterogeneity of H-2Kk antigens. J Immunogenet. 1981 Apr; 8(2):101-6.
    View in: PubMed
  572. Quagliata F, Beckerdite-Quagliata S, Russo C, Bisno A, Indiveri F, Pellegrino M, Ferrone S. Induction of Ia-like antigens by a group A streptococcal product with mitogenic activity. Transplant Proc. 1981 Mar; 13(1 Pt 2):1049-50.
    View in: PubMed
  573. Imai K, Galloway DR, Ferrone S. Serological and immunochemical analysis of the specificity of xenoantiserum 8986 elicited with hybrids between human melanoma cells and murine fibroblasts. Cancer Res. 1981 Mar; 41(3):1028-33.
    View in: PubMed
  574. Natali PG, Quaranta V, Nicotra MR, Apollonj C, Pellegrino MA, Ferrone S. Tissue distribution of Ia-like antigens in different species: analysis with monoclonal antibodies. Transplant Proc. 1981 Mar; 13(1 Pt 2):1026-9.
    View in: PubMed
  575. Wilson BS, Indiveri F, Quaranta V, Pellegrino MA, Ferrone S. Level of Ia-like antigens on human B and T lymphocytes. Transplant Proc. 1981 Mar; 13(1 Pt 2):1033-4.
    View in: PubMed
  576. Imai K, Ng AK, Ferrone S. Characterization of monoclonal antibodies to human melanoma-associated antigens. J Natl Cancer Inst. 1981 Mar; 66(3):489-96.
    View in: PubMed
  577. Wilson BS, Ferrone S. Antibodies to human Ia-like antigens and heterologous anti-human lymphocyte sera. J Immunogenet. 1981 Feb; 8(1):1-5.
    View in: PubMed
  578. Galloway DR, Imai K, Ferrone S, Reisfeld RA. Molecular profiles of human melanoma-associated antigens. Fed Proc. 1981 Feb; 40(2):231-6.
    View in: PubMed
  579. Quaranta V, Pellegrino MA, Ferrone S. Serologic and immunochemical characterization of the specificity of four monoclonal antibodies to distinct antigenic determinants expressed on subpopulations of human Ia-like antigens. J Immunol. 1981 Feb; 126(2):548-52.
    View in: PubMed
  580. Curry RA, Quaranta V, Pellegrino MA, Ferrone S. Lysis of cultured human melanoma M10 cells by polyclonal xenoantibodies to melanoma-associated antigens. Cancer Res. 1981 Feb; 41(2):463-6.
    View in: PubMed
  581. Galloway DR, McCabe RP, Pellegrino MA, Ferrone S, Reisfeld RA. Tumor-associated antigens in spent medium of human melanoma cells: immunochemical characterization with xenoantisera. J Immunol. 1981 Jan; 126(1):62-6.
    View in: PubMed
  582. Quaranta V, Pellegrino MA, Ferrone S. The monoclonal xenoantibody Q6/64 recognizes a determinant expressed by certain gene products of the A and B loci of the HLA region. Immunogenetics. 1981; 14(5):403-13.
    View in: PubMed
  583. Natali PG, De Martino C, Quaranta V, Nicotra MR, Frezza F, Pellegrino MA, Ferrone S. Expression of Ia-like antigens in normal human nonlymphoid tissues. Transplantation. 1981 Jan; 31(1):75-8.
    View in: PubMed
  584. Pellegrino MA, Ng AK, Russo C, Glassy M, Ferrone S. Immunochemical analysis of anti-HLA-A2, HLA-A3, and HLA-B27 xenoantisera elicited with hybrids between human and murine cells. Immunogenetics. 1981; 14(1-2):141-52.
    View in: PubMed
  585. Quaranta V, Tanigaki N, Ferrone S. Distribution of antigenic determinants recognized by three monoclonal antibodies (Q2/70, Q5/6 and Q5/13) on human Ia-like alloantigens and on their subunits. Immunogenetics. 1981; 12(1-2):175-82.
    View in: PubMed
  586. Russo C, Indiveri F, Quaranta V, Molinaro GA, Pellegrino MA, Ferrone S. Stimulation of human T lymphocytes by PHA-activated autologous T lymphocytes: analysis of the role of Ia-like antigens with monoclonal antibodies. Immunogenetics. 1981; 12(3-4):267-74.
    View in: PubMed
  587. Quaranta V, Pellegrino MA, Callahan GN, Ferrone S. Cross-reactivity between human and murine lymphocyte antigens. IV. Reactivity of H-2 alloantisera with HLA-A, B antigens. Immunogenetics. 1981; 13(4):311-7.
    View in: PubMed
  588. Quaranta V, Walker LE, Ruberto G, Pellegrino MA, Ferrone S. The free and the beta 2-microglobulin-associated heavy chains of HLA-A, B alloantigens share the antigenic determinant recognized by the monoclonal antibody Q1/28. Immunogenetics. 1981; 13(4):285-95.
    View in: PubMed
  589. Natali PG, De Martino C, Quaranta V, Bigotti A, Pellegrino MA, Ferrone S. Changes in Ia-like antigen expression on malignant human cells. Immunogenetics. 1981; 12(3-4):409-13.
    View in: PubMed
  590. Natali PG, De Martino C, Pellegrino MA, Ferrone S. Analysis of the expression of I-Ak-like antigens in murine fetal and adult tissues with the monoclonal antibody 10-2.16. Scand J Immunol. 1981; 13(6):541-6.
    View in: PubMed
  591. Walker LE, Ferrone S, Pellegrino MA, Reisfeld RA. Structural polymorphism of the beta chain of human HLA-DR antigens. Mol Immunol. 1980 Dec; 17(12):1443-8.
    View in: PubMed
  592. Sarkar S, Glassy MC, Ferrone S, Jones OW. Cell cycle and the differential expression of HLA-A,B and HLA-DR antigens on human B lymphoid cells. Proc Natl Acad Sci U S A. 1980 Dec; 77(12):7297-301.
    View in: PubMed
  593. Indiveri F, Wilson BS, Russo C, Quaranta V, Pellegrino MA, Ferrone S. Ia-like antigens on human T lymphocytes: relationship to other surface markers, role in mixed lymphocyte reactions, and structural profile. J Immunol. 1980 Dec; 125(6):2673-8.
    View in: PubMed
  594. Curry RA, Pellegrino MA, Saxton RE, Jensen F, Ferrone S. Appearance of receptors for Macaca speciosa red blood cells on human fibroblasts transformed by simian virus 40. J Immunol. 1980 Nov; 125(5):2017-9.
    View in: PubMed
  595. Fitchen JH, Ferrone S, Quaranta V, Molinaro GA, Cline MJ. Monoclonal antibodies to HLA-A,B, and Ia-like antigens inhibit colony formation by human myeloid progenitor cells. J Immunol. 1980 Nov; 125(5):2004-8.
    View in: PubMed
  596. Quaranta V, Walker LE, Pellegrino MA, Ferrone S. Purification of immunologically functional subsets of human Ia-like antigens on a monoclonal antibody (Q5/13) immunoadsorbent. J Immunol. 1980 Oct; 125(4):1421-5.
    View in: PubMed
  597. McCabe RP, Indiveri F, Galloway DR, Ferrone S, Reisfeld RA. Lack of association of serologically detectable human melanoma-associated antigens with beta 2 microglobulin: serologic and immunochemical evidence. J Natl Cancer Inst. 1980 Oct; 65(4):703-7.
    View in: PubMed
  598. Quaranta V, Indiveri F, Glassy MC, Ng A, Russo C, Molinaro GA, Pellegrino MA, Ferrone S. Serological, functional, and immunochemical characterization of a monoclonal antibody (MoAb Q2/70) to human Ia-like antigens. Hum Immunol. 1980 Oct; 1(3):211-23.
    View in: PubMed
  599. Russo C, Indiveri F, Quaranta V, Molinaro GA, Pellegrino MA, Ferrone S. Use of monoclonal antibodies to investigate immunologic cross-reactivity of histocompatibility antigens from various animal species. Transplant Proc. 1980 Sep; 12(3):376-9.
    View in: PubMed
  600. Imai K, Molinaro GA, Ferrone S. Monoclonal antibodies to human melanoma-associated antigens. Transplant Proc. 1980 Sep; 12(3):380-3.
    View in: PubMed
  601. Imai K, Ferrone S. Indirect rosette microassay to characterize human melanoma-associated antigens recognized by operationally specific xenoantisera. Cancer Res. 1980 Jul; 40(7):2252-6.
    View in: PubMed
  602. Belvedere M, Richiardi P, Pellegrino MA, Ferrone S. Fab2 fragments from HLA xenoantisera specifically block cytolysis mediated by HLA-AB alloantisera. J Immunogenet. 1980 Jun; 7(3):215-9.
    View in: PubMed
  603. Fitchen JH, Ferrone S, Lusis AJ, Cline MJ. Cytotoxicity of anti-beta 2-microglobulin xenoantisera to human and murine myeloid progenitor cells and lack of cross-reactivity with colony-stimulating activity. J Immunol. 1980 Jun; 124(6):2906-8.
    View in: PubMed
  604. Ng AK, Indiveri F, Pellegrino MA, Molinaro GA, Quaranta V, Ferrone S. Natural cytotoxicity and antibody-dependent cellular cytotoxicity of human lymphocytes depleted of HLA-DR bearing cells with monoclonal HLA-DR antibodies. J Immunol. 1980 May; 124(5):2336-40.
    View in: PubMed
  605. Conner BR, Ferrone S, Pellegrino MA, Glaser R. Lymphoid cell line identification and the detection of cross contamination. In Vitro. 1980 May; 16(5):446-52.
    View in: PubMed
  606. Belvedere M, Pellegrino MA, Ferrone S. Xenoantisera to DRw allospecificities. J Immunogenet. 1980 Apr; 7(2):167-72.
    View in: PubMed
  607. Belvedere M, Richiardi P, Ferrone S, Pellegrino MA. [Use of F (ab')2 blocking test for anti HLA antibody detection in xenoantisera]. Haematologica. 1980 Apr; 65(2):178-88.
    View in: PubMed
  608. Messner RP, De Horatius R, Ferrone S. Lymphocytotoxic antibodies in systemic lupus erythematosus patients and their relatives: reactivity with the HLA antigenic molecular complex. Arthritis Rheum. 1980 Mar; 23(3):265-72.
    View in: PubMed
  609. Wilson BS, Indiveri F, Molinaro GA, Quaranta V, Ferrone S. Characterization of DR antigens on cultured melanoma cells by using monoclonal antibodies. Transplant Proc. 1980 Mar; 12(1):125-9.
    View in: PubMed
  610. Indiveri F, Wilson BS, Natali PG, Pellegrino MA, Ferrone S. Immunogenicity of DR antigens isolated from body fluids. Transplant Proc. 1980 Mar; 12(1):121-4.
    View in: PubMed
  611. Ferrone S, Pellegrino MA, Callahan GN. Human and murine tumours: changes in cell surface structures coded by the major histocompatibility complex region. J Immunogenet. 1980 Feb; 7(1):71-9.
    View in: PubMed
  612. Russo C, Quaranta V, Indiveri F, Pellegrino MA, Ferrone S. Effect of polyclonal and monoclonal HLA-DR xenoantibodies on xenogeneic mixed lymphocyte reactions. Immunogenetics. 1980; 11(4):413-6.
    View in: PubMed
  613. Callahan GN, Pellegrino MA, Ferrone S. Cross-reacting xenoantibodies to the heavy chain of H-2 and HLA-A,B antigens: serologic and immunochemical characterization. Scand J Immunol. 1980; 12(4):297-302.
    View in: PubMed
  614. Indiveri F, Pellegrino MA, Quaranta V, Molinaro GA, Ferrone S. Monoclonal and polyclonal xenoantibodies to the HLA-A, B, C antigenic molecular complex do not affect the functional activity of C3 receptors. Immunobiology. 1980; 158(1-2):17-21.
    View in: PubMed
  615. Indiveri F, Huddlestone J, Pellegrino MA, Ferrone S. Isolation of human T lymphocytes: comparison between nylon wool filtration and rosetting with neuraminidase (VCN) and 2-aminoethylisothiouronium bromide (AET)-treated sheep red blood cells (SRBC). J Immunol Methods. 1980; 34(2):107-15.
    View in: PubMed
  616. Ades EW, Ferrone S, Balch CM. Immunochemical characterization of a human B lymphocyte differentiation antigen (p65). Scand J Immunol. 1980; 12(6):519-23.
    View in: PubMed
  617. Indiveri F, Ng AK, Russo C, Quaranta V, Pellegrino MA, Ferrone S. Isolation of Ia-like antigen-bearing cells from human peripheral lymphocytes through the use of a monoclonal antibody to framework determinants of Ia-like antigens. J Immunol Methods. 1980; 39(4):343-54.
    View in: PubMed
  618. Callahan GN, Pellegrino MA, Ferrone S, Haubrich L, Reisfeld RA. Expression of a sheep red blood cell receptor by a murine lymphoma. J Immunol. 1979 Dec; 123(6):2725-8.
    View in: PubMed
  619. Pellegrino MA, Wilson BS, Ferrone S. Immunogenicity of HLA-A,B antigens expressed by human melanoma-murine fibroblast cell hybrids. Transplant Proc. 1979 Dec; 11(4):1706-9.
    View in: PubMed
  620. Silver J, Ferrone S. Structural organization of human DR antigens and their murine analog, I-E antigens: serologic, genetic, and functional implications. Transplant Proc. 1979 Dec; 11(4):1743-4.
    View in: PubMed
  621. Molinaro GA, Quaranta V, Ferrone S. Characterization of the specificity of DR monoclonal antibodies. Transplant Proc. 1979 Dec; 11(4):1748-50.
    View in: PubMed
  622. Glassy MC, Pellegrino MA, Quaranta V, Molinaro GA, Ferrone S. Lack of DR antigens on human B-lymphocyte-mouse fibroblast hybrids that express HLA-A,B antigens. Transplant Proc. 1979 Dec; 11(4):1719-21.
    View in: PubMed
  623. Callahan GN, Ng A, Pellegrino MA, Ferrone S. Cross-reacting xenoantibodies to human and murine beta 2-microglobulin. Transplant Proc. 1979 Dec; 11(4):1739-42.
    View in: PubMed
  624. Richiardi P, Pellegrino MA, Ferrone S. Xenoantisera to allotypic specificities of HLA-A and B antigens. Serological characterization. Transplantation. 1979 Oct; 28(4):333-8.
    View in: PubMed
  625. Belvedere M, Olivetti E, Pellegrino MA, Ferrone S. Reactivity of DR xenoantisera in a cytotoxic test with human complement. Transplant Proc. 1979 Jun; 11(2):1327-8.
    View in: PubMed
  626. Noguchi P, Wallace R, Johnson J, Earley EM, O'Brien S, Ferrone S, Pellegrino MA, Milstien J, Needy C, Browne W, Petricciani J. Characterization of the WIDR: a human colon carcinoma cell line. In Vitro. 1979 Jun; 15(6):401-8.
    View in: PubMed
  627. Curry RA, Quaranta V, Pellegrino MA, Ferrone S. Serologically detectable human melanoma-associated antigens are not genetically linked to HLA-A and B antigens. J Immunol. 1979 Jun; 122(6):2630-2.
    View in: PubMed
  628. Silver J, Ferrone S. Structural polymorphism of human DR antigens. Nature. 1979 May 31; 279(5712):436-7.
    View in: PubMed
  629. Wilson BS, Indiveri F, Pellegrino MA, Ferrone S. Production and characterization of DR xenoantisera: use for detection of serum DR antigens. J Immunol. 1979 May; 122(5):1967-71.
    View in: PubMed
  630. Wilson BS, Indiveri F, Pellegrino MA, Ferrone S. Absence of DR antigens on human T lymphoid cells: serologic and immunochemical studies with xenoantisera. Transplant Proc. 1979 Mar; 11(1):712-4.
    View in: PubMed
  631. Indiveri F, Fagiolo U, Pellegrino MA, Ferrone S. Uremic patients immunized with planned blood transfusions: detection of HLA antibodies with the cytotoxic test and an indirect rosette microassay. Transplant Proc. 1979 Mar; 11(1):167-70.
    View in: PubMed
  632. Wilson BS, Indiveri F, Pellegrino MA, Ferrone S. DR (Ia-like) antigens on human melanoma cells. Serological detection and immunochemical characterization. J Exp Med. 1979 Mar 1; 149(3):658-68.
    View in: PubMed
  633. McCabe RP, Quaranta V, Frugis L, Ferrone S, Reisfeld RA. A radioimmunometric antibody-binding assay for evaluation of xenoantisera to melanoma-associated antigens. J Natl Cancer Inst. 1979 Mar; 62(3):455-63.
    View in: PubMed
  634. Cochrum K, Hanes D, Van Speybroeck J, Perkins H, Ferrone S, Indeveri F, Amend W, Vincenti F, Feduska N, Salvatierra O. HLA-D antigen disparity and HLA-DRw antibodies in intrafamilial renal allograft survival. Transplant Proc. 1979 Mar; 11(1):404-10.
    View in: PubMed
  635. Indiveri F, Wilson BS, Pellegrino MA, Ferrone S. Detection of human histocompatibility (HLA) antigens with an indirect rosette microassay. J Immunol Methods. 1979; 29(2):101-9.
    View in: PubMed
  636. Indiveri F, Pellegrino MA, Molinaro GA, Quaranta V, Ferrone S. Rosetting of human T lymphocytes with goat red blood cells: effect of treatment with 2-aminoethylisothiouronium bromide (AET) and comparison with AET treated sheep red blood cells. J Immunol Methods. 1979; 30(4):317-28.
    View in: PubMed
  637. Belvedere M, Richiardi P, Curtoni ES, Pellegrino MA, Ferrone S. Sera from volunteers immunized by planned blood transfusions as source of DR cytotoxic typing reagents. Immunol Commun. 1979; 8(1):93-106.
    View in: PubMed
  638. Silver J, Walker LE, Reisfeld RA, Pellegrino MA, Ferrone S. Structural studies of murine I-E and human DR antigens. Mol Immunol. 1979 Jan; 16(1):37-42.
    View in: PubMed
  639. Natali PG, Pellegrino MA, Walker L, Ferrone S, Reisfeld RA. Antibody-coated protein A-bearing Staphylococcus aureus: a versatile and stable immune reagent. J Immunol Methods. 1979; 25(3):255-64.
    View in: PubMed
  640. Strong DM, Pellegrino MA, Ferrone S. Human lymphoid cell lines as targets for DRw. In Vitro. 1978 Dec; 14(12):989-95.
    View in: PubMed
  641. Wilson BS, Pellegrino MA, Reisfeld RA, Ferrone S. A simple method for production of specific xenoantisera to human histocompatibility (HLA-A,-B,-C) antigens. Transplant Proc. 1978 Dec; 10(4):741-3.
    View in: PubMed
  642. Kovithavongs T, Ferrone S, Thorsby E, Schlaut J, Pazderka F, Dossetor JB. ADCC detects a public B-cell specificity broader than DRw3 and DRw6. Transplant Proc. 1978 Dec; 10(4):829-32.
    View in: PubMed
  643. Balch CM, Dougherty PA, Vogler LB, Ades EW, Ferrone S. A new B cell differentiation antigen (BDA) on normal and leukemic human B lymphocytes that is distinct from known DR (Ia-like) antigens. J Immunol. 1978 Dec; 121(6):2322-8.
    View in: PubMed
  644. Allison JP, Ferrone S, Walker LE, Pellegrino MA, Silver J, Reisfeld RA. Partial amino acid sequence of HLA-A9 antigen purified with a specific xenoantiserum. Transplantation. 1978 Dec; 26(6):451-4.
    View in: PubMed
  645. Ferrone S, Naeim F, Indiveri F, Walker LE, Pellegrino MA. Xenoantisera to human DR antigens: Serological and immunochemical characterization. Immunogenetics. 1978 Dec; 7(1):349-58.
    View in: PubMed
  646. Jordan TF, Ferrone S, Pellegrino MA, Dennert G. Human lymphoblastoid cell lines as effector cells in mitogen-dependent and antibody-dependent cell-mediated lysis. Cancer Res. 1978 Nov; 38(11 Pt 1):3707-11.
    View in: PubMed
  647. Allison JP, Belvedere M, Reisfeld RA, Pellegrino MA, Ferrone S. Serologic and immunochemical characterization of HLA-A9 xenoantisera. J Immunol. 1978 Aug; 121(2):579-85.
    View in: PubMed
  648. Allison JP, Walker LE, Russell WA, Pellegrino MA, Ferrone S, Reisfeld RA, Frelinger JA, Silver J. Murine Ia and human DR antigens: homology of amino-terminal sequences. Proc Natl Acad Sci U S A. 1978 Aug; 75(8):3953-6.
    View in: PubMed
  649. Ferrone S. The major portion of rabbit antibody to serum HLA-A9 antigens is directed to allospecificity. Tissue Antigens. 1978 Aug; 12(2):153-5.
    View in: PubMed
  650. Strong DM, Ahmed A, Ferrone S, Mittal K, Hartzman RJ, Salvatierra O, Sell KW. Detection of B cell antibodies in renal transplant recipients. Transplantation. 1978 Apr; 25(4):208-11.
    View in: PubMed
  651. McCabe RP, Ferrone S, Pellegrino MA, Kern DH, Holmes EC, Reisfeld RA. Purification and immunologic evaluation of human melnoma-associated antigens. J Natl Cancer Inst. 1978 Apr; 60(4):773-7.
    View in: PubMed
  652. Saxton RE, Irie RF, Ferrone S, Pellegrino MA, Morton DL. Establishment of paired tumor cells and autologous virus-transformed cell lines to define humoral immune responses in melanoma and sarcoma patients. Int J Cancer. 1978 Mar 15; 21(3):299-306.
    View in: PubMed
  653. Pellegrino MA, Ferrone S. Receptors for sheep red blood cells on human B lymphoid WI-L2 cells. Clin Immunol Immunopathol. 1978 Mar; 9(3):277-86.
    View in: PubMed
  654. Pellegrino MA, Belvedere M, Pellegrino AG, Ferrone S. B peripheral lymphocytes express more HLA antigens than T peripheral lymphocytes. Transplantation. 1978 Feb; 25(2):93-5.
    View in: PubMed
  655. Ferrone S, Allison JP, Pellegrino MA. Human DR (Ia-like) antigens: biological and molecular profile. Contemp Top Mol Immunol. 1978; 7:239-81.
    View in: PubMed
  656. Allison JP, Pellegrino MA, Reisfeld RA, Ferrone S. An immune adsorption technique for analysis of antigenic determinants reacting with HLA antisera. Transplant Proc. 1977 Dec; 9(4):1691-3.
    View in: PubMed
  657. Ferrone S. Xenoantisera to allospecificities of human histocompatibility antigenic systems. Transplantation. 1977 Nov; 24(5):387-8.
    View in: PubMed
  658. Reisfeld RA, David GS, Ferrone S, Pellegrino MA, Holmes EC. Approaches for the isolation of biologically functional tumor-associated antigens. Cancer Res. 1977 Aug; 37(8 Pt 2):2860-5.
    View in: PubMed
  659. Glaser R, Lenoir G, Ferrone S, Pellegrino MA, de-Thé G. Cell surface markers on epithelial-Burkitt hybrid cells superinfected with Epstein-Barr virus. Cancer Res. 1977 Jul; 37(7 Pt 1):2291-6.
    View in: PubMed
  660. Pellegrino MA, Ferrone S, Reisfeld RA, Irie RF, Golub SH. Expression of histocompatibility (HLA) antigens on tumor cells and normal cells from patients with melanoma. Cancer. 1977 Jul; 40(1):36-41.
    View in: PubMed
  661. Ferrone S, Pellegrino MA. Cytotoxic antibodies to cultured melanoma cells in the sera of melanoma patients. J Natl Cancer Inst. 1977 May; 58(5):1201-4.
    View in: PubMed
  662. Ferrone S. Rabbit complement in the lymphocytotoxicity test. Tissue Antigens. 1977 Apr; 9(4):223-6.
    View in: PubMed
  663. Allison JP, Pellegrino MA, Ferrone S, Callahan GN, Reisfeld RA. Biologic and chemical characterization of HLA antigens in human serum. J Immunol. 1977 Mar; 118(3):1004-9.
    View in: PubMed
  664. Thompson JS, Severson CD, Greazel NA, Ferrone S. Detection of HLA (Ia) and non-HLA specificities by "B-cell" antisera. Transplant Proc. 1977 Mar; 9(1):597-600.
    View in: PubMed
  665. Thompson JS, Braun WE, Carpenter CB, Dossetor JB, Dupont B, Falk JA, Ferrone S, Johnson AH, Shaw JF, Sinal DP, Terasaki PI, Troup GM, Walford RL. Report on the second new world B-cell workshop. Transplant Proc. 1977 Mar; 9(1 Suppl 1):9-12.
    View in: PubMed
  666. Allison JP, Ferrone S, Pellegrino MA, Reisfeld RA. Procedure for the selection of HLA xenoantisera for immunochemical characterization of HLA antigens. Transplant Proc. 1977 Mar; 9(1):601-4.
    View in: PubMed
  667. Ferrone S, Pellegrino MA, Reisfeld RA. Immunogenicity of human B cell antigens solubilized from cultured human lymphoid cells. J Immunol. 1977 Mar; 118(3):1036-41.
    View in: PubMed
  668. Ferrone S, Pellegrino MA, van Rood JJ, van Leeuwen A. Functional properties of anti-B-cell antigen alloantisera. Transplant Proc. 1977 Mar; 9(1):675-8.
    View in: PubMed
  669. Ferrone S, Halasz NA, Collins G, Pellegrino MA. Humoral immunity in kidney transplant recipients. Transplantation. 1977 Feb; 23(2):113-8.
    View in: PubMed
  670. Ferrone S, Mittal KK, Pellegrino MA, Allison JP, Reisfeld RA. Immunogenicity of HLA antigens purified from serum. Transplantation. 1977 Jan; 23(1):7-15.
    View in: PubMed
  671. Reisfeld RA, Pellegrino MA, Ferrone S. The immunologic and molecular profiles of HLA antigens isolated from urine. J Immunol. 1977 Jan; 118(1):264-9.
    View in: PubMed
  672. Ferrone S, Pellegrino MA, Mittal KK. Cytotoxic antibodies to cultured human lymphoid cells in polytransfused thrombocytopenic patients: association with reduced survival of allogeneic transfused platelets. Immunol Commun. 1977; 6(3):267-82.
    View in: PubMed
  673. Ferrone S, Pellegrino MA, Allison JP, Reisfeld RA. [Biological and chemical aspects of histocompatibility antigens in serum]. Haematologica. 1976 Dec; 61(4):397-417.
    View in: PubMed
  674. Thompson JS, Braun WE, Carpenter CB, Dossetor JB, Dupont B, Falk JA, Ferrone S, Johnson AH, Shaw JF, Singal DP, Terasaki TI, Troup GM, Walford RL. Summary report on the second New World B-cell workshop. Tissue Antigens. 1976 Nov; 8(5):355-7.
    View in: PubMed
  675. Ferrone S, Pellegrino MA, Cooper NR. Cell line identification. Science. 1976 Oct 29; 194(4264):480.
    View in: PubMed
  676. Callahan GN, Ferrone S, Poulik MD, Reisfeld RA, Klein J. Characterization of Ia antigens in mouse serum. J Immunol. 1976 Oct; 117(4):1351-5.
    View in: PubMed
  677. Ferrone S, Pellegrino MA, Cooper NR. Expression of C4 on human lymphoid cells and possible involvement in immune recognition phenomena. Science. 1976 Jul 2; 193(4247):53-5.
    View in: PubMed
  678. Ferrone S, Mickey MR, Terasaki PI, Reisfeld RA, Pellegrino MA. Humoral sensitization in parous women: cytotoxic antibodies to non HL-A antigens. Transplantation. 1976 Jul; 22(1):61-8.
    View in: PubMed
  679. Reisfeld RA, Allison JP, Ferrone S, Pellegrino MA, Poulik MD. HL-A antigens in serum and urine: isolation, characterization, and immunogenic properties. Transplant Proc. 1976 Jun; 8(2):173-8.
    View in: PubMed
  680. Pellegrino MA, Ferrone S, Reisfeld RA. Receptor for complement components and xenogeneic erythrocytes on human T- and B-lymphoid cells. Ric Clin Lab. 1976 Apr-Jun; 6(2):99-110.
    View in: PubMed
  681. Pellegrino MA, Ferrone S, Brautbar C, Hayflick L. Changes in HL-A antigen profiles on SV40-transformed human fibroblasts. Exp Cell Res. 1976 Feb; 97(2):340-5.
    View in: PubMed
  682. Pellegrino MA, Ferrone S, Pellegrino AG, Reisfeld RA. Inhibition of T-lymphocyte rosetting by HL-A alloantisera and complement. Proc Soc Exp Biol Med. 1976 Feb; 151(2):321-5.
    View in: PubMed
  683. Ferrone S, Pellegrino MA, Reisfeld RA. The major histocompatibility complex in man: biological and molecular approaches. Prog Allergy. 1976; 21:114-77.
    View in: PubMed
  684. Ferrone S, Pellegrino MA, Mittal KK. Natural antibodies to human lymphocytes in murine strains. J Natl Cancer Inst. 1976 Jan; 56(1):75-8.
    View in: PubMed
  685. Golub SH, Hanson DC, Sulit HL, Morton DL, Pellegrino MA, Ferrone S. Comparison of histocompatibility antigens on cultured human tumor cells and fibroblasts by quantitative antibody absorption and sensitivity to cell-mediated cytotoxicity. J Natl Cancer Inst. 1976 Jan; 56(1):167-70.
    View in: PubMed
  686. Pellegrino MA, Ferrone S, Theofilopoulos AN. Isolation of human T and B lymphocytes by rosette formation with 2-aminoethylisothiquronium bromide (AET) -treated sheep red blood cells with monkey red blood cells. J Immunol Methods. 1976; 11(3-4):273-9.
    View in: PubMed
  687. Callahan GN, Ferrone S, Allison JP, Reisfeld RA. Detection of H-2 antigens in serum. Transplantation. 1975 Nov; 20(5):431-3.
    View in: PubMed
  688. Pellegrino MA, Ferrone S, Theofilopoulos AN. Rosette formation of human lymphoid cells with monkey red blood cells. J Immunol. 1975 Oct; 115(4):1065-71.
    View in: PubMed
  689. Reisfeld RA, Pellegrino MA, Dierich MP, Ferrone S. Cultured human lymphoid cells: tools for the biological and molecular characterization of antigens and their recognition systems. In Vitro. 1975 Jul-Aug; 11(4):173-85.
    View in: PubMed
  690. Pellegrino MA, Ferrone S, Dierich MP, Pellegrino A, Reisfeld RA. Inhibitory effect of normal mammalian sera on the rosette formation of human lymphocytes with sheep red blood cells. Clin Immunol Immunopathol. 1975 May; 4(1):85-95.
    View in: PubMed
  691. Hock JA, Dierich MP, Pellegrino MA, Ferrone S, Reisfeld RA. Distinction between malignant L cells and normal mouse fibroblasts by rosette formation with sheep red blood cells. J Immunol. 1975 May; 114(5):1638-40.
    View in: PubMed
  692. Oh SK, Pellegrino MA, Ferrone S, Sevier ED, Reisfeld RA. Soluble HL-A antigens in serum. I. Isolation and purification. Eur J Immunol. 1975 Mar; 5(3):161-6.
    View in: PubMed
  693. Ferrone S, Ting A, Pellegrino MA, Terasaki PI, Reisfeld RA. Utilization of cultured human lymphoid cells for detection of humoral sensitization in prospective recipients of kidney transplants. J Clin Invest. 1975 Feb; 55(2):388-94.
    View in: PubMed
  694. Ferrone S, Pellegrino MA, Billing R, Terasaki PI, Reisfeld RA. Production of anti-W24 xenoantisera in rabbits. Tissue Antigens. 1975 Feb; 5(1):41-7.
    View in: PubMed
  695. Pellegrino MA, Ferrone S, Dierich MP, Reisfeld RA. Enhancement of sheep red blood cell human lymphocyte rosette formation by the sulfhydryl compound 2-amino ethylisothiouronium bromide. Clin Immunol Immunopathol. 1975 Jan; 3(3):324-33.
    View in: PubMed
  696. Dierich MP, Ferrone S, Pellegrino MA, Reisfeld RA. Chemical modulation of cell surfaces by sulfhydryl compounds: effect on C3b receptors. J Immunol. 1974 Sep; 113(3):940-7.
    View in: PubMed
  697. Pellegrino MA, Ferrone S, Cooper NR, Dierich MP, Reisfeld RA. Variation in susceptibility of a human lymphoid cell line to immune lysis during the cell cycle. Lack of correlation with antigen density and complement binding. J Exp Med. 1974 Aug 1; 140(2):578-90.
    View in: PubMed
  698. Dierich MP, Pellegrino MA, Ferrone S, Reisfeld RA. Evaluation of C3 receptors on lymphoid cells with different complement sources. J Immunol. 1974 May; 112(5):1766-73.
    View in: PubMed
  699. Pellegrino MA, Ferrone S, Pellegrino AG, Oh SK, Reisfeld RA. Evaluation of two sources of soluble HL-A antigens: platelets and serum. Eur J Immunol. 1974 Apr; 4(4):250-5.
    View in: PubMed
  700. Ferrone S, Cooper NR, Pellegrino MA, Reisfeld RA. The role of complement in the HL-A antibody-mediated lysis of lymphocytes. Transplant Proc. 1974 Mar; 6(1):13-9.
    View in: PubMed
  701. Ferrone S, Polli EE. Cell growth cycle and expression of histocompatibility antigens on cultured human lymphoid cells. Haematologica. 1974 Mar; 59(1):25-37.
    View in: PubMed
  702. Ferrone S, Pellegrino MA, Dierich MP, Reisfeld RA. Expression of histocompatibility antigens during the growth cycle of cultured lymphoid cells. Curr Top Microbiol Immunol. 1974; 66:1-27.
    View in: PubMed
  703. Poulik MD, Ferrone S, Pellegrino MA, Sevier DE, Oh SK, Reisfeld RA. Association of HL-A antigens and beta 2-microglobulin: concepts and questions. Transplant Rev. 1974; 21(0):106-25.
    View in: PubMed
  704. Ferrone S, Pellegrino MA, Dierich MP, Reisfeld RA. Effect of inhibitors of macromolecular synthesis on HL-A antibody mediated lysis of cultured lymphoblasts. Tissue Antigens. 1974; 4(4):275-82.
    View in: PubMed
  705. Ferrone S. Leucocyte cytotoxic isoantibodies after massive transfusion for open heart surgery. Boll Ist Sieroter Milan. 1974 Jan-Feb; 50(1):3-5.
    View in: PubMed
  706. Brautbar C, Stanbridge EJ, Pellegrino MA, Ferrone S, Reisfeld RA, Payne R, Hayflick L. Expression of HL-A antigens on cultured human fibroblasts infected with mycoplasmas. J Immunol. 1973 Dec; 111(6):1783-9.
    View in: PubMed
  707. Ferrone S, Cooper NR, Pellegrino MA, Reisfeld RA. Activation of human complement by human lymphoid cells sensitized with histocompatibility alloantisera. Proc Natl Acad Sci U S A. 1973 Dec; 70(12):3665-8.
    View in: PubMed
  708. Pellegrino MA, Ferrone S, Pellegrino A, Reisfeld RA. A rapid microtechnique for in vitro stimulation of human lymphocytes by phytohemagglutinin. Clin Immunol Immunopathol. 1973 Nov; 2(1):67-73.
    View in: PubMed
  709. Mittal KK, Ferrone S, Mickey MR, Pellegrino MA, Reisfeld RA, Terasaki PI. Serological characterization of natural antihuman lymphocytotoxic antibodies in mammalian sera. Transplantation. 1973 Oct; 16(4):287-94.
    View in: PubMed
  710. Pellegrino MA, Pellegrino A, Ferrone S, Kahan BD, Reisfeld RA. Extraction and purification of soluble HL-A antigens from exhausted media of human lymphoid cell lines. J Immunol. 1973 Sep; 111(3):783-8.
    View in: PubMed
  711. Sirchia G, Marubini E, Mercuriali F, Ferrone S. Study of two in vitro diagnostic tests for paroxysmal nocturnal haemoglobinuria. Br J Haematol. 1973 Jun; 24(6):751-9.
    View in: PubMed
  712. Brautbar C, Pellegrino MA, Ferrone S, Reisfeld RA, Payne R, Hayflick L. Fate of HL-A antigens in aging cultured human diploid cell strains. II. Quantitative absorption studies. Exp Cell Res. 1973 Apr; 78(2):367-75.
    View in: PubMed
  713. Pellegrino MA, Ferrone S, Del Villano B, Reisfeld RA. Effects of inhibitors of macromolecular synthesis on cell surface expression of HL-A antigens. Transplant Proc. 1973 Mar; 5(1):91-4.
    View in: PubMed
  714. Reisfeld RA, Pellegrino MA, Ferrone S, Kahan BD. Chemical and molecular nature of HL-A antigens. Transplant Proc. 1973 Mar; 5(1):447-50.
    View in: PubMed
  715. Ting A, Hasegawa T, Ferrone S, Reisfeld RA. Presensitization detected by sensitive crossmatch tests. Transplant Proc. 1973 Mar; 5(1):813-7.
    View in: PubMed
  716. Götze BD, Lee S, Ferrone S, Pellegrino MA, Reisfeld RA. Cross-reactivity between HL-A and H-2 antigens. II. Allogeneic sensitization by xenogeneic soluble lymphocyte antigens (HL-A). Transplant Proc. 1973 Mar; 5(1):467-70.
    View in: PubMed
  717. Ferrone S, Pellegrino MA. HL-A antigens, antibody, and complement in the lymphocytotoxic reaction. Contemp Top Mol Immunol. 1973; 2:185-235.
    View in: PubMed
  718. Pellegrino MA, Ferrone S, Pellegrino A, Reisfeld RA. The expression of HL-A antigens during the growth cycle of cultured human lymphoid cells. Clin Immunol Immunopathol. 1973 Jan; 1(2):182-9.
    View in: PubMed
  719. Ferrone S, Cooper NR, Pellegrino MA, Reisfeld RA. Interaction of histocompatibility (HL-A) antibodies and complement with synchronized human lymphoid cells in continuous culture. J Exp Med. 1973 Jan 1; 137(1):55-68.
    View in: PubMed
  720. Mittal KK, Ferrone S, Mickey MR, Pellegrino MA, Reisfeld RA, Terasaki PI. Specificity of lymphocytotoxic anti-human antibodies in normal rabbit sera. Tissue Antigens. 1973; 3(2):88-94.
    View in: PubMed
  721. Polli E, Sirchia G, Ferrone S, Mercuriali F, Zanella A. [Paroxysmal nocturnal hemoglobinuria]. Haematologica. 1973; 58(5):243-312.
    View in: PubMed
  722. Pellegrino MA, Ferrone S, Mittal KK, Pellegrino A, Reisfeld RA. A quantitative study of cross reactivity in the HL-A system with human cultured lymphoid cells and soluble HL-A antigens. Transplantation. 1973 Jan; 15(1):42-7.
    View in: PubMed
  723. Götze D, Ferrone S, Reisfeld RA. Serologic cross-reactivity between H-2 and HL-A antigens. I. Specific reactivity of rabbit anti-HL-A sera against murine cells. J Immunol. 1972 Sep; 109(3):439-50.
    View in: PubMed
  724. Ferrone S, Marubini E, Mercuriali F, Sirchia G. Study of in vitro lysis of paroxysmal nocturnal haemoglobinuria (PNH) and PNH-like red cells. Br J Haematol. 1972 Jul; 23(1):5-12.
    View in: PubMed
  725. Pellegrino MA, Ferrone S, Safford JW, Hirata AA, Terasaki PI, Reisfeld RA. Stimulation of lymphocyte transformation by streptococcal type M1 protein: relationship to HL-A antigens. J Immunol. 1972 Jul; 109(1):97-102.
    View in: PubMed
  726. Ferrone S, Pellegrino MA, Reisfeld RA. Typing of cultured human lymphoid cells. Lancet. 1972 Jun 3; 1(7762):1237-8.
    View in: PubMed
  727. Ferrone S, Natali PG, Hunter A, Terasaki PI, Reisfeld RA. Immunogenicity of soluble HL-A alloantigens. J Immunol. 1972 Jun; 108(6):1718-22.
    View in: PubMed
  728. Sirchia G, Zanella A, Perrella M, Mercuriali F, Ferrone S. PNH-like red cells: mechanism of action of sulfhydryl compounds on normal red cells. Experientia. 1972 Feb 15; 28(2):191.
    View in: PubMed
  729. Pellegrino MA, Ferrone S, Pellegrino A. A simple microabsorption technique for HL-A typing. Proc Soc Exp Biol Med. 1972 Feb; 139(2):484-8.
    View in: PubMed
  730. Pellegrino MA, Ferrone S, Natali PG, Pellegrino A, Reisfeld RA. Expression of HL-A antigens in synchronized cultures of human lymphocytes. J Immunol. 1972 Feb; 108(2):573-6.
    View in: PubMed
  731. Götze D, Pellegrino MA, Ferrone S, Reisfeld RA. Expression of H-2 antigens during growth of cultured tumor cells. Immunol Commun. 1972; 1(6):533-44.
    View in: PubMed
  732. Götze D, Ferrone S. A rapid micromethod for direct H-2 typing of mouse cultured lymphoid cells. J Immunol Methods. 1972 Jan; 1(2):203-6.
    View in: PubMed
  733. Sirchia G, Ferrone S. The laboratory substitutes of the red cell of paroxysmal nocturnal haemoglobinuria (PNH): PNH-like red cells. Ser Haematol. 1972; 5(3):137-75.
    View in: PubMed
  734. Ferrone S, Mittal KK, Pellegrino MA, Terasaki PI, Reisfeld RA. Serologic specificity and crossreactivity of soluble HL-A alloantigens. Immunol Commun. 1972; 1(1):77-91.
    View in: PubMed
  735. Ferrone S, Del Villano BC, Pellegrino MA, Lerner RA, Reisfeld RA. Expression of HL-A antigens on the surface of cultured human lymphoid cells: effect of inhibitors of protein and nucleic acid synthesis. Tissue Antigens. 1972; 2(6):447-53.
    View in: PubMed
  736. Lambertenghi-Deliliers G, Ferrone S, Ranzi T, Sirchia G. Immune lysis of normal and AET-treated lymphocytes: a study of transmission and scanning electron microscopy. Blood. 1971 Dec; 38(6):759-68.
    View in: PubMed
  737. Lewis SM, Lambertenghi G, Ferrone S, Sirchia G. Electron microscope study of PNH red cells and AET-treated normal red cells (PNH-like cells). J Clin Pathol. 1971 Nov; 24(8):677-84.
    View in: PubMed
  738. Ferrone S, Cooper NR, Pellegrino MA, Reisfeld RA. The lymphocytotoxic reaction: the mechanism of rabbit complement action. J Immunol. 1971 Oct; 107(4):939-47.
    View in: PubMed
  739. Ferrone S, Pellegrino MA, Reisfeld RA. A rapid method for direct HL-A typing of cultured lymphoid cells. J Immunol. 1971 Aug; 107(2):613-5.
    View in: PubMed
  740. Sirchia G, Ferrone S. Normal human lymphocytes treated in vitro with the sulfhydryl compound AET: relationship to the lymphocytes of paroxysmal nocturnal hemoglobinuria. Blood. 1971 May; 37(5):563-7.
    View in: PubMed
  741. Sirchia G, Ferrone S, Mercuriali F. [Leukocyte antigens and histocompatibility]. Policlinico Prat. 1971 Apr 15; 78(8):315-31.
    View in: PubMed
  742. Ferrone S, Mercuriale F, Scalamogna M. Cephalothin positive direct Coombs test. Relationship to serum immunoglobulin concentration. Experientia. 1971 Feb 15; 27(2):193-4.
    View in: PubMed
  743. Ferrone S, Zanella A, Scalamogna M. Red cell metabolism in positive direct Coombs test after cephalothin therapy. Experientia. 1971 Feb 15; 27(2):194-5.
    View in: PubMed
  744. Ferrone S, Lambertenghi-Deliliers G, Ranzi T. Normal human red cells treated in vitro with cephalothin. A scanning electron microscope study. Acta Haematol. 1971; 45(4):245-9.
    View in: PubMed
  745. Ferrone S, Zanella A, Mercuriali F, Sirchia G. Normal human blood treated in vitro with cephalothin. Relationship between serologic and metabolic abnormalities of red blood cells. Experientia. 1970 Nov 15; 26(11):1255-7.
    View in: PubMed
  746. Sirchia G, Ferrone S, Mercuriali F, Zanella A. Red cell acetylcholinesterase activity in autoimmune haemolytic anaemias. Br J Haematol. 1970 Sep; 19(3):411-5.
    View in: PubMed
  747. Sirchia G, Ferrone S, Mercuriali F. Leukocyte antigen-antibody reaction and lysis of paroxysmal nocturnal hemoglobinuria erythrocytes. Blood. 1970 Sep; 36(3):334-6.
    View in: PubMed
  748. Sirchia G, Ferrone S, Mercuriali F. Prevention of leucocyte-antibody formation. Lancet. 1970 Apr 25; 1(7652):898.
    View in: PubMed
  749. Sirchia G, Ferrone S, Marubini E, Zanella A. Statistical evaluation of the determination of red cell acetylcholinesterase activity. Enzymol Biol Clin (Basel). 1970; 11(4):369-74.
    View in: PubMed
  750. Sirchia G, Ferrone S, Zanella A. Determination of red cell acetylcholinesterase activity by diagnostic kit; modification of the method. Acta Vitaminol Enzymol. 1970; 24(6):219-21.
    View in: PubMed
  751. Sirchia G, Ferrone S, Marubini E, Mercuriali F, Morosini P, Zanella A. [Enzymatic and metabolic activities in erythrocytes in hemolytic autoimmune diseases]. Haematologica. 1970; 55(2):81-152.
    View in: PubMed
  752. Lambertenghi G, Ferrone S, Sirchia G. Surface ultramicroscopy of paroxysmal nocturnal haemoglobinuria erythrocytes. Acta Haematol. 1970; 44(5):257-64.
    View in: PubMed
  753. Ferrone S, Zanella A, Bianchi Porro G, Flores A, Ranzi T. [Study of some erythrocytic enzyme and metabolic activities in chronic nephropathies]. Acta Vitaminol Enzymol. 1970; 24(3):70-80.
    View in: PubMed
  754. Ferrone S, Zanella A, Sirchia G. Erythrocyte glutathione reductase activity in chronic renal disease. Scand J Haematol. 1970; 7(6):409-12.
    View in: PubMed
  755. Ferrone S, Zanella A, Sirchia G. Study of the acetylcholinesterase activity of AET-treated (2-aminoethylisothiouronium bromide) normal red cells (PNH-like cells). Acta Vitaminol Enzymol. 1970; 24(6):222-5.
    View in: PubMed
  756. Ferrone S, Zanella A, Sirchia G. [Enzymatic and metabolic activities of erythrocytes in paroxysmal nocturnal hemoglobinuria]. Acta Vitaminol Enzymol. 1970; 24(6):237-63.
    View in: PubMed
  757. Polli E, Sirchia G, Ferrone S, Mercuriali F. [Problem of isoimmunization from blood transfusion in recipients of homografts]. Riv Emoter Immunoematol. 1970; 17(1):1-22.
    View in: PubMed
  758. Ferrone S, Zanella A, Flores A, Sirchia G. Red cell metabolism in anaemia. The oxygen uptake in the presence of methylene blue. Acta Haematol. 1970; 44(5):279-86.
    View in: PubMed
  759. Sirchia G, Ferrone S, Mercuriali F. In-vitro lysis of AET-treated normal red cells (PNH-like cells) by normal and cirrhotic sera. Br J Haematol. 1969 Sep; 17(3):245-9.
    View in: PubMed
  760. Sirchia G, Ferrone S, Mercuriali F. The in vitro lysis of the red cells of paroxysmal nocturnal haemoglobinuria by the serum of patients with cirrhosis of the liver. Br J Haematol. 1969 Mar; 16(3):269-75.
    View in: PubMed
  761. Ferrone S, Mercuriali F, Sirchia G. The positive direct Coombs test of cephalothin-treated blood. Experientia. 1969 Jan 15; 25(1):78-9.
    View in: PubMed
  762. Ferrone S, Sirchia G. Survival of cephalothin-treated erythrocytes. JAMA. 1968 Oct 7; 206(2):378.
    View in: PubMed
  763. Sirchia G, Ferrone S, Mercuriali F. [Determination of erythrocyte acetylcholinesterase by the dithiobisnitrobenzoic acid method, carried out with ready made reagents]. Haematol Lat. 1968 Oct-Dec; 11(4):383-6.
    View in: PubMed
  764. Ferrone S, Mercuriali F, Zanella A. [Action of cephalothin on the blood "in vitro": influence of some plasmatic components on the sensitivity of the erythrocytes to the drug]. G Clin Med. 1968 Sep; 49(9):870-84.
    View in: PubMed
  765. Ferrone S, Zanella A, Mercuriali F, Pizzi C. Some enzymatic and metabolic activities of normal human erythrocytes treated in vitro with cephalothin. Eur J Pharmacol. 1968 Sep; 4(2):211-4.
    View in: PubMed
  766. Sirchia G, Mercuriali F, Ferrone S. Cephalothin-treated normal red cells: a new type of PNH-like cells. Experientia. 1968 May 15; 24(5):495-6.
    View in: PubMed
  767. Ferrone S, Zanella A, Sirchia G. Red cell acetylcholinesterase in ABO haemolytic disease of the newborn. Experientia. 1968 May 15; 24(5):495.
    View in: PubMed
  768. Ferrone S, Mercuriali F, Farina C. [Paroxysmal nocturnal hemoglobinuria and paroxysmal "cold" hemoglobinuria. Comparative study on the kinetics of the hemolysis]. Haematol Lat. 1968 Jan-Mar; 11(1):61-9.
    View in: PubMed
  769. Sirchia G, Ferrone S, Milani R, Mercuriali F. Observations on certain enzyme activites of normal human red cells treated with sulfhydryl compounds. Blood. 1966 Jul; 28(1):98-101.
    View in: PubMed
  770. Sirchia G, Ferrone S, Milani R, Masera G. [Study of the acetylcholinesterase activity of the erythrocytes in hemolytic disease of the newborn]. Haematol Lat. 1966 Jul-Sep; 9(3):215-20.
    View in: PubMed
  771. Praga C, Jean G, Ferrone S. [Effect of 2-amino-ethylisothiouronium bromide (AET) on blood coagulation]. Thromb Diath Haemorrh. 1966 Jan 31; 15(1):131-42.
    View in: PubMed
  772. D'Amico G, Sirchia G, Ferrone S, Romagnoni M. Cation transport in normal human red cells treated with sulfhydryl compounds. Experientia. 1966 Jan 15; 22(1):32-3.
    View in: PubMed
  773. Sirchia G, Ferrone S, Nocca G. Some red cell enzyme activities in paroxysmal nocturnal haemoglobinuria. Enzymol Biol Clin (Basel). 1966; 7(3):145-8.
    View in: PubMed
  774. Sirchia G, Ferrone S, Mercuriali F. A case of paroxysmal cold haemoglobinuria with unusual serological findings. Haematol Lat. 1965 Apr-Jun; 8(2):103-12.
    View in: PubMed
  775. SIRCHIA G, FERRONE S, MERCURIALI F. THE ACTION OF TWO SULFHYDRYL COMPOUNDS ON NORMAL HUMAN RED CELLS. RELATIONSHIP TO RED CELLS OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA. Blood. 1965 Apr; 25:502-10.
    View in: PubMed
  776. Sirchia G, Ferrone S, Zanella A. [Normal human erythrocytes treated with sulfhydryl compounds. Study of the kinetics of hemolysis and of the hemolytic system in relation to the erythrocytes of nocturnal paroxysmal hemoglobinuria]. Haematol Lat. 1965 Jan-Mar; 8(1):53-63.
    View in: PubMed
  777. SIRCHIA G, FERRONE S, MERCURIALI F. [SOME OBSERVATIONS ON THE DIFFERENT HEMOLYTIC CAPACITY OF DIVERSE SERUMS TOWARD ERYTHROCYTES OF NOCTURNAL PAROXYSMAL HEMOGLOBINURIA. PRELIMINARY NOTE]. Minerva Med. 1964 Nov 21; 55:3709-10.
    View in: PubMed
  778. Sirchia G, Mercuriali F, Ferrone S. The erythrocytic reduced glutathione in paroxysmal nocturnal hemoglobinuria. Haematol Lat. 1964 Oct-Dec; 7(4):273-6.
    View in: PubMed
  779. SIRCHIA G, MONTELLA S, FERRONE S, MERCURIALI F. [NOCTURNAL PAROXYSMAL HEMOGLOBINURIA. STUDY OF 2 CASES]. Haematol Lat. 1964 Jul-Sep; 7:203-17.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Ferrone's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department